Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
A4GALT	"A14GALT, Gb3S, P(k), P1"	ENSG00000128274	"Alpha 1,4-galactosyltransferase (P blood group)"	Q9NPC4	22	42692121-42721298	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 70.7;Proximal tubular cells: 91.0;Urothelial cells: 74.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 38.7;ASC TERT1: 31.3;RPTEC TERT1: 27.1;TIME: 29.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001141			Uncertain	Mitochondria		NA	NA		22000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 72: Non-specific - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Mitochondria		"HPA001141: AB_1078139"	"unprognostic (2.59e-2)"	"prognostic favorable (2.48e-4)"	"unprognostic (2.24e-2)"	"unprognostic (4.54e-3)"	"unprognostic (7.41e-2)"	"unprognostic (1.53e-1)"	"unprognostic (8.20e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.28e-1)"	"unprognostic (4.82e-3)"	"unprognostic (4.16e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.96e-1)"	"unprognostic (8.72e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.74e-1)"	41.5	14.3	6.2	6.1	6.0	4.1	31.3	5.0	8.0	29.6	8.0	30.9	4.5	28.1	3.3	30.6	29.2	4.4	77.0	6.2	5.3	51.3	4.3	26.0	6.8	7.8	5.8	7.8	6.2	1.2	16.7	9.1	5.6	35.1	1.7	0.3	36.1	21.3	19.4	20.8	18.2	6.9	6.0	16.2	26.6	6.2	7.1	1.6	25.1	6.3	5.1	38.1	38.2	6.0	1.2	13.6	0.0	0.0	38.7	31.3	20.1	5.5	5.8	1.2	2.1	4.3	2.2	13.6	9.4	9.7	6.7	1.3	12.9	6.5	0.2	0.0	2.7	0.3	21.1	0.5	11.5	0.0	0.9	18.6	1.8	5.5	0.9	1.8	4.7	0.0	0.1	0.0	5.1	19.0	0.0	0.0	1.6	0.9	3.3	0.0	3.0	1.4	27.1	23.4	0.2	0.0	16.9	0.3	0.0	2.4	10.6	1.6	29.3	0.0	2.6	24.3	7.3	2.8	13.1	0.1	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.9	0.0	0.0	6.2	6.0	5.0	8.0	6.2	5.3	7.8	5.8	5.6	6.0	7.1	6.0	47.1	0.0	0.5	0.3	1.6	9.2	28.9	70.7	0.0	0.1	4.2	1.5	15.8	1.5	41.2	18.4	0.0	48.7	0.4	0.2	13.7	23.1	0.7	11.1	10.3	43.7	0.0	10.7	0.1	1.1	35.3	43.8	2.6	17.4	1.3	0.2	30.7	0.2	5.3	0.0	0.1	0.0	14.2	1.0	11.8	4.4	46.3	4.0	7.2	7.5	30.0	0.8	0.0	0.5	0.0	3.6	0.0	30.1	0.1	40.1	0.0	91.0	12.1	0.6	39.5	7.6	29.3	0.6	0.6	1.2	8.8	9.4	1.5	19.9	0.1	74.7
A4GNT	alpha4GnT	ENSG00000118017	Alpha-1,4-N-acetylglucosaminyltransferase	Q9UNA3	3	138123713-138132390	"Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"stomach 1: 23.6"	"Group enriched"	"Detected in some"	25	"Cholangiocytes: 4.3;Gastric mucus-secreting cells: 16.3"	"Group enriched"	"Detected in some"	6	"pancreatic cancer: 2.5;stomach cancer: 3.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA008017	Enhanced				"Intracellular and membrane"	NA	NA				"Cluster 4: Stomach - Digestion"		"Cluster 16: Pancreatic endocrine cells - Mixed function"			"HPA008017: AB_1078073"	"unprognostic (1.21e-1)"	"unprognostic (2.52e-1)"			"unprognostic (2.14e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.48e-2)"	"unprognostic (8.79e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.85e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.03e-1)"	"unprognostic (7.79e-2)"	"unprognostic (2.55e-2)"	"unprognostic (6.48e-3)"	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.1	2.7	0.1	0.0	0.0	0.0	1.9	0.0	0.0	0.0	1.4	0.1	0.2	0.0	0.2	0.4	0.1	3.2	0.0	0.0	0.0	0.1	0.1	0.0	0.9	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.2	23.6	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.4	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	16.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ACER1	ASAH3	ENSG00000167769	"Alkaline ceramidase 1"	Q8TDN7	19	6306142-6333612	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"skin 1: 88.1"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 2.7;Inhibitory neurons: 2.1;Melanocytes: 1.8;Spermatocytes: 1.7;Suprabasal keratinocytes: 5.8"	"Group enriched"	"Detected in some"	7	"head and neck cancer: 1.0;melanoma: 2.2;prostate cancer: 0.6"	"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Lineage enriched"	"Detected in single"	4	"T-cells: 1.2"	"Cell line enhanced"	"Detected in single"		"T-47d: 2.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 61: Skin - Cornification"	"Cluster 6: T47d - Mammary gland"	"Cluster 51: Myeloid cells - Hemostasis"				"unprognostic (1.13e-2)"	"unprognostic (2.87e-4)"		"unprognostic (5.04e-2)"	"unprognostic (6.18e-2)"	"unprognostic (8.16e-4)"	"unprognostic (7.27e-4)"	"unprognostic (2.17e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.02e-4)"	"unprognostic (1.02e-1)"	"unprognostic (1.30e-5)"	"unprognostic (2.11e-1)"	"unprognostic (4.44e-2)"	"unprognostic (4.22e-1)"	"unprognostic (2.24e-1)"	0.1	0.1	0.1	0.1	0.1	0.1	3.3	0.4	0.2	3.4	0.3	0.0	0.0	0.2	0.2	12.2	0.2	0.0	0.0	0.1	0.1	0.0	0.5	0.0	0.5	0.1	0.1	0.3	0.0	0.0	0.1	0.0	0.2	1.7	0.0	0.0	3.2	0.1	0.5	88.1	0.2	0.1	0.0	0.3	0.0	1.1	0.2	1.3	0.0	0.0	0.7	0.0	5.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	1.2	0.5	0.0	0.1	0.7	0.7	0.1	0.3	0.0	0.1	0.8	0.2	0.1	0.1	0.4	0.2	0.1	0.1	0.1	0.1	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.2	0.0	0.0	2.7	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	2.1	0.0	0.0	0.0	0.5	0.1	0.9	1.0	1.8	0.0	0.0	0.0	0.0	1.0	0.5	0.1	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.0	0.0	1.7	1.0	0.0	5.8	0.0	0.4	0.0	0.0	0.1
ACER2	"ALKCDase2, ASAH3L, FLJ41587"	ENSG00000177076	"Alkaline ceramidase 2"	Q5QJU3	9	19409009-19452505	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"stomach 1: 61.8;urinary bladder: 39.2"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 19.7;Gastric mucus-secreting cells: 21.9;Inhibitory neurons: 10.3;Microglial cells: 26.2;Oligodendrocytes: 7.0"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 15.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"BEWO: 29.7;RT4: 73.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 4: Stomach - Digestion"	"Cluster 15: RT4 - Unknown function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"				"unprognostic (1.94e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.95e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.90e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.42e-2)"	"unprognostic (8.46e-3)"	6.9	1.4	4.5	1.1	3.4	0.6	5.0	2.7	5.0	1.7	2.0	3.3	4.5	1.4	4.2	2.2	3.7	1.7	2.9	4.4	3.1	1.9	2.4	2.2	1.0	3.2	3.1	1.0	6.8	2.5	1.1	9.7	4.3	3.7	4.3	3.8	1.9	4.5	1.2	5.9	2.7	1.3	2.8	1.4	61.8	1.9	5.9	2.4	2.5	1.0	1.3	39.2	1.7	3.7	1.2	2.0	3.9	2.0	6.2	0.5	29.7	2.1	1.4	0.7	1.0	0.6	1.9	1.3	0.7	0.3	0.4	4.5	0.8	5.8	1.5	2.4	1.1	2.1	1.6	3.0	1.3	0.5	2.0	1.8	5.6	2.2	2.4	0.6	6.2	2.1	3.1	3.8	2.0	1.7	3.6	1.8	3.1	11.1	0.9	3.2	1.0	0.7	0.6	73.6	6.9	1.8	0.4	2.2	0.5	9.3	2.7	2.5	3.1	0.5	1.5	0.6	0.9	1.4	1.7	1.4	0.6	1.5	1.3	0.0	0.0	0.0	0.1	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	4.5	3.4	2.7	5.0	4.4	3.1	3.2	3.1	4.3	2.8	5.9	3.7	3.2	0.0	0.0	1.0	0.7	0.3	0.4	0.1	0.6	1.0	0.3	0.4	0.1	0.0	0.1	0.0	2.1	0.5	0.4	0.0	0.0	0.1	2.6	0.3	0.2	0.8	0.0	0.8	19.7	0.0	0.6	0.3	21.9	0.4	0.0	0.0	1.4	0.0	0.1	0.0	10.3	0.0	0.0	0.0	0.0	4.0	0.3	0.2	0.0	26.2	0.0	0.6	0.0	5.5	7.0	0.1	0.0	0.0	0.4	0.2	0.0	0.1	0.1	0.6	0.0	0.6	0.4	0.4	0.4	0.8	0.0	4.0	0.3	0.0	0.0	1.1
ACER3	"APHC, FLJ11238, PHCA"	ENSG00000078124	"Alkaline ceramidase 3"	Q9NUN7	11	76860859-77026797	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	Hydrolase	"Disease variant, Leukodystrophy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocyte precursor cells: 159.3;Oligodendrocytes: 335.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070087	Approved					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA070087: AB_2732147"	"unprognostic (1.32e-1)"	"unprognostic (1.51e-1)"	"unprognostic (9.54e-3)"	"unprognostic (1.37e-1)"	"unprognostic (4.06e-2)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (2.49e-4)"	"unprognostic (7.13e-2)"	"unprognostic (2.35e-3)"	"unprognostic (8.45e-3)"	"unprognostic (1.30e-1)"	"unprognostic (3.68e-3)"	"prognostic unfavorable (2.73e-4)"	"unprognostic (5.24e-2)"	"unprognostic (3.37e-1)"	"unprognostic (9.88e-2)"	"unprognostic (7.97e-2)"	10.9	3.0	6.2	4.8	8.5	3.0	5.4	8.5	9.3	5.2	4.0	6.4	6.2	4.2	3.1	6.9	4.1	3.2	3.4	6.3	8.5	4.7	2.5	8.0	4.2	8.6	7.1	2.3	2.9	3.5	2.1	6.2	9.5	4.1	5.5	2.3	4.2	2.3	1.6	2.9	4.6	3.9	8.4	5.6	3.4	6.0	7.3	2.2	3.3	1.2	3.8	4.5	4.4	12.0	7.3	7.7	6.4	7.6	29.2	14.0	5.7	11.2	10.7	8.2	9.2	6.0	7.3	6.4	8.4	8.0	10.3	12.9	10.9	10.6	10.0	8.6	4.3	9.0	4.8	3.6	8.1	9.3	15.0	6.3	5.0	11.8	10.9	4.8	16.8	5.8	6.1	4.2	9.9	5.9	0.7	6.2	3.6	19.3	8.8	4.3	22.8	5.0	6.8	7.2	2.2	5.5	13.9	12.6	3.5	4.9	10.7	5.1	22.2	8.2	6.4	23.3	8.3	3.1	7.1	8.6	5.1	4.7	8.9	0.1	4.3	2.5	0.7	3.1	0.8	1.2	0.5	0.9	4.6	0.4	0.3	0.4	0.9	0.2	2.4	1.5	1.2	1.6	6.2	8.5	8.5	9.3	6.3	8.5	8.6	7.1	9.5	8.4	7.3	12.0	32.4	41.7	35.0	52.9	11.5	31.9	21.4	17.0	33.0	18.8	11.3	11.0	7.5	11.5	27.6	9.2	10.4	13.6	11.3	54.6	7.9	15.5	66.8	6.3	29.0	29.4	2.4	13.5	65.0	17.6	7.5	17.0	26.0	11.5	83.5	30.9	27.8	10.0	44.4	43.7	71.9	30.5	18.3	64.1	67.1	31.7	20.2	64.0	17.8	61.8	40.0	11.3	12.3	159.3	335.1	18.6	37.9	25.9	8.6	15.6	20.0	15.3	12.3	10.0	6.6	17.0	21.0	69.8	25.9	26.3	16.8	26.8	15.2	7.2	20.1	24.1
ALG1L	ALG1L1	ENSG00000189366	"ALG1 chitobiosyldiphosphodolichol beta-mannosyltransferase like"	Q6GMV1	3	125929275-125937039	"Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"epididymis: 10.8;urinary bladder: 9.4"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 33.6;Club cells: 15.2;Endometrial ciliated cells: 10.5;Ionocytes: 12.2;Respiratory ciliated cells: 46.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 15.9;CAPAN-2: 14.3;HaCaT: 15.2;MCF7: 30.1;OE19: 19.1;T-47d: 19.7"									HPA036108	Uncertain					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA036108: AB_10673344"	"unprognostic (7.06e-3)"	"unprognostic (1.50e-3)"	"unprognostic (1.47e-1)"	"unprognostic (4.14e-2)"	"prognostic favorable (3.00e-4)"	"unprognostic (2.40e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.37e-2)"	"unprognostic (5.79e-2)"	"unprognostic (4.50e-6)"	"unprognostic (1.35e-1)"	"unprognostic (3.30e-1)"	"unprognostic (1.57e-2)"	"prognostic favorable (6.24e-4)"	0.5	1.1	2.5	1.1	2.7	0.3	1.4	2.0	3.0	1.6	1.4	1.4	0.4	1.4	10.8	1.6	2.2	0.8	0.7	2.4	2.6	1.7	1.4	1.0	0.4	2.5	2.4	2.3	1.3	0.6	1.8	1.5	2.5	1.8	0.8	0.6	1.9	0.9	6.7	5.8	0.5	0.5	2.1	0.3	1.5	1.2	2.4	1.1	1.6	2.6	2.7	9.4	1.5	2.5	1.1	0.8	0.4	0.0	0.0	0.2	1.8	0.1	0.0	0.2	0.4	15.9	14.3	4.4	6.8	0.0	0.3	15.2	0.4	0.0	0.8	0.6	3.6	0.8	2.4	0.0	0.2	0.2	0.2	0.1	0.1	0.0	0.1	0.0	0.0	4.1	1.2	1.4	0.0	30.1	1.0	0.3	6.4	19.1	3.8	0.1	0.1	7.4	0.0	0.9	2.4	0.9	0.5	0.2	0.7	3.2	19.7	0.4	0.3	0.2	2.2	0.2	0.1	10.9	1.7	5.9	0.2	0.0	1.0	2.5	0.0	0.1	2.0	0.1	1.1	1.6	1.0	2.2	0.0	0.9	1.2	0.7	0.4	3.2	0.0	1.3	2.7	0.9	2.5	2.7	2.0	3.0	2.4	2.6	2.5	2.4	2.5	2.1	2.4	2.5	0.2	0.0	0.5	0.3	0.7	3.3	1.7	33.6	0.6	0.3	2.1	2.4	0.0	0.0	15.2	1.8	0.0	3.5	0.5	0.3	1.9	0.4	1.7	10.5	0.8	0.3	1.8	0.0	1.2	0.4	2.0	1.1	0.0	0.4	1.3	1.4	0.0	0.1	0.3	0.0	1.7	0.2	12.2	0.0	1.2	1.8	1.8	0.1	1.8	0.0	0.2	1.5	2.1	1.0	0.6	0.6	1.4	3.0	0.4	0.5	0.0	1.0	46.0	0.0	0.0	2.7	2.6	1.4	1.6	0.3	5.1	1.4	0.5	2.4	0.4	8.2
ALG1L2		ENSG00000251287	"ALG1 chitobiosyldiphosphodolichol beta-mannosyltransferase like 2"	C9J202	3	130081831-130113227	"Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 1.4;retina: 2.5"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 6.0;Erythroid cells: 6.1;Granulosa cells: 16.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.0"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"											HPA060392	Uncertain		Uncertain	"Nucleoli fibrillar center,Endoplasmic reticulum"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 77: Retina - Visual perception"		"Cluster 40: Granulosa cells - Unknown function"	"Endoplasmic reticulum"	"Nucleoli fibrillar center"	"HPA060392: AB_2684273"	"unprognostic (1.05e-1)"	"unprognostic (5.13e-2)"	"unprognostic (5.44e-3)"	"unprognostic (8.15e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.38e-1)"	"unprognostic (3.91e-1)"	"prognostic favorable (7.75e-4)"	"unprognostic (4.58e-2)"	"unprognostic (4.17e-2)"	"unprognostic (5.93e-4)"	"unprognostic (1.24e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.35e-2)"	"unprognostic (4.28e-3)"	0.0	0.0	0.1	0.2	0.5	0.3	0.0	0.1	0.3	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.2	0.0	0.1	0.5	0.1	0.3	0.0	1.4	0.3	0.2	0.2	0.0	0.5	0.7	1.2	0.0	2.6	0.7	1.7	0.0	6.0	0.0	0.0	1.7	1.4	1.7	0.4	0.0	0.6	1.8	4.2	0.3	0.9	0.8	1.9	0.2	0.4	0.7	3.0	0.9	0.0	6.1	0.8	0.0	0.3	1.7	1.5	0.9	0.0	16.7	0.7	0.4	0.2	5.0	0.6	1.4	0.0	0.0	0.0	0.0	3.7	0.9	0.0	0.0	0.3	3.2	0.0	0.5	0.8	0.0	0.0	2.6	1.1	3.3	1.2	1.1	0.7	3.0	0.0	3.3	2.2	1.3	0.2	0.5	0.0	0.0	1.5	1.5	1.5	1.7
ARSA		ENSG00000100299	"Arylsulfatase A"	P15289	22	50622754-50628173	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease variant, Ichthyosis, Leukodystrophy, Metachromatic leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 127.5;Plasma cells: 132.0;Proximal enterocytes: 93.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 80.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005554, CAB025183"	Enhanced		Uncertain	"Golgi apparatus,Cytosol"	"Intracellular and membrane"	NA	NA		5600000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 71: Testis - DNA repair"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Golgi apparatus"	Cytosol	"CAB025183: , HPA005554: AB_1078220"	"unprognostic (1.55e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.07e-2)"	"prognostic favorable (2.96e-5)"	"unprognostic (4.66e-2)"	"unprognostic (4.40e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.61e-2)"	"unprognostic (2.16e-1)"	"unprognostic (4.47e-2)"	"unprognostic (2.76e-1)"	"unprognostic (9.90e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.87e-1)"	"unprognostic (7.73e-3)"	28.8	25.1	14.4	15.6	18.0	18.4	27.2	16.8	21.8	21.3	27.5	31.3	30.8	22.4	8.6	28.1	25.1	15.7	33.0	14.9	15.2	31.4	42.8	29.1	19.8	20.0	15.9	11.3	46.7	11.7	34.7	10.9	19.1	28.9	8.2	4.4	39.6	16.2	25.3	17.5	33.8	6.5	16.3	44.5	30.3	54.0	19.4	9.8	32.3	5.1	9.5	23.9	24.7	21.0	8.5	11.0	5.3	10.9	41.8	21.8	13.5	13.0	15.9	5.7	9.3	3.3	12.9	5.3	8.2	22.9	10.8	12.8	1.2	12.3	1.0	2.7	8.0	3.4	14.3	12.5	28.3	5.2	32.7	26.0	24.4	9.5	6.3	19.9	12.8	11.5	3.5	80.4	12.1	9.6	4.6	5.8	1.7	9.0	11.2	4.0	0.4	26.7	9.9	13.5	2.5	8.2	18.2	17.2	10.1	5.1	7.7	6.6	22.1	3.8	15.1	14.9	4.1	18.4	1.9	4.5	11.7	4.3	13.6	10.4	27.7	36.1	17.3	33.3	15.1	10.4	12.4	14.2	22.7	12.5	7.3	10.0	60.4	8.9	43.2	32.1	18.2	16.3	14.4	18.0	16.8	21.8	14.9	15.2	20.0	15.9	19.1	16.3	19.4	21.0	22.8	6.4	12.9	24.5	22.2	4.7	14.0	23.8	18.8	5.3	18.9	13.1	8.0	27.1	15.5	12.9	4.2	11.5	14.0	85.4	1.9	29.4	62.4	24.4	10.3	13.4	36.7	9.7	9.4	21.3	19.9	19.6	41.3	21.3	6.3	15.3	8.2	28.6	36.8	6.7	8.6	30.6	14.2	29.0	9.5	127.5	10.8	29.2	17.8	10.3	28.7	10.3	8.2	8.0	11.9	24.2	75.2	6.0	132.0	10.8	93.9	22.7	21.2	7.2	0.0	6.6	9.9	48.3	4.1	18.3	5.5	13.3	17.2	7.2	25.0	16.1
ASAH1	"AC, ACDase, ASAH, FLJ21558, PHP32"	ENSG00000104763	"N-acylsphingosine amidohydrolase 1"	Q13510	8	18055992-18084998	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid metabolism, Sphingolipid metabolism"	Hydrolase	"Disease variant, Epilepsy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 573.9"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 777.0;Hofbauer cells: 921.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 392.8;SK-MEL-30: 590.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005468	Supported				"Intracellular and membrane"	NA	NA		400000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 4: Macrophages - Innate immune response"			"HPA005468: AB_1845062"	"unprognostic (1.99e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.15e-3)"	"unprognostic (9.23e-2)"	"unprognostic (4.69e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.25e-2)"	"unprognostic (4.29e-3)"	"unprognostic (2.44e-1)"	"unprognostic (4.85e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.03e-2)"	"prognostic favorable (3.08e-8)"	"unprognostic (1.95e-1)"	"unprognostic (3.91e-2)"	"unprognostic (6.54e-3)"	"unprognostic (7.36e-3)"	214.3	71.9	50.1	51.6	51.5	107.7	95.8	62.1	50.8	98.5	62.6	84.3	54.7	55.8	131.5	73.2	70.4	99.1	573.9	49.9	66.2	204.0	60.9	190.3	65.9	66.0	59.4	50.1	49.6	117.8	83.6	121.5	69.0	84.3	87.0	79.5	66.6	77.9	66.0	52.6	56.8	61.7	66.3	85.4	61.2	18.2	59.1	26.0	325.5	70.7	57.7	112.8	54.8	102.2	48.1	66.4	25.9	63.3	392.8	46.0	39.2	48.2	67.3	23.0	41.0	35.4	66.1	30.2	60.3	54.5	159.1	62.6	15.0	25.3	28.4	22.9	38.9	134.4	46.7	96.7	107.5	27.7	140.7	100.2	86.5	33.6	22.9	53.2	6.2	50.6	24.3	61.7	67.9	46.0	15.5	48.3	30.3	105.2	40.5	19.4	25.5	41.4	112.0	273.0	40.4	55.0	43.8	145.2	590.5	35.6	47.9	31.3	43.6	30.3	43.1	55.8	23.7	75.5	184.3	22.0	89.5	61.3	24.6	285.2	455.4	318.7	47.6	676.4	43.1	83.9	35.5	36.1	175.1	65.9	40.8	37.9	627.6	60.5	731.4	33.0	43.7	407.2	50.1	51.5	62.1	50.8	49.9	66.2	66.0	59.4	69.0	66.3	59.1	102.2	98.5	317.3	405.0	36.9	92.8	58.6	83.3	103.7	35.3	97.5	105.6	87.8	777.0	100.1	280.9	450.6	45.9	177.4	67.6	83.4	60.7	150.6	2.8	85.7	51.5	79.7	98.1	106.3	49.8	104.1	65.2	122.0	43.3	133.8	257.0	49.3	134.6	50.6	921.2	77.4	53.2	99.3	201.4	564.3	89.9	6.0	88.6	524.6	318.4	56.2	259.2	532.6	53.5	49.8	49.0	64.7	125.5	105.7	87.4	87.8	77.6	304.2	147.3	88.0	177.5	74.5	157.0	14.0	63.6	84.9	64.2	148.2	61.3	53.4	89.7	139.9
ASAH2		ENSG00000188611	"N-acylsphingosine amidohydrolase 2"	Q9NR71	10	50182778-50279720	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Lipid metabolism, Sphingolipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"intestine: 81.5"	"Cell type enhanced"	"Detected in some"		"Late spermatids: 12.5;Muller glia cells: 9.0;Proximal enterocytes: 17.1;Sertoli cells: 6.6"	"Low cancer specificity"	"Detected in single"			"Region enhanced"	"Detected in many"		"cerebellum: 8.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA061171	Supported		Approved	"Focal adhesion sites"	"Intracellular and membrane"	NA	NA		2200000	"Cluster 32: T-cells - Unknown function"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 45: Enterocytes - Digestion"	"Focal adhesion sites"		"HPA061171: AB_2684442"	"unprognostic (3.59e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.84e-2)"	"unprognostic (3.66e-1)"	"unprognostic (4.48e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.65e-2)"	"unprognostic (4.33e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.29e-2)"	"unprognostic (1.86e-2)"	"unprognostic (5.64e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.02e-3)"	0.4	0.8	0.0	0.2	1.1	0.0	0.5	8.1	0.4	0.7	0.1	0.8	81.5	0.8	0.5	0.7	0.8	0.3	0.8	0.1	0.4	0.5	2.9	0.6	0.3	3.2	2.9	0.8	1.4	0.6	0.6	0.6	2.2	0.4	0.4	7.3	0.6	0.2	0.8	0.7	64.6	1.2	1.5	0.2	5.0	0.8	0.6	0.5	0.7	0.4	0.1	0.5	0.4	0.6	1.2	0.9	1.0	1.4	1.8	0.7	1.3	1.2	0.9	2.5	2.2	0.7	3.0	0.0	1.4	1.9	2.0	1.1	1.4	0.4	3.0	1.6	2.5	0.9	2.2	1.9	1.1	0.3	0.1	0.2	1.7	4.3	4.8	0.3	0.5	0.0	1.7	0.8	1.7	1.1	1.0	0.0	3.2	0.0	2.7	0.0	4.2	1.1	1.3	0.2	1.8	4.8	1.7	1.2	2.1	2.4	1.0	0.7	1.4	1.2	2.8	3.2	4.0	1.2	0.1	0.0	3.5	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.4	0.2	0.0	0.3	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.2	0.1	0.0	0.0	1.1	8.1	0.4	0.1	0.4	3.2	2.9	2.2	1.5	0.6	0.6	0.1	0.0	0.0	0.7	0.0	0.4	0.3	0.4	0.0	2.8	0.4	0.3	3.8	0.0	0.9	0.0	2.1	0.4	1.4	0.5	0.0	0.9	4.8	0.1	0.2	0.5	0.0	3.2	1.1	1.6	0.3	0.6	0.0	0.2	0.0	0.2	0.4	2.1	0.2	1.7	1.5	1.8	0.0	0.0	0.0	12.5	1.2	0.0	0.0	0.0	0.0	9.0	1.0	0.0	0.2	1.6	0.1	1.5	0.0	0.3	17.1	1.0	0.7	2.1	6.6	0.6	0.9	1.9	0.9	0.0	0.1	0.3	0.5	0.2	1.2	0.2
B3GALNT1	"B3GALT3, beta3Gal-T3, galT3, GLOB, P1"	ENSG00000169255	"Beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)"	O75752	3	161083883-161105411	"Blood group antigen proteins, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Blood group antigen, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 53.3"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 56.3;Cardiomyocytes: 56.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"basophil: 8.8;NK-cell: 22.1"	"Group enriched"	"Detected in many"	7	"granulocytes: 8.8;NK-cells: 22.1"	"Cell line enhanced"	"Detected in many"		"RT4: 128.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041204			Approved	Vesicles		NA	NA		400000	"Cluster 48: NK-cells - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 15: RT4 - Unknown function"	"Cluster 56: Bipolar cells - Visual perception"	Vesicles		"HPA041204: AB_10795585"	"unprognostic (3.85e-2)"	"unprognostic (5.11e-3)"	"unprognostic (3.02e-1)"	"unprognostic (1.06e-2)"	"unprognostic (7.83e-2)"	"unprognostic (4.07e-2)"	"unprognostic (9.26e-5)"	"unprognostic (1.49e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.88e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.24e-1)"	"unprognostic (2.09e-3)"	"unprognostic (1.32e-1)"	"unprognostic (4.90e-2)"	"unprognostic (3.66e-2)"	"unprognostic (3.19e-3)"	5.3	7.2	20.7	3.9	21.5	4.8	9.8	14.7	19.6	20.1	8.0	2.7	1.9	9.9	8.5	6.8	14.2	9.9	53.3	21.7	26.7	19.4	1.2	14.6	4.9	12.8	21.7	18.8	11.1	8.6	9.8	13.9	18.0	11.6	2.4	26.6	22.3	8.5	1.4	2.5	2.4	9.9	14.1	6.2	10.7	8.4	25.7	2.8	27.0	3.2	5.4	12.3	5.4	13.0	17.3	0.3	7.5	0.1	1.0	2.8	0.1	9.3	8.7	22.3	7.3	11.3	13.2	0.0	35.7	8.0	12.7	3.9	0.0	16.9	7.5	0.0	0.0	9.0	5.7	0.0	11.2	0.2	0.0	23.3	5.4	6.1	1.4	15.6	31.6	0.0	0.0	0.0	8.3	29.4	0.1	0.0	17.4	0.2	38.9	0.1	0.0	0.2	9.3	128.3	15.1	0.1	23.7	8.8	6.3	3.0	35.6	13.3	0.0	0.2	15.5	0.5	0.2	3.6	0.1	0.2	14.7	0.0	0.0	8.8	0.2	0.0	0.4	0.2	0.4	2.3	0.2	0.4	1.7	0.2	0.4	0.9	0.4	22.1	0.1	1.1	0.0	0.7	20.7	21.5	14.7	19.6	21.7	26.7	12.8	21.7	18.0	14.1	25.7	13.0	5.0	19.2	2.2	10.1	2.1	5.0	5.2	5.7	6.2	56.3	7.5	6.2	56.9	0.0	8.0	14.7	12.5	21.2	1.2	0.1	11.7	3.5	0.7	4.9	5.8	7.7	1.8	17.0	22.3	8.5	13.0	13.3	4.6	8.7	10.2	13.0	6.1	0.2	9.8	6.7	27.5	0.1	6.1	2.1	6.8	2.2	7.2	3.4	10.6	9.4	4.3	12.6	1.0	14.6	3.2	9.8	0.1	5.3	0.2	6.2	0.1	15.8	3.1	8.4	0.0	5.3	13.2	6.5	20.7	8.4	2.6	5.1	1.2	4.6	0.7	4.5
B3GALNT2	MGC39558	ENSG00000162885	"Beta-1,3-N-acetylgalactosaminyltransferase 2"	Q8NCR0	1	235447190-235504452	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"	"Congenital muscular dystrophy, Disease variant, Dystroglycanopathy, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Cone photoreceptor cells: 252.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007846, HPA050662"	Approved		Uncertain	"Golgi apparatus"	"Intracellular and membrane"	NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 20: HeLa - Mitochondria"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Golgi apparatus"		"HPA007846: , HPA050662: AB_2681209"	"unprognostic (5.50e-2)"	"unprognostic (3.16e-3)"	"unprognostic (6.60e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.28e-1)"	"unprognostic (7.59e-3)"	"unprognostic (1.96e-2)"	"unprognostic (3.39e-2)"	"unprognostic (3.38e-1)"	"unprognostic (7.19e-3)"	"unprognostic (2.89e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.52e-2)"	"unprognostic (3.40e-1)"	"unprognostic (3.53e-3)"	"unprognostic (8.34e-3)"	4.7	5.4	2.3	2.8	2.2	1.6	4.0	2.5	2.4	5.3	5.7	8.1	3.2	7.3	4.8	8.9	5.5	5.3	6.1	2.4	2.6	3.3	3.2	3.4	2.2	2.4	2.7	5.1	22.3	6.7	3.8	4.3	2.3	7.3	5.3	3.9	6.0	6.6	23.3	6.2	5.1	10.6	2.3	2.7	8.9	5.9	2.5	3.6	7.3	16.7	3.4	7.9	5.4	2.2	15.0	10.4	11.1	16.2	14.2	15.7	21.6	14.1	11.8	9.8	10.0	7.7	13.1	8.2	15.3	15.5	7.0	17.3	21.3	14.8	12.5	14.5	11.7	5.8	12.7	9.3	10.0	17.9	4.3	9.9	9.5	10.4	21.5	7.0	14.1	19.2	10.9	10.9	9.2	7.3	10.0	8.8	15.7	7.9	3.1	10.6	19.9	18.8	6.4	21.1	14.2	16.8	23.7	7.8	12.2	3.9	18.5	15.6	13.1	9.7	13.3	16.6	18.1	11.3	14.8	5.0	6.7	12.1	21.7	1.1	1.1	0.5	0.6	1.6	0.8	0.6	0.6	0.7	2.3	0.5	0.5	0.9	0.2	1.2	1.4	1.9	0.3	0.4	2.3	2.2	2.5	2.4	2.4	2.6	2.4	2.7	2.3	2.3	2.5	2.2	9.6	9.6	5.0	38.8	7.8	31.2	39.0	15.1	36.5	33.1	8.9	6.7	6.7	1.5	9.5	5.5	252.3	20.3	14.6	5.2	0.0	6.9	26.7	20.2	14.8	7.0	9.0	5.0	38.4	7.2	7.0	11.5	10.7	19.9	5.7	11.9	4.6	4.7	3.9	28.6	56.2	6.2	4.1	3.0	16.3	7.3	10.5	6.9	1.8	23.4	11.5	11.2	7.2	29.1	21.7	9.2	5.4	16.1	14.0	27.6	9.7	2.3	8.1	18.4	0.0	21.0	20.5	35.8	40.3	28.5	29.7	22.4	9.0	17.6	7.0	33.1
B3GALT1	beta3Gal-T1	ENSG00000172318	"Beta-1,3-galactosyltransferase 1"	Q9Y5Z6	2	167868948-167874041	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 5.8;skeletal muscle: 5.2;tongue: 17.8"	"Group enriched"	"Detected in some"	6	"Astrocytes: 920.7;Excitatory neurons: 519.3;Inhibitory neurons: 723.8"	"Cancer enhanced"	"Detected in some"		"glioma: 2.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"AN3-CA: 35.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 47: Non-specific - Unknown function"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"				"unprognostic (1.98e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.12e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.23e-3)"	"unprognostic (2.49e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.94e-2)"	"unprognostic (8.72e-2)"	"unprognostic (6.44e-2)"	"unprognostic (2.30e-3)"	"unprognostic (8.34e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.79e-1)"	0.2	0.5	4.0	0.2	5.4	0.1	0.4	2.0	5.8	0.3	0.0	3.6	0.0	0.2	0.4	0.1	0.6	0.0	0.0	5.8	3.0	0.1	0.0	0.1	0.0	2.4	2.9	0.2	0.3	0.0	1.8	0.0	1.4	0.2	3.6	2.4	0.2	0.7	5.2	0.2	0.2	0.2	2.0	0.2	0.0	0.5	2.6	0.0	0.2	17.8	0.0	0.0	0.2	3.4	0.0	0.0	2.8	35.7	0.3	0.0	0.0	0.5	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.0	1.4	0.1	0.0	0.0	0.0	0.0	4.6	0.0	1.2	0.0	0.2	0.0	0.5	0.0	2.3	0.4	0.0	0.0	0.7	1.6	0.0	0.0	0.0	0.2	0.1	0.3	0.4	0.0	0.8	0.0	0.7	0.0	3.3	0.5	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.2	0.3	0.2	0.2	0.1	0.0	0.1	0.1	0.0	4.0	5.4	2.0	5.8	5.8	3.0	2.4	2.9	1.4	2.0	2.6	3.4	0.2	0.0	1.3	920.7	0.2	0.1	0.0	0.0	0.0	3.0	0.1	2.4	0.8	0.0	0.0	0.0	0.0	0.0	0.1	18.3	0.0	0.1	0.5	0.1	0.6	0.7	0.0	0.0	519.3	0.2	0.0	0.5	0.0	0.4	1.3	0.0	0.0	0.0	0.1	1.7	723.8	3.8	0.0	0.0	0.3	0.0	0.6	0.3	1.8	39.4	0.0	2.4	0.0	108.0	30.3	0.0	3.4	1.5	0.0	0.4	0.0	0.4	0.0	1.3	0.0	1.1	0.6	0.0	1.7	0.0	0.0	0.0	0.1	0.1	7.4	0.1
B3GALT2	beta3Gal-T2	ENSG00000162630	"Beta-1,3-galactosyltransferase 2"	O43825	1	193178730-193186613	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.2;gallbladder: 15.0;heart muscle: 21.0"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 46.6;Cardiomyocytes: 34.4;Excitatory neurons: 27.6;Inhibitory neurons: 28.3;Leydig cells: 31.7;Peritubular cells: 21.1"	"Cancer enhanced"	"Detected in some"		"glioma: 2.4"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	4	"MAIT T-cell: 8.4"	"Lineage enriched"	"Detected in single"	53	"T-cells: 8.4"	"Group enriched"	"Detected in some"	4	"AF22: 18.3;ASC TERT1: 8.1;LHCN-M2: 12.6;WM-115: 21.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078659			Approved	"Plasma membrane"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 56: Bipolar cells - Visual perception"	"Plasma membrane"		"HPA078659: AB_2686887"	"unprognostic (1.83e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.67e-1)"	"unprognostic (1.58e-3)"	"unprognostic (2.34e-3)"	"unprognostic (2.43e-3)"	"unprognostic (1.63e-1)"	"unprognostic (2.44e-1)"	"unprognostic (6.14e-4)"	"unprognostic (4.41e-2)"	"unprognostic (8.10e-3)"	"unprognostic (2.72e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.56e-3)"	0.3	1.2	13.4	0.7	15.3	0.2	0.3	4.9	17.1	0.2	2.3	1.0	0.9	0.1	1.0	0.6	0.2	15.0	21.0	17.2	7.1	0.9	0.2	1.8	0.2	5.8	7.4	10.4	0.2	0.0	0.5	0.3	5.8	4.7	1.2	6.6	0.1	5.1	0.1	0.2	3.0	0.1	7.0	0.8	1.3	0.7	8.5	0.0	1.0	0.3	0.9	1.4	0.3	15.9	0.0	0.0	18.3	0.0	0.5	8.1	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	3.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	12.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	1.6	1.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.9	0.0	0.0	0.0	0.2	0.0	8.4	0.0	1.9	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.8	0.2	13.4	15.3	4.9	17.1	17.2	7.1	5.8	7.4	5.8	7.0	8.5	15.9	0.6	0.0	0.5	1.6	0.9	0.3	0.1	0.0	0.6	46.6	0.0	0.1	34.4	11.5	0.0	1.8	4.2	0.0	0.2	0.1	0.0	0.1	0.0	0.3	1.3	1.1	3.0	0.8	27.6	0.0	0.0	2.0	0.0	0.9	2.5	0.4	0.7	0.1	0.3	8.4	28.3	0.7	0.0	0.6	0.3	0.7	31.7	0.7	0.0	4.7	0.0	2.4	0.0	12.1	9.3	0.5	0.1	21.1	0.4	0.1	3.4	0.1	2.2	6.2	0.0	0.3	1.2	0.0	0.0	0.3	0.3	0.0	4.9	0.3	0.5	0.0
B3GALT4	"beta3Gal-T4, GalT4"	ENSG00000235863	"Beta-1,3-galactosyltransferase 4"	O96024	6	33277123-33284832	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 27.9"	"Cell type enhanced"	"Detected in many"		"Late spermatids: 71.8;Spermatocytes: 81.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 4.0;MOLT-4: 1.1;SCLC-21H: 2.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043001	Approved					NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA043001: AB_2678265"	"unprognostic (3.71e-2)"	"unprognostic (1.33e-2)"	"unprognostic (6.02e-2)"	"unprognostic (1.00e-1)"	"unprognostic (6.10e-3)"	"unprognostic (1.66e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.17e-3)"	"unprognostic (6.83e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.22e-2)"	"unprognostic (3.75e-2)"	9.3	8.8	0.4	0.0	0.8	0.0	8.0	1.8	1.2	8.5	0.5	11.7	0.0	8.1	0.0	19.5	6.5	0.0	8.5	0.2	0.4	7.0	1.5	7.6	0.0	1.5	0.9	3.5	3.4	0.0	5.6	0.0	1.2	9.0	0.0	0.0	12.4	0.0	2.5	15.2	10.8	0.0	0.8	12.8	9.5	27.9	0.8	0.0	7.3	0.0	0.0	9.7	11.2	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	7.7	4.6	2.4	1.8	1.8	1.8	3.1	2.5	8.8	1.8	2.4	2.8	5.0	5.7	4.7	4.5	2.0	0.4	0.8	1.8	1.2	0.2	0.4	1.5	0.9	1.2	0.8	0.8	1.3	12.6	12.8	4.8	1.3	12.0	3.2	6.3	18.9	4.0	14.5	7.6	4.2	3.8	15.7	18.9	14.7	4.2	18.4	20.2	38.2	5.9	17.7	36.8	12.1	3.1	11.1	12.6	5.2	1.0	18.4	12.9	8.2	13.3	11.0	10.2	5.0	15.0	0.4	20.3	11.8	1.4	15.8	16.2	22.3	8.6	71.8	7.8	15.2	8.8	4.7	27.2	9.8	54.6	1.5	2.1	20.0	32.6	6.0	6.2	9.1	35.5	6.1	26.0	15.0	6.6	3.3	5.9	81.2	2.7	13.2	4.8	32.0	14.2	5.1	11.2	17.0
B3GALT5	"B3GalT-V, B3T5, beta3Gal-T5, GLCT5"	ENSG00000183778	"Beta-1,3-galactosyltransferase 5"	Q9Y2C3	21	39556442-39673137	"Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"intestine: 37.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 196.4;Intestinal goblet cells: 47.4;Paneth cells: 72.5;Proximal enterocytes: 94.1;Undifferentiated cells: 57.7"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 5.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"CAPAN-2: 23.5;RPTEC TERT1: 27.1"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"basal ganglia: 8.6"	"HPA054092, HPA054684"	Approved				"Intracellular and membrane"	NA	NA				"Cluster 9: Intestine - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA054092: AB_2682375, HPA054684: AB_2682573"	"unprognostic (1.40e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.52e-1)"	"prognostic favorable (6.36e-4)"	"unprognostic (9.23e-2)"	"unprognostic (4.62e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.25e-2)"	"unprognostic (7.86e-3)"	"unprognostic (1.67e-1)"	"unprognostic (6.09e-4)"	"unprognostic (1.12e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.55e-3)"	0.0	0.3	2.5	0.9	8.6	0.0	2.6	0.7	3.7	2.2	1.9	22.4	27.3	0.7	1.3	1.6	1.3	5.5	0.0	2.4	4.6	0.2	0.1	0.1	0.0	2.0	2.1	0.3	3.3	0.0	1.8	0.0	1.3	0.4	37.4	0.8	4.5	0.1	0.0	0.8	33.7	0.8	1.3	0.0	5.0	0.4	6.9	1.0	1.2	0.3	2.0	1.3	2.3	0.7	0.0	0.9	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	23.5	0.0	0.2	0.2	2.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	6.3	0.2	0.6	0.0	2.7	0.1	27.1	1.7	4.6	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.8	0.7	0.2	1.0	0.0	0.0	0.0	1.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	8.6	0.7	3.7	2.4	4.6	2.0	2.1	1.3	1.3	6.9	0.7	0.1	0.0	0.0	6.5	0.3	0.0	0.5	0.1	0.0	7.4	8.0	8.1	2.2	10.0	5.3	5.5	0.0	0.0	0.2	196.4	0.0	7.5	0.4	0.2	5.9	0.4	28.9	0.0	3.6	4.7	0.0	0.2	13.3	0.2	4.5	0.8	0.0	0.0	0.0	0.0	4.8	47.4	0.0	0.0	0.0	1.1	0.6	0.0	0.0	0.0	0.0	1.4	0.0	11.1	1.0	9.2	72.5	0.0	0.0	0.6	94.1	0.1	1.5	0.2	0.0	0.1	0.4	0.1	1.7	0.5	0.0	0.0	0.5	0.0	57.7	9.7
B3GLCT	"B3GALTL, B3Glc-T, B3GTL"	ENSG00000187676	"Beta 3-glucosyltransferase"	Q6Y288	13	31199975-31332276	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Fucose metabolism"	"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 23.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 59.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"	NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"				"unprognostic (3.31e-2)"	"unprognostic (2.53e-1)"	"unprognostic (4.71e-2)"	"unprognostic (6.17e-3)"	"unprognostic (5.26e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.91e-1)"	"unprognostic (3.28e-3)"	"unprognostic (6.74e-2)"	"unprognostic (5.51e-3)"	"unprognostic (2.26e-1)"	"unprognostic (5.70e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.51e-1)"	3.7	2.0	8.6	3.1	11.4	3.9	4.6	6.2	7.8	3.5	12.8	3.1	2.8	12.9	3.9	3.0	6.0	3.5	18.2	8.2	6.9	6.6	3.4	3.7	3.8	6.9	11.2	4.8	3.1	8.1	3.0	7.0	7.1	3.5	3.3	8.0	3.8	6.2	4.7	3.4	2.9	12.7	8.0	3.5	3.4	3.8	13.2	4.9	4.9	2.8	5.6	2.5	3.5	8.0	4.8	6.7	27.1	4.9	5.1	5.1	4.4	11.6	13.0	13.9	9.8	3.5	13.2	19.4	8.3	13.6	26.2	7.9	6.1	7.5	12.9	59.8	11.7	1.3	5.9	5.1	3.2	7.8	10.1	5.9	8.4	8.0	6.8	14.2	12.5	9.5	3.5	3.0	11.0	6.1	11.7	2.4	7.9	7.0	4.1	10.4	8.8	0.6	6.2	6.7	2.5	11.0	10.0	4.7	13.2	6.3	2.3	8.9	17.6	14.0	9.4	6.5	11.7	2.4	5.6	7.3	4.5	5.8	18.9	1.7	0.4	1.3	2.4	0.4	3.5	1.3	1.5	2.7	0.4	0.6	1.2	1.6	0.2	1.4	0.4	0.4	0.9	1.4	8.6	11.4	6.2	7.8	8.2	6.9	6.9	11.2	7.1	8.0	13.2	8.0	4.5	0.0	3.1	0.0	6.6	0.0	3.6	0.0	14.2	10.6	5.1	3.4	23.7	2.8	0.6	9.2	16.7	0.3	7.9	2.5	1.9	4.3	12.1	9.2	5.3	6.5	1.2	1.7	0.0	4.6	2.1	9.0	5.6	4.2	0.0	3.3	8.9	5.5	3.6	0.0	0.0	1.5	0.0	3.2	0.0	2.5	1.5	3.3	0.0	0.0	0.9	5.8	6.2	0.0	0.0	5.6	2.3	3.4	6.4	2.3	2.6	2.6	1.5	4.3	13.1	4.1	5.2	2.1	13.5	7.7	0.0	0.3	6.5	2.3	1.7	1.6
B3GNT2	"B3GN-T1, B3GN-T2, B3GNT-2, B3GNT1, BETA3GNT"	ENSG00000170340	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2"	Q9NY97	2	62196115-62224731	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"REH: 115.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005997	Approved		Approved	Vesicles		NA	NA		99000000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 14: REH - Unknown function"	"Cluster 48: Smooth muscle cells - ECM organization"	Vesicles		"HPA005997: AB_1845234"	"unprognostic (1.38e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.55e-2)"	"unprognostic (2.13e-2)"	"unprognostic (3.76e-1)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (3.63e-1)"	"unprognostic (1.11e-2)"	"unprognostic (9.55e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.25e-1)"	17.3	20.8	6.6	13.3	13.6	72.7	26.1	5.9	9.8	25.9	9.0	19.4	27.7	24.6	6.2	25.1	12.7	27.4	19.0	6.8	8.6	33.4	21.8	34.2	24.1	6.9	8.3	5.9	39.7	7.6	13.2	30.6	9.7	10.8	24.3	5.2	15.5	8.2	3.2	11.0	14.4	24.1	6.1	14.9	18.2	7.6	8.5	25.5	19.5	9.0	18.3	20.1	12.8	6.7	20.7	14.0	20.9	9.3	22.5	10.0	60.0	19.8	21.8	15.4	20.5	29.2	32.5	22.3	17.8	18.5	21.6	19.4	13.3	16.6	26.5	46.8	10.8	55.1	6.4	17.2	16.8	33.2	23.8	12.3	30.7	29.6	10.5	11.0	23.4	15.3	30.4	13.7	18.9	15.7	63.7	49.6	20.0	37.4	5.8	115.0	14.4	12.3	29.2	20.1	20.1	14.9	14.1	29.9	23.5	33.4	8.6	38.7	26.7	18.6	16.4	31.7	19.9	38.2	14.4	96.2	14.6	56.5	18.4	14.9	9.0	56.2	20.0	8.6	28.0	14.8	14.7	34.6	10.6	16.6	17.3	26.0	21.3	41.0	11.7	13.3	26.2	17.6	6.6	13.6	5.9	9.8	6.8	8.6	6.9	8.3	9.7	6.1	8.5	6.7	40.3	64.1	9.8	2.0	31.4	71.5	30.9	20.8	92.2	15.6	40.0	20.7	9.2	18.6	21.9	18.4	0.0	40.9	43.8	42.7	23.5	24.0	0.1	51.1	30.3	31.8	9.5	61.6	11.2	57.2	38.3	19.5	36.7	97.3	3.8	9.7	37.5	21.3	60.4	0.0	3.4	22.7	87.5	20.5	58.5	0.7	2.5	34.4	35.6	14.0	19.7	8.6	18.6	2.5	7.2	36.3	24.8	2.2	25.8	25.5	14.2	19.0	19.1	2.1	65.7	8.1	68.2	0.3	1.6	77.4	64.8	65.3	45.9	10.6	13.9	41.1
B3GNT3	"B3GN-T3, B3GNT-3, beta3Gn-T3, HP10328, TMEM3"	ENSG00000179913	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3"	Q9Y2A9	19	17794828-17813576	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 44.0;salivary gland: 31.4;stomach 1: 43.2"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 65.8;Cytotrophoblasts: 78.9;Distal enterocytes: 108.4;Paneth cells: 67.4;Proximal enterocytes: 50.5;Syncytiotrophoblasts: 68.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 44.2;BEWO: 40.9;CAPAN-2: 112.5;OE19: 102.1;RT4: 41.3;SK-BR-3: 38.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA024298	Enhanced				"Intracellular and membrane"	NA	NA		74000	"Cluster 32: T-cells - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA024298: AB_1845236"	"unprognostic (1.10e-1)"	"unprognostic (5.19e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.84e-3)"		"unprognostic (1.10e-1)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (4.25e-5)"	"unprognostic (3.26e-1)"	"unprognostic (4.64e-2)"	"prognostic unfavorable (2.16e-4)"	"unprognostic (1.91e-1)"	"unprognostic (1.44e-2)"	"unprognostic (7.38e-2)"	"unprognostic (1.26e-1)"	"unprognostic (7.10e-2)"	"unprognostic (2.57e-2)"	0.3	0.1	0.3	5.7	0.1	0.2	3.4	0.7	0.4	4.4	0.3	44.0	32.6	0.4	0.0	21.7	1.0	23.8	0.0	0.3	0.3	3.8	2.4	0.5	0.5	0.3	0.2	0.1	3.9	0.5	0.0	12.6	0.3	2.2	40.5	0.0	31.4	3.2	0.0	2.7	29.5	1.7	0.0	0.1	43.2	0.1	0.1	0.2	0.3	0.0	4.7	18.5	8.1	0.5	44.2	12.5	0.0	0.2	0.0	0.0	40.9	0.0	0.0	0.0	0.0	0.7	112.5	0.0	28.9	0.0	0.1	4.2	0.0	12.9	0.0	0.0	0.2	0.0	0.2	5.6	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.7	0.2	0.1	0.4	102.1	19.2	0.2	0.0	1.2	23.9	41.3	0.0	0.1	0.0	38.4	0.0	0.0	1.7	0.2	0.1	0.3	3.3	0.2	0.1	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.7	0.4	0.3	0.3	0.3	0.2	0.3	0.0	0.1	0.5	0.1	0.0	2.3	0.0	0.2	0.1	3.6	5.1	0.0	0.0	7.1	6.2	0.4	65.8	17.1	16.5	0.0	78.9	0.5	108.4	1.9	17.9	0.0	3.8	0.8	2.3	16.3	0.0	0.1	28.4	7.5	0.7	19.9	7.7	5.7	0.0	0.7	0.2	6.0	0.0	0.2	40.7	6.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.1	33.2	67.4	0.0	0.0	7.8	50.5	3.5	7.7	0.0	0.0	0.0	0.9	0.2	0.3	0.2	0.0	68.3	0.2	0.5	28.4	39.6
B3GNT4	"B3GN-T4, beta3Gn-T4"	ENSG00000176383	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4"	Q9C0J1	12	122203681-122208952	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.9;skin 1: 3.1"	"Cell type enhanced"	"Detected in some"		"Basal respiratory cells: 3.3;Excitatory neurons: 3.2;Proximal tubular cells: 9.7;Spermatogonia: 2.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 5.1;hTCEpi: 4.0;T-47d: 4.2;U-266/84: 3.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA055261	Uncertain		Approved	Nucleoli,Mitochondria		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria	Nucleoli	"HPA055261: AB_2682765"	"unprognostic (1.67e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.10e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.98e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.82e-2)"	"unprognostic (3.69e-1)"	"prognostic unfavorable (3.52e-6)"	"unprognostic (1.24e-1)"	"unprognostic (2.79e-1)"	"unprognostic (8.97e-2)"	"unprognostic (9.47e-2)"	0.2	0.7	2.3	0.1	2.6	1.5	0.2	4.9	3.1	0.3	0.0	0.3	0.2	0.1	0.0	1.3	0.6	0.2	0.1	3.8	0.5	2.7	0.4	0.3	0.1	0.0	0.0	0.2	0.3	0.3	1.4	0.1	0.0	0.4	0.0	0.5	0.5	0.0	0.2	3.1	0.3	0.0	0.0	0.5	0.3	1.6	0.9	0.0	0.4	0.0	0.1	0.1	0.5	1.2	3.4	0.6	0.2	1.4	0.1	0.1	0.6	0.1	0.0	0.2	0.3	2.2	0.3	0.3	0.5	0.0	0.2	1.3	1.7	1.2	0.1	5.1	1.9	0.1	1.3	0.2	0.4	0.5	0.7	0.3	4.0	0.1	0.2	0.5	0.0	1.3	1.0	0.4	0.0	3.2	0.0	0.5	0.4	0.1	1.4	0.2	0.4	0.7	0.5	0.4	0.8	1.1	0.9	0.7	0.4	0.5	4.2	0.1	0.1	0.3	1.7	0.4	0.2	0.4	3.6	0.8	0.3	0.5	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.1	0.0	0.0	2.3	2.6	4.9	3.1	3.8	0.5	0.0	0.0	0.0	0.0	0.9	1.2	0.4	0.0	1.8	0.7	0.3	1.3	0.7	3.3	0.6	0.2	0.7	0.8	0.5	0.0	1.1	0.0	0.0	0.5	0.5	0.6	1.9	1.0	0.4	0.6	0.3	0.3	0.0	0.0	3.2	0.2	1.1	0.3	0.0	0.8	0.0	0.1	0.4	0.0	0.2	0.0	1.4	0.0	2.0	0.6	0.6	0.1	0.3	0.3	0.0	1.9	0.0	0.2	0.0	0.5	0.6	0.4	1.3	0.0	0.4	0.3	0.1	9.7	1.1	0.2	0.0	0.5	0.2	0.8	2.9	0.8	1.4	0.5	0.4	0.1	0.3	0.4
B3GNT5	"B3GN-T5, beta3Gn-T5"	ENSG00000176597	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5"	Q9BYG0	3	183253253-183298504	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Developmental protein, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 76.5"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 151.2;Distal enterocytes: 150.4;Squamous epithelial cells: 169.9;Syncytiotrophoblasts: 157.9;Urothelial cells: 144.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	6	"neutrophil: 5.6"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 5.6"	"Cell line enhanced"	"Detected in many"		"GAMG: 82.4;HBEC3-KT: 70.3;hTCEpi: 83.5"	"Region enriched"	"Detected in many"	4	"cerebellum: 14.7"	"Low region specificity"	"Detected in all"			HPA017292	Uncertain		Approved	Nucleoli		NA	NA		28000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoli		"HPA017292: AB_1845237"	"unprognostic (2.17e-1)"	"unprognostic (5.73e-2)"	"unprognostic (1.07e-2)"	"unprognostic (4.83e-3)"	"unprognostic (1.89e-1)"	"unprognostic (3.08e-2)"	"prognostic unfavorable (5.09e-4)"	"unprognostic (7.10e-3)"	"unprognostic (7.78e-2)"	"unprognostic (8.48e-2)"	"prognostic unfavorable (7.23e-6)"	"unprognostic (4.20e-1)"	"prognostic unfavorable (1.30e-7)"	"unprognostic (1.18e-2)"	"unprognostic (2.71e-1)"	"unprognostic (3.53e-2)"	"unprognostic (8.10e-3)"	11.9	2.4	3.3	13.7	3.5	76.5	5.5	2.3	3.2	6.0	0.9	22.6	38.2	5.1	9.1	37.5	9.6	21.3	3.5	3.7	4.0	3.8	3.3	15.0	1.1	5.6	3.8	4.6	7.5	3.5	5.7	13.9	4.6	7.9	19.6	1.2	10.1	3.3	7.4	10.3	42.0	6.7	4.3	1.6	11.3	7.3	3.5	7.6	5.2	4.5	5.3	24.2	13.8	5.5	46.2	4.4	23.8	14.7	19.5	57.0	21.5	0.7	1.1	4.6	3.8	9.0	23.6	0.0	2.7	0.1	82.4	20.6	24.7	70.3	3.9	0.1	15.3	2.4	1.9	0.0	24.8	23.4	10.9	27.0	83.5	3.7	62.1	6.2	43.4	0.1	26.6	0.1	38.1	0.0	0.1	7.6	10.1	26.9	38.5	7.3	12.0	0.1	14.4	12.7	1.0	22.6	12.7	0.1	5.3	10.6	0.0	28.0	64.6	1.1	9.0	1.4	11.0	0.0	0.0	0.0	8.8	54.1	23.8	0.0	1.0	1.0	0.0	0.1	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.2	0.3	3.3	3.5	2.3	3.2	3.7	4.0	5.6	3.8	4.6	4.3	3.5	5.5	151.2	6.4	17.5	2.3	1.2	65.1	70.2	35.8	101.3	10.0	18.4	10.4	2.2	21.5	40.5	5.5	22.9	31.0	1.9	150.4	1.9	18.0	13.4	58.0	13.1	26.3	38.2	6.3	1.8	11.8	10.7	9.2	70.3	55.3	14.0	2.4	2.2	0.6	29.6	3.3	1.5	88.2	34.6	15.6	123.2	26.5	1.5	76.8	12.4	80.6	9.4	3.1	0.0	4.5	0.8	35.7	126.4	0.4	1.4	43.1	74.9	4.8	118.5	13.1	0.0	23.6	5.4	7.9	0.8	169.9	84.8	157.9	4.3	0.2	36.2	144.4
B3GNT6	B3Gn-T6	ENSG00000198488	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6"	Q6ZMB0	11	77034398-77041973	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"intestine: 21.8;salivary gland: 6.4;stomach 1: 24.9"	"Group enriched"	"Detected in some"	20	"Gastric mucus-secreting cells: 23.0;Intestinal goblet cells: 60.8"	"Group enriched"	"Detected in some"	14	"colorectal cancer: 6.3;lung cancer: 3.9;pancreatic cancer: 5.1;prostate cancer: 5.0;stomach cancer: 4.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA039805	Enhanced				"Intracellular and membrane"	NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 37: Intestine - Unknown function"		"Cluster 27: Mucus-secreting cells - Mucin production"			"HPA039805: AB_2676690"		"unprognostic (1.71e-1)"	"prognostic favorable (2.31e-4)"	"unprognostic (4.79e-2)"	"unprognostic (5.42e-2)"	"unprognostic (7.64e-2)"		"unprognostic (1.95e-1)"		"unprognostic (2.72e-1)"	"unprognostic (1.23e-2)"	"unprognostic (7.77e-2)"		"unprognostic (2.19e-1)"		"unprognostic (9.30e-2)"	"unprognostic (1.71e-1)"	0.1	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	21.8	5.4	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	16.8	0.0	6.4	0.0	0.0	0.0	7.0	0.3	0.0	0.0	24.9	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.2	0.1	0.0	0.5	0.0	0.1	0.0	0.6	0.2	0.0	0.0	0.1	0.1	0.4	0.0	1.0	0.0	0.0	0.0	1.4	2.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.2	23.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	60.8	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.6	1.4	0.0	0.0	0.3	1.2	0.1	0.2	0.0	0.0	0.7	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	1.5	0.2
B3GNT7	beta3GnT7	ENSG00000156966	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7"	Q8NFL0	2	231395710-231401164	"Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 71.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 272.8;Intestinal goblet cells: 145.2;Paneth cells: 126.4;Undifferentiated cells: 354.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 32.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 19.5;HEL: 15.6;THP-1: 14.0;WM-115: 23.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA013881, HPA035625, HPA035626"	Enhanced		Approved	"Golgi apparatus,Mitotic spindle,Cytosol"	"Intracellular and membrane"	Yes	NA		3600000	"Cluster 40: NK-cells - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"	"Mitotic spindle, Cytosol"	"HPA013881: , HPA035625: AB_10601118, HPA035626: AB_2674707"	"unprognostic (2.21e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.57e-3)"	"unprognostic (1.46e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.31e-2)"	"unprognostic (6.18e-2)"	"unprognostic (5.82e-2)"	"unprognostic (2.17e-2)"	"unprognostic (7.77e-2)"	"unprognostic (4.27e-3)"	"unprognostic (6.96e-2)"	"unprognostic (1.18e-1)"	"prognostic favorable (6.00e-4)"	"unprognostic (3.57e-1)"	3.1	12.9	5.9	2.8	5.1	14.2	3.8	4.0	5.8	2.5	4.6	56.2	25.2	1.9	6.8	2.9	4.6	14.0	4.7	5.6	6.5	2.2	1.2	15.3	1.6	6.0	7.0	16.7	25.4	14.3	8.8	5.4	5.3	3.2	71.2	2.1	7.5	4.4	0.4	5.0	28.4	2.3	4.3	5.1	35.6	1.3	7.3	2.4	8.4	0.3	1.5	3.7	0.6	5.4	0.7	2.8	0.3	0.6	0.1	0.2	1.0	0.2	1.1	0.1	0.1	1.4	19.5	2.2	5.8	0.3	0.2	5.1	0.2	0.0	0.1	0.3	0.5	15.6	0.5	0.9	0.1	0.1	0.8	0.1	1.4	0.2	0.3	1.1	0.2	0.4	0.5	0.4	0.1	0.9	0.2	0.7	6.3	7.7	3.3	0.3	0.1	0.4	0.6	1.7	0.5	0.8	0.3	1.7	0.7	6.9	0.6	14.0	0.2	0.4	0.4	0.2	0.2	2.3	0.9	0.7	0.3	0.2	23.7	0.7	0.1	0.7	2.9	0.5	0.5	9.9	0.1	0.4	6.5	7.0	0.1	0.7	0.2	32.1	0.6	3.1	0.2	1.0	5.9	5.1	4.0	5.8	5.6	6.5	6.0	7.0	5.3	4.3	7.3	5.4	0.9	41.7	30.2	0.3	8.7	2.3	1.7	8.7	0.0	0.4	5.2	2.5	1.1	95.8	29.7	1.8	2.1	0.6	61.7	272.8	0.0	16.1	0.4	13.3	2.2	4.7	103.0	0.4	0.5	84.3	64.9	2.3	51.5	18.5	9.5	17.3	3.3	0.2	11.2	0.0	0.4	145.2	18.3	10.1	38.6	1.2	1.5	9.7	3.6	0.0	2.9	0.5	10.3	55.3	0.2	69.8	126.4	8.2	5.5	11.6	93.2	0.4	82.2	1.8	0.0	0.5	2.3	0.9	1.4	0.0	2.7	2.1	10.0	0.4	354.6	16.2
B3GNT8	"B3GALT7, beta3Gn-T8, BGALT15"	ENSG00000177191	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8"	Q7Z7M8	19	41425359-41428730	"Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 44.5;vagina: 19.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 37.2;Distal enterocytes: 58.1;Ionocytes: 44.7;Paneth cells: 45.0;Proximal enterocytes: 68.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	4	"basophil: 95.0;eosinophil: 117.5;neutrophil: 159.0"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 159.0"	"Cell line enhanced"	"Detected in some"		"HMC-1: 6.5;HUVEC TERT2: 3.5;K-562: 3.1;THP-1: 3.4;U-937: 5.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA043669	Enhanced				"Intracellular and membrane"	NA	NA		57000000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 45: Enterocytes - Digestion"			"HPA043669: AB_2678608"	"unprognostic (6.89e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.98e-2)"	"prognostic unfavorable (4.11e-4)"	"unprognostic (6.44e-3)"	"unprognostic (6.51e-3)"	"unprognostic (1.84e-2)"	"unprognostic (9.92e-3)"	"unprognostic (7.30e-2)"	"unprognostic (2.56e-2)"	"prognostic favorable (9.31e-6)"	"unprognostic (5.04e-2)"	"unprognostic (2.62e-3)"	"unprognostic (2.07e-1)"	"unprognostic (6.16e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.46e-1)"	2.3	1.2	0.2	1.6	0.4	3.9	2.0	1.1	0.4	11.1	0.2	10.5	15.5	2.4	0.3	44.5	1.8	0.5	6.4	0.1	0.2	3.9	0.5	9.0	0.7	0.5	0.2	0.8	1.5	0.5	1.9	0.5	0.6	3.3	2.7	0.1	6.3	2.6	0.8	5.3	15.3	0.8	0.0	8.6	2.0	0.2	0.3	0.3	1.2	0.9	1.6	2.7	19.5	0.7	0.2	0.0	0.2	0.0	0.3	1.4	0.3	0.4	0.1	0.0	0.0	2.1	0.0	0.1	0.5	1.0	0.0	1.4	0.0	0.3	0.0	0.1	0.2	0.0	0.1	1.1	0.5	0.5	6.5	1.7	1.2	0.0	0.0	0.0	3.5	0.1	3.1	0.2	0.0	0.5	0.0	2.0	0.5	0.0	0.0	0.1	0.4	0.0	0.1	0.7	0.9	0.6	0.0	0.1	0.0	0.2	0.0	3.4	1.3	0.0	0.1	0.0	0.0	0.3	0.2	0.0	0.1	5.5	0.0	95.0	16.3	117.5	2.4	12.3	28.4	0.0	1.2	5.2	6.0	0.0	0.1	0.6	159.0	1.5	26.5	0.5	0.6	7.1	0.2	0.4	1.1	0.4	0.1	0.2	0.5	0.2	0.6	0.0	0.3	0.7	0.9	6.4	37.2	0.0	0.0	1.8	5.2	16.3	2.2	0.4	1.4	2.2	0.5	0.0	10.6	23.9	0.0	0.9	0.3	58.1	3.9	5.8	0.0	0.8	0.5	1.7	15.0	1.3	0.1	0.6	2.1	3.0	0.5	1.8	5.1	0.1	2.5	0.0	11.2	0.0	0.1	23.8	44.7	8.8	0.6	0.0	1.5	5.6	0.0	0.0	3.8	0.1	1.0	0.0	0.1	2.9	45.0	0.7	0.1	7.4	68.7	0.3	3.5	0.4	0.0	0.6	2.7	0.0	0.1	20.5	1.7	2.3	1.2	0.0	18.5	13.4
B3GNT9	MGC4655	ENSG00000237172	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 9"	Q6UX72	16	67148104-67150998	"Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Fibroblasts: 12.9;Leydig cells: 11.5;Peritubular cells: 13.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SiHa: 50.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052743, HPA062734"	Approved		Approved	"Nucleoli fibrillar center,Golgi apparatus"	"Intracellular and membrane"	NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	"Golgi apparatus"	"Nucleoli fibrillar center"	"HPA052743: AB_2681934, HPA062734: AB_2684854"	"unprognostic (2.56e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.07e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.32e-3)"	"unprognostic (3.28e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.96e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.96e-3)"	"unprognostic (7.56e-3)"	7.7	8.4	7.1	4.2	8.0	0.2	5.7	7.5	6.8	15.0	8.4	7.6	3.2	13.4	7.3	5.2	13.7	6.8	13.8	7.1	8.0	7.4	2.5	9.0	2.9	8.7	9.7	15.0	3.5	21.8	20.5	7.9	8.7	11.8	3.3	1.4	9.0	14.8	1.9	5.9	5.6	7.8	9.3	5.6	6.1	6.0	7.7	1.5	18.7	2.1	2.5	11.7	8.9	11.1	4.9	8.8	0.7	0.9	27.7	28.6	1.0	22.5	36.2	14.4	18.5	4.0	0.8	0.6	1.5	34.9	6.0	11.1	0.3	1.0	7.8	7.6	3.2	0.7	9.7	3.5	22.3	0.6	0.5	23.7	8.3	14.0	0.4	35.8	2.0	0.5	1.0	2.7	22.6	2.6	2.6	1.2	5.4	3.8	7.7	7.4	12.9	4.4	2.3	6.0	5.0	11.2	50.9	0.2	0.8	4.3	1.3	3.9	4.6	25.6	1.1	25.9	10.2	3.2	2.4	0.8	31.9	1.3	12.7	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	7.1	8.0	7.5	6.8	7.1	8.0	8.7	9.7	8.7	9.3	7.7	11.1	1.2	6.4	5.0	1.0	1.2	3.2	2.8	2.4	9.6	1.6	3.2	2.3	2.6	5.7	2.4	3.7	0.0	0.3	0.1	0.4	0.0	1.3	5.3	2.5	7.6	2.0	2.4	0.0	0.4	1.7	0.5	12.9	2.6	2.2	0.0	3.0	6.4	0.1	1.8	0.0	1.3	0.9	2.0	0.6	3.3	6.9	11.5	0.4	1.8	0.0	0.1	0.9	0.0	1.0	2.3	0.9	0.1	13.5	4.7	2.4	0.1	0.9	4.2	0.3	6.6	3.2	6.6	4.4	2.8	2.7	4.1	0.8	1.5	2.9	0.8	1.3
B3GNTL1	B3GNT8	ENSG00000175711	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase like 1"	Q67FW5	17	82942155-83051810	"Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 19.9;Respiratory ciliated cells: 20.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 25.1;HL-60: 27.0;THP-1: 25.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023585, HPA024547"	Supported		Approved	"Nucleoli,Nucleoli fibrillar center,Vesicles"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoli, Nucleoli fibrillar center"	Vesicles	"HPA023585: AB_2061075, HPA024547: AB_1845240"	"unprognostic (1.51e-2)"	"unprognostic (9.84e-2)"	"unprognostic (4.11e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.38e-1)"	"unprognostic (8.11e-2)"	"unprognostic (2.61e-7)"	"unprognostic (9.95e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.62e-1)"	"unprognostic (8.74e-2)"	"unprognostic (2.80e-2)"	"unprognostic (4.17e-9)"	"unprognostic (2.02e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.88e-1)"	"unprognostic (3.39e-3)"	2.9	2.8	1.8	2.9	2.1	7.8	2.4	1.4	2.3	3.5	3.9	2.0	1.7	3.7	1.2	2.4	3.7	1.3	3.0	1.9	1.4	1.9	2.4	3.0	2.3	1.3	1.5	3.9	2.3	0.8	2.6	1.4	1.6	2.6	0.9	0.5	2.1	1.5	3.8	2.3	2.1	1.8	1.3	4.2	2.0	3.0	2.1	2.3	2.4	1.4	1.1	3.1	2.5	1.6	11.9	7.8	0.2	3.7	2.1	6.6	4.7	4.2	3.7	4.8	3.7	4.7	25.1	5.8	8.1	5.2	11.7	2.2	1.9	0.0	4.1	8.9	5.1	12.2	12.6	16.0	7.5	27.0	0.5	2.4	2.1	2.9	4.8	2.4	5.9	8.9	5.4	5.5	3.9	2.7	7.6	10.3	1.8	8.1	5.6	9.8	0.9	0.4	2.7	2.5	2.4	0.9	3.6	2.7	3.7	3.4	0.0	25.5	9.7	9.2	6.2	1.4	7.6	1.1	2.9	4.4	10.3	3.6	1.3	3.0	6.0	1.0	2.8	5.9	4.4	3.0	4.4	3.3	10.4	5.5	3.9	4.7	19.0	3.2	3.2	4.1	13.5	4.0	1.8	2.1	1.4	2.3	1.9	1.4	1.3	1.5	1.6	1.3	2.1	1.6	2.6	3.2	4.5	4.6	2.9	1.0	2.0	4.4	3.4	3.5	3.0	3.0	2.8	1.5	6.4	5.5	4.2	5.7	3.6	1.3	1.9	1.9	15.3	6.8	4.2	2.3	1.2	7.6	11.3	1.0	3.1	4.0	3.1	1.9	7.0	7.6	1.4	2.0	7.7	3.3	9.2	1.5	6.1	7.3	2.8	19.9	3.1	8.9	1.8	6.5	5.5	1.3	8.2	5.0	4.7	2.1	2.7	4.9	5.2	2.8	0.2	2.4	20.7	3.5	0.0	2.5	2.3	0.9	5.0	5.6	1.7	1.9	6.8	4.8	3.5	2.1
B4GALNT1	"beta1-4GalNAc-T, GALGT, SPG26"	ENSG00000135454	"Beta-1,4-N-acetyl-galactosaminyltransferase 1"	Q00973	12	57623409-57633239	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid metabolism, Sphingolipid metabolism"	"Glycosyltransferase, Transferase"	"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 61.1"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 10.0;Excitatory neurons: 22.0;Horizontal cells: 21.9;Inhibitory neurons: 13.4;Smooth muscle cells: 7.5"	"Cancer enriched"	"Detected in many"	6	"glioma: 10.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 67.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008968	Enhanced				"Intracellular and membrane"	NA	NA		35000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA008968: AB_1078253"	"unprognostic (3.18e-1)"	"unprognostic (8.34e-2)"	"unprognostic (2.05e-2)"	"unprognostic (3.33e-3)"	"unprognostic (2.54e-1)"	"unprognostic (2.70e-3)"	"unprognostic (3.73e-5)"	"unprognostic (1.26e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (3.18e-14)"	"unprognostic (2.52e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.44e-2)"	"unprognostic (4.92e-4)"	1.9	1.1	26.9	1.9	29.7	0.0	0.7	29.3	61.1	1.3	0.6	2.7	0.5	2.1	2.7	0.7	0.7	1.1	3.3	34.9	21.9	0.8	0.4	0.6	0.6	16.7	11.8	0.3	0.3	0.3	1.7	0.4	20.5	2.6	1.2	4.2	1.8	5.0	9.5	0.6	1.2	2.5	8.1	0.6	0.9	0.7	19.1	0.3	1.2	7.2	1.0	1.2	1.6	29.9	7.5	38.2	18.2	38.7	0.3	0.1	0.4	3.0	11.3	19.0	17.5	2.8	21.9	3.0	47.9	13.2	35.9	3.3	15.3	2.1	5.2	67.4	2.6	1.8	10.1	9.9	0.4	3.1	4.1	0.1	0.9	11.0	0.5	6.7	0.2	11.4	8.7	34.8	2.4	13.5	2.5	0.1	13.0	0.9	7.7	0.1	27.1	8.0	0.1	0.1	34.9	12.3	3.1	1.1	0.4	0.9	7.0	3.3	0.0	22.8	28.1	24.0	26.1	37.0	34.0	2.6	28.9	2.3	45.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	26.9	29.7	29.3	61.1	34.9	21.9	16.7	11.8	20.5	8.1	19.1	29.9	0.8	0.0	0.0	2.6	0.0	0.4	0.0	0.0	0.0	10.0	0.0	0.5	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.2	1.0	0.8	0.0	0.0	22.0	0.2	0.2	1.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	21.9	13.4	0.0	0.0	0.0	0.3	0.7	2.8	0.1	3.6	2.8	2.6	0.7	0.0	4.5	2.7	0.5	0.0	3.0	0.0	0.1	0.0	0.2	0.0	2.6	6.6	0.6	7.5	1.6	4.0	0.0	0.0	0.0	0.4	0.2	0.0	0.1
B4GALNT2	"Cad, GALGT2, Sda"	ENSG00000167080	"Beta-1,4-N-acetyl-galactosaminyltransferase 2"	Q8NHY0	17	49132460-49176840	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 33.5"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 5.5;Distal enterocytes: 3.9;Glandular and luminal cells: 5.2;Intestinal goblet cells: 11.5;Ionocytes: 4.1;Proximal enterocytes: 14.8"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 6.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA015721	Approved					NA	NA				"Cluster 9: Intestine - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"			"HPA015721: AB_1845245"	"unprognostic (4.39e-4)"	"unprognostic (3.18e-1)"	"unprognostic (8.26e-3)"	"unprognostic (2.03e-4)"		"unprognostic (1.72e-2)"	"unprognostic (2.62e-2)"	"unprognostic (3.67e-2)"	"unprognostic (7.67e-2)"	"unprognostic (4.06e-1)"	"unprognostic (7.18e-3)"	"unprognostic (2.43e-1)"	"prognostic favorable (1.29e-5)"	"unprognostic (3.53e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.81e-3)"	"unprognostic (2.15e-1)"	1.2	1.3	1.4	7.8	1.0	4.7	0.7	6.6	2.1	0.2	2.3	33.5	2.1	1.1	0.6	0.7	0.4	2.2	1.0	1.7	0.8	9.1	0.9	1.4	2.2	0.7	0.4	1.0	1.7	0.1	0.0	0.7	0.5	0.7	14.2	7.5	2.0	0.3	0.8	2.8	8.4	2.7	0.0	2.2	5.9	1.5	1.1	0.2	5.9	0.1	0.8	0.6	0.0	1.5	0.9	1.7	1.7	3.0	0.1	0.0	0.9	1.3	1.0	0.0	0.1	4.0	1.4	2.1	2.1	0.0	0.6	0.9	0.7	0.1	0.2	1.8	1.8	2.2	5.1	2.1	0.0	1.1	3.5	0.2	1.4	0.3	0.2	0.7	0.0	1.6	1.3	3.3	0.0	1.1	1.4	1.5	2.1	0.3	0.8	2.5	0.7	0.6	5.4	1.4	1.4	1.5	0.6	0.7	0.6	1.7	1.8	1.4	0.6	2.2	1.3	1.3	0.7	2.6	0.9	2.3	0.7	1.4	0.9	0.3	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	1.4	1.0	6.6	2.1	1.7	0.8	0.7	0.4	0.5	0.0	1.1	1.5	0.0	0.0	1.5	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.1	0.3	0.5	0.0	0.9	5.5	0.0	0.0	0.0	3.9	1.9	0.6	0.7	0.6	0.5	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	11.5	4.1	0.0	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	14.8	0.1	0.8	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.1	0.0	0.1	0.0	2.1	0.1
B4GALNT3	"B4GalNac-T3, FLJ16224, FLJ40362"	ENSG00000139044	"Beta-1,4-N-acetyl-galactosaminyltransferase 3"	Q6L9W6	12	459939-563509	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 61.0"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 81.1;Gastric mucus-secreting cells: 128.0;Glandular and luminal cells: 47.4;Late spermatids: 89.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 33.5;HDLM-2: 13.2;HEK 293: 12.5;NTERA-2: 14.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA011404	Enhanced		Supported	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA				"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Golgi apparatus"	Vesicles	"HPA011404: AB_1845242"	"unprognostic (2.38e-2)"	"unprognostic (9.59e-3)"	"unprognostic (1.38e-1)"	"prognostic favorable (1.69e-10)"	"unprognostic (4.22e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.46e-2)"	"unprognostic (9.53e-3)"	"unprognostic (3.29e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.46e-2)"	"unprognostic (9.99e-3)"	"unprognostic (2.82e-1)"	"unprognostic (2.48e-2)"	"unprognostic (2.98e-1)"	0.2	7.0	0.5	3.2	0.7	2.1	1.3	0.0	1.0	7.4	1.0	18.4	1.0	6.2	2.7	7.5	3.7	2.2	23.9	0.5	0.0	4.6	0.1	5.2	0.1	0.0	0.0	0.4	2.6	16.9	9.3	0.1	0.0	2.0	12.5	0.1	4.8	0.7	1.5	14.8	2.0	2.2	0.0	0.3	61.0	8.0	0.0	2.3	2.3	0.1	0.7	1.4	5.6	0.7	0.0	0.0	0.3	1.2	0.0	0.0	33.5	0.0	0.0	0.0	0.0	8.0	6.6	0.0	0.9	0.0	0.7	3.6	8.0	1.1	0.1	13.2	12.5	0.0	0.0	1.8	0.0	0.1	5.3	0.0	5.3	0.0	0.0	0.1	0.0	0.9	0.1	0.0	0.0	0.4	0.0	0.1	14.8	10.5	0.6	0.5	5.0	0.0	7.1	6.8	3.8	2.7	0.8	0.3	1.0	4.9	0.8	2.9	0.0	0.0	2.7	0.2	0.9	0.0	0.0	0.0	0.0	9.2	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.7	0.0	1.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	7.0	1.3	0.3	7.5	6.0	3.4	0.0	0.6	2.9	0.6	15.1	1.5	6.2	9.2	0.0	0.0	0.6	81.1	0.0	12.0	26.3	20.4	4.8	0.6	10.3	0.0	32.6	4.8	0.1	1.6	128.0	47.4	0.0	0.1	0.0	0.1	0.7	0.0	5.2	18.6	2.0	0.0	1.1	89.2	0.0	0.5	0.0	2.8	0.6	0.0	0.0	1.0	3.6	16.6	33.4	0.0	0.2	12.7	1.9	0.2	9.1	0.2	0.0	0.2	0.8	2.8	1.3	0.9	17.3	0.0	1.5	1.9	26.1	14.4
B4GALNT4	"FLJ25045, NGalNAc-T1"	ENSG00000182272	"Beta-1,4-N-acetyl-galactosaminyltransferase 4"	Q76KP1	11	369499-382117	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 33.3;ovary: 27.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 133.2;Bipolar cells: 23.8;Excitatory neurons: 31.2;Horizontal cells: 33.7;Inhibitory neurons: 32.3;Muller glia cells: 45.6;Oligodendrocyte precursor cells: 28.1;Oligodendrocytes: 32.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 35.4;NTERA-2: 32.0;SCLC-21H: 39.5;SH-SY5Y: 47.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043276, HPA053126"	Uncertain		Uncertain	Nucleoplasm,Vesicles,Cytosol	"Intracellular and membrane"	NA	No				"Cluster 35: Non-specific - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoplasm, Cytosol"	Vesicles	"HPA043276: , HPA053126: AB_2682049"	"unprognostic (6.11e-2)"	"unprognostic (7.82e-2)"	"unprognostic (1.79e-1)"	"unprognostic (6.92e-3)"	"unprognostic (5.36e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.69e-3)"	"unprognostic (4.99e-3)"	"unprognostic (1.52e-10)"	"unprognostic (9.01e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.92e-4)"	"unprognostic (1.25e-1)"	0.9	0.6	23.1	0.9	17.2	0.0	3.3	5.1	33.3	17.2	0.0	5.9	0.6	14.1	0.6	2.3	11.9	0.5	1.6	23.8	12.9	1.0	0.3	0.5	0.3	19.3	20.7	27.8	1.1	2.6	17.9	0.0	14.9	6.3	0.2	5.3	2.0	1.2	0.0	2.1	2.9	1.0	8.4	0.3	2.1	1.5	15.1	0.3	0.5	0.0	0.3	1.8	6.3	13.4	0.0	4.8	35.4	20.4	0.0	0.1	8.4	6.5	1.7	2.9	0.8	3.7	0.0	0.0	4.8	0.7	5.6	1.4	4.8	8.5	0.8	0.0	12.3	0.0	13.4	11.4	0.4	0.0	8.7	0.6	5.0	0.2	3.8	12.7	0.4	1.9	11.5	0.0	0.0	10.8	0.4	0.0	32.0	0.6	14.0	0.0	0.0	4.9	0.4	0.0	39.5	47.6	2.4	1.7	0.5	3.7	14.0	0.0	9.0	2.0	11.1	3.5	0.4	0.1	1.7	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.1	17.2	5.1	33.3	23.8	12.9	19.3	20.7	14.9	8.4	15.1	13.4	0.1	0.0	0.0	133.2	0.2	0.8	1.5	1.4	0.6	23.8	6.5	8.9	12.5	0.0	0.1	1.8	4.2	0.1	0.3	0.1	0.0	1.3	0.0	0.6	7.1	0.6	1.8	0.0	31.2	0.0	0.0	2.4	0.0	1.1	0.0	6.9	0.0	0.0	0.2	33.7	32.3	0.1	2.0	0.0	0.0	0.0	3.1	0.1	3.6	2.8	0.2	45.6	0.0	28.1	32.5	0.2	0.0	1.2	0.0	2.6	0.0	0.0	0.1	8.6	0.0	0.0	3.3	0.1	0.2	0.1	0.3	0.3	0.1	0.6	0.5	0.4
B4GALT1	"beta4Gal-T1, GGTB2"	ENSG00000086062	"Beta-1,4-galactosyltransferase 1"	P15291	9	33104082-33167356	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 333.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 215.3"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 346.6;SiHa: 635.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010806, HPA010807"	Enhanced		Enhanced	"Golgi apparatus"	"Intracellular and membrane"	NA	NA		97000000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 20: HeLa - Mitochondria"	"Cluster 30: Mammary glandular cells - Lactation"	"Golgi apparatus"		"HPA010806: AB_1078255, HPA010807: AB_1078254"	"unprognostic (7.57e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.09e-1)"	"prognostic favorable (6.85e-7)"	"unprognostic (1.83e-2)"	"unprognostic (9.94e-2)"	"unprognostic (3.08e-2)"	"prognostic unfavorable (1.25e-4)"	"unprognostic (1.07e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.68e-3)"	"unprognostic (2.78e-1)"	"unprognostic (7.93e-3)"	"unprognostic (4.98e-2)"	"unprognostic (3.91e-2)"	"unprognostic (7.07e-2)"	"unprognostic (3.46e-2)"	52.4	39.2	5.6	43.9	5.1	80.2	91.1	7.3	6.4	64.9	17.9	38.0	21.9	35.7	35.7	49.7	49.3	47.8	55.4	5.4	6.8	42.1	89.4	50.1	33.3	8.6	6.4	77.4	43.9	77.1	21.2	52.9	7.7	38.8	34.3	26.2	70.3	34.0	30.9	35.8	28.1	55.2	8.1	39.7	52.1	38.3	8.3	26.8	60.8	16.7	41.2	79.4	44.9	9.4	99.1	71.8	13.1	18.1	64.9	113.7	235.9	100.6	125.7	59.5	58.8	44.0	112.1	37.8	62.4	147.3	77.2	51.9	13.7	124.5	59.4	346.6	13.6	21.6	277.6	34.1	127.4	17.9	35.0	128.0	218.1	68.0	82.2	127.6	64.0	11.5	24.9	45.5	57.0	86.1	16.3	35.4	8.1	54.1	21.8	21.0	12.2	25.1	177.0	84.6	9.8	12.7	635.5	122.2	25.8	40.4	154.8	32.3	59.9	42.2	49.4	137.2	39.8	7.6	17.9	23.3	131.0	24.2	15.8	30.6	33.2	20.3	45.2	30.5	59.2	87.1	30.4	40.7	23.3	69.9	17.9	23.3	96.5	72.4	24.8	215.3	22.0	24.0	5.6	5.1	7.3	6.4	5.4	6.8	8.6	6.4	7.7	8.1	8.3	9.4	104.4	86.6	71.9	3.3	112.0	141.9	53.0	59.2	75.7	3.8	215.8	66.7	37.2	88.6	59.5	167.3	20.9	94.9	206.2	146.1	15.6	78.2	21.9	108.6	39.7	60.6	8.4	12.8	4.1	125.9	155.8	99.9	80.0	163.7	36.8	19.6	91.1	195.4	53.9	0.0	4.5	64.0	24.4	82.3	333.3	11.1	50.7	129.0	96.0	33.7	31.3	7.7	39.1	3.0	1.0	157.8	57.4	44.4	116.4	89.0	23.9	57.7	33.8	40.1	52.6	80.0	50.8	6.4	13.8	86.1	108.4	173.9	92.7	33.9	41.6	93.2
B4GALT2	beta4Gal-T2	ENSG00000117411	"Beta-1,4-galactosyltransferase 2"	O60909	1	43978943-43991170	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007620, HPA047739"	Supported		Supported	"Golgi apparatus,Vesicles"		NA	NA		3100000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	"Golgi apparatus, Vesicles"		"HPA007620: AB_2667879, HPA047739: AB_2680141"	"unprognostic (1.11e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.15e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.35e-1)"	"prognostic unfavorable (2.96e-5)"	"unprognostic (1.12e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.08e-2)"	"unprognostic (4.23e-3)"	"unprognostic (7.58e-2)"	"prognostic unfavorable (3.62e-5)"	"unprognostic (6.54e-2)"	"unprognostic (1.52e-1)"	"unprognostic (7.66e-2)"	"unprognostic (3.12e-3)"	29.0	19.0	61.4	13.0	55.0	6.6	24.6	48.0	70.1	28.4	44.0	43.7	12.5	31.0	9.6	32.4	20.0	14.9	40.8	58.4	51.6	24.6	38.8	19.6	5.9	53.6	53.6	19.6	51.5	14.2	24.7	10.1	53.0	31.2	10.2	8.9	27.3	23.8	61.0	32.8	15.2	26.3	52.6	12.0	22.4	22.6	55.2	3.1	14.3	33.2	6.8	37.0	26.8	52.6	61.6	38.4	45.3	76.0	51.3	54.5	37.8	54.2	55.9	54.8	50.9	30.4	51.4	38.4	31.6	112.3	52.5	39.9	36.8	72.8	14.0	39.6	80.2	23.2	37.8	66.9	43.2	20.6	0.8	47.0	79.1	39.3	71.4	55.3	65.5	15.9	51.7	25.3	46.7	45.3	15.3	18.6	65.6	35.7	56.7	44.3	48.2	62.7	33.9	29.3	72.7	58.5	31.1	89.4	38.5	16.9	38.6	17.5	39.3	90.8	102.4	63.8	78.5	7.6	17.8	15.9	40.4	16.9	64.6	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.1	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	61.4	55.0	48.0	70.1	58.4	51.6	53.6	53.6	53.0	52.6	55.2	52.6	9.7	0.0	8.8	7.5	2.2	7.8	10.3	10.8	1.8	13.3	15.0	18.9	14.0	7.2	7.4	14.7	4.2	2.0	1.2	10.2	1.9	13.3	16.4	6.2	16.2	10.4	16.3	1.3	8.0	20.6	8.0	15.2	13.7	8.7	0.0	23.8	6.1	18.7	2.3	18.5	5.6	22.6	2.0	1.0	3.3	6.7	16.4	1.5	3.6	1.0	1.6	15.0	0.0	5.0	9.8	27.3	6.1	12.4	5.0	25.9	6.4	8.8	4.4	12.2	6.6	9.8	14.3	6.2	15.6	7.6	12.6	0.5	1.7	21.1	15.3	16.1
B4GALT3	beta4Gal-T3	ENSG00000158850	"Beta-1,4-galactosyltransferase 3"	O60512	1	161171310-161177968	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Plasma cells: 114.8;Syncytiotrophoblasts: 114.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/70: 246.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010793	Approved		Supported	"Golgi apparatus,Cytosol"		NA	NA		130000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Golgi apparatus"	Cytosol	"HPA010793: AB_1078256"	"unprognostic (5.67e-3)"	"unprognostic (7.68e-3)"	"unprognostic (1.20e-2)"	"unprognostic (8.15e-3)"	"unprognostic (3.91e-1)"	"unprognostic (1.10e-2)"	"prognostic unfavorable (5.87e-5)"	"unprognostic (3.11e-2)"	"unprognostic (3.13e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.69e-1)"	"prognostic unfavorable (7.12e-7)"	"unprognostic (1.86e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.38e-1)"	28.4	21.9	20.0	16.0	20.5	19.0	21.6	17.9	21.1	21.8	18.6	19.4	17.2	14.7	18.3	25.1	19.0	14.4	24.9	20.5	22.0	27.7	22.5	25.1	23.4	18.4	19.3	29.0	34.0	21.9	32.5	21.7	19.1	21.8	17.5	8.0	32.3	12.3	24.6	24.6	18.6	10.6	18.2	31.2	27.6	19.4	22.9	16.9	21.9	16.3	20.7	23.7	21.4	19.3	35.2	22.3	32.8	43.6	47.5	24.7	52.5	19.2	34.7	39.6	36.3	44.8	68.4	32.2	54.2	22.1	37.8	34.3	34.9	21.7	22.8	34.1	42.5	18.6	14.2	35.8	34.1	37.0	48.6	33.7	31.1	36.5	39.6	47.0	45.2	41.3	60.3	69.3	32.2	35.4	24.1	34.4	40.9	70.3	48.0	28.5	18.2	79.4	33.5	20.9	46.6	54.7	19.7	50.4	41.7	44.2	50.7	64.8	18.9	19.5	35.4	22.4	57.7	246.6	146.5	43.0	28.5	31.2	32.0	10.7	14.9	12.6	27.0	17.2	24.3	26.2	25.9	26.0	18.0	21.2	25.0	23.2	9.7	25.9	23.3	37.4	43.1	21.0	20.0	20.5	17.9	21.1	20.5	22.0	18.4	19.3	19.1	18.2	22.9	19.3	18.1	19.2	20.0	1.6	34.7	38.5	36.6	26.2	19.9	17.3	32.8	19.9	10.2	15.7	17.7	25.8	2.1	44.8	30.3	15.3	5.9	28.7	10.1	8.2	7.8	24.4	28.8	34.5	6.2	22.9	91.7	24.7	15.3	10.9	9.5	21.0	27.8	13.2	29.7	26.9	7.1	20.7	26.4	16.6	17.9	5.7	9.6	16.2	23.2	4.7	10.2	9.4	47.4	5.0	4.5	31.4	20.0	7.2	114.8	46.1	19.0	20.9	12.4	8.6	26.3	11.1	24.7	14.9	46.9	21.7	41.9	114.2	29.5	11.8	22.7	51.4
B4GALT4	beta4Gal-T4	ENSG00000121578	"Beta-1,4-galactosyltransferase 4"	O60513	3	119211732-119240946	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 76.0"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 123.6;Urothelial cells: 171.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ: 125.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046819, HPA063546"	Approved		Supported	"Golgi apparatus"	"Intracellular and membrane"	NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 37: Intestine - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Golgi apparatus"		"HPA046819: AB_2679824, HPA063546: AB_2685036"	"unprognostic (4.07e-2)"	"unprognostic (1.78e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.14e-3)"	"unprognostic (4.59e-2)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (4.04e-4)"	"unprognostic (6.30e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.58e-1)"	"unprognostic (6.10e-3)"	"unprognostic (2.26e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.11e-1)"	12.4	9.1	6.8	10.7	8.4	20.1	11.1	6.5	8.1	16.4	8.7	30.6	28.6	14.8	76.0	17.7	21.8	33.2	12.9	7.0	6.9	24.1	16.6	9.9	9.9	6.9	6.7	18.4	19.5	15.1	18.2	25.7	6.9	13.7	35.2	9.9	12.2	14.7	6.3	14.1	32.5	13.6	7.0	9.4	29.3	8.3	7.5	7.4	16.4	6.5	11.5	37.6	10.5	7.2	60.1	100.3	12.8	9.8	36.0	31.1	65.3	125.8	54.4	54.4	56.2	65.4	18.3	11.8	23.9	61.3	32.2	78.6	20.7	15.0	59.9	23.5	6.8	15.1	20.3	31.7	25.3	8.9	15.7	21.2	21.4	23.0	19.3	21.6	5.8	8.0	11.2	11.7	25.5	18.4	5.3	10.7	17.6	34.0	27.2	4.9	11.8	4.7	31.2	60.3	10.9	24.0	29.4	14.6	27.9	28.2	30.2	5.7	4.9	27.3	24.0	15.2	13.5	27.2	21.5	16.1	23.5	10.1	23.5	20.1	4.1	8.3	13.3	5.2	7.3	4.2	7.3	7.9	5.5	3.2	13.6	7.1	2.5	14.8	5.0	3.4	2.7	5.7	6.8	8.4	6.5	8.1	7.0	6.9	6.9	6.7	6.9	7.0	7.5	7.2	8.5	0.0	9.4	7.2	17.1	10.7	22.2	48.9	12.0	10.8	14.9	12.4	9.2	61.5	69.1	7.3	4.2	36.2	46.0	43.2	1.9	30.7	2.1	40.1	16.9	8.4	13.8	7.8	11.9	33.2	123.6	24.0	36.2	74.5	13.3	35.0	3.9	10.8	14.4	18.5	11.1	78.7	16.2	9.8	14.8	2.4	14.9	14.9	14.2	6.5	10.9	22.2	39.1	10.6	10.2	40.5	50.2	28.2	27.4	30.7	59.3	22.6	52.6	10.2	19.7	13.9	16.9	1.7	8.4	14.0	10.5	52.3	23.1	20.0	23.6	171.6
B4GALT5	beta4GalT-V	ENSG00000158470	"Beta-1,4-galactosyltransferase 5"	O43286	20	49632945-49713878	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Sphingolipid metabolism"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Urothelial cells: 128.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 6.6"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 6.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077777			Approved	Vesicles	"Intracellular and membrane"	NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 44: Endometrium - Transcription"	Vesicles		"HPA077777: "	"unprognostic (7.98e-2)"	"unprognostic (5.27e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.88e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.61e-2)"	"prognostic unfavorable (2.69e-5)"	"unprognostic (1.73e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (1.87e-5)"	"unprognostic (1.04e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.30e-2)"	"unprognostic (5.41e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.69e-2)"	28.7	47.8	14.7	21.7	14.5	93.7	18.6	14.6	16.1	21.2	6.5	24.9	25.3	23.5	8.6	37.3	18.5	31.5	20.5	15.5	18.1	22.8	25.8	27.3	9.6	14.7	19.2	19.0	12.6	11.3	12.6	27.2	15.4	17.1	23.7	7.7	19.0	21.9	67.1	7.9	21.3	37.6	14.6	27.6	25.8	22.3	19.0	8.1	11.5	24.3	11.5	51.4	17.2	12.0	48.8	55.0	71.4	30.4	72.8	49.3	62.4	23.5	43.7	104.8	50.0	71.1	59.0	14.8	98.0	39.0	99.1	75.4	45.5	35.0	61.3	45.6	12.5	39.4	28.8	42.9	22.9	51.6	73.7	74.3	32.2	45.5	21.8	96.5	64.8	25.9	64.5	8.9	30.8	24.1	3.1	47.3	37.4	47.8	35.3	26.6	61.9	21.4	50.6	34.0	84.9	43.0	83.6	105.3	47.8	52.5	24.1	70.0	50.1	62.7	50.5	33.6	49.8	10.9	10.0	35.2	32.6	48.5	40.7	1.4	1.0	2.6	1.4	1.0	1.5	0.2	0.6	1.3	0.7	0.3	0.1	0.9	6.6	1.2	1.1	0.6	0.8	0.4	14.7	14.5	14.6	16.1	15.5	18.1	14.7	19.2	15.4	14.6	19.0	12.0	39.5	16.0	43.1	36.2	5.8	18.9	27.3	39.7	7.4	8.3	17.3	18.2	18.3	42.9	84.5	36.8	10.4	23.4	21.3	61.3	1.9	35.3	5.2	59.1	28.4	42.7	34.3	33.2	52.1	19.7	27.7	27.3	17.9	100.8	83.2	36.2	58.5	22.7	24.5	11.8	59.5	21.3	40.7	28.2	81.5	6.8	19.9	45.0	21.4	30.9	21.4	5.6	20.6	25.6	42.5	39.7	34.1	32.7	7.3	66.8	13.4	33.5	57.0	4.9	26.3	29.9	25.9	10.3	16.0	27.5	17.5	5.6	17.4	33.1	20.0	128.9
B4GALT6	beta4GalT-VI	ENSG00000118276	"Beta-1,4-galactosyltransferase 6"	Q9UBX8	18	31622247-31685836	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Sphingolipid metabolism"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 25.3"	"Group enriched"	"Detected in many"	5	"Bipolar cells: 101.3;Cone photoreceptor cells: 39.6;Excitatory neurons: 71.5;Inhibitory neurons: 103.7;Oligodendrocyte precursor cells: 81.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	4	"NK-cell: 1.2"	"Lineage enriched"	"Detected in single"	4	"NK-cells: 1.2"	"Cell line enhanced"	"Detected in many"		"REH: 46.8;WM-115: 126.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020701, HPA058284"	Approved				"Intracellular and membrane"	NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 56: Bipolar cells - Visual perception"			"CAB020701: , HPA058284: AB_2683668"	"unprognostic (3.79e-1)"	"unprognostic (4.52e-1)"	"unprognostic (6.54e-3)"	"unprognostic (2.23e-4)"	"unprognostic (1.05e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.31e-2)"	"unprognostic (4.50e-2)"	"unprognostic (5.18e-1)"	"unprognostic (1.13e-1)"	"prognostic favorable (5.65e-4)"	"unprognostic (2.77e-1)"	"prognostic favorable (6.40e-5)"	"unprognostic (5.37e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.10e-2)"	"unprognostic (4.00e-1)"	3.8	12.1	2.0	2.7	3.1	4.5	1.3	8.4	10.2	1.1	1.6	3.4	7.2	1.9	2.0	4.5	2.3	6.6	3.6	5.2	4.8	3.2	2.6	1.1	1.4	1.2	2.7	3.8	1.9	7.4	1.8	2.6	2.1	5.1	3.3	25.3	4.5	3.8	3.5	2.1	9.2	1.7	0.9	1.6	3.0	5.2	5.0	6.3	2.0	6.4	1.1	2.4	0.6	0.4	6.0	13.1	23.7	13.4	0.4	0.5	8.7	1.9	0.0	0.4	0.2	25.2	5.0	9.4	10.9	2.3	28.4	2.4	12.7	10.7	1.5	37.1	11.2	12.4	1.3	0.6	2.6	22.6	2.0	2.4	2.3	3.6	7.5	12.0	13.3	21.9	1.8	0.0	0.1	3.6	25.4	1.7	10.2	7.1	7.2	46.8	4.2	0.0	2.9	12.3	12.6	19.7	8.7	1.5	15.7	19.1	1.7	6.8	13.4	26.5	5.5	0.0	14.9	8.9	0.5	19.4	10.8	20.2	126.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	1.2	0.1	0.0	0.0	0.1	2.0	3.1	8.4	10.2	5.2	4.8	1.2	2.7	2.1	0.9	5.0	0.4	3.2	0.0	0.5	12.7	0.0	5.5	0.9	1.5	12.0	101.3	2.0	1.8	7.6	0.0	1.2	1.8	39.6	0.6	5.9	2.6	3.9	1.3	6.1	1.2	6.2	3.6	3.0	4.6	71.5	1.1	0.2	3.0	2.6	1.3	0.0	4.5	4.2	2.1	0.7	13.5	103.7	2.1	0.0	0.6	1.2	3.5	1.2	1.5	0.0	9.4	0.3	4.6	6.2	81.4	5.3	2.3	3.1	2.6	1.1	2.3	5.4	1.2	0.6	5.6	0.0	1.2	1.6	1.0	9.7	3.7	1.7	0.3	1.4	1.4	3.8	0.7
B4GALT7	"beta4Gal-T7, XGALT-1"	ENSG00000027847	"Beta-1,4-galactosyltransferase 7"	Q9UBV7	5	177600132-177610330	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"	"Disease variant, Dwarfism, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 132.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042330	Supported					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 35: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 38: Extravillous trophoblasts - Unknown function"			"HPA042330: AB_10796576"	"unprognostic (1.19e-1)"	"unprognostic (1.82e-1)"	"unprognostic (3.12e-1)"	"unprognostic (5.97e-2)"	"prognostic unfavorable (2.29e-4)"	"unprognostic (9.53e-2)"	"unprognostic (4.19e-3)"	"unprognostic (3.86e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.82e-3)"	"unprognostic (2.00e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.39e-1)"	"unprognostic (4.44e-2)"	"unprognostic (2.90e-1)"	"unprognostic (4.00e-2)"	19.0	43.7	21.1	15.3	20.1	24.8	17.0	20.6	25.5	18.4	21.8	15.1	16.9	20.1	12.5	16.6	16.0	12.5	23.4	20.1	21.8	20.2	30.5	13.4	20.1	24.8	25.1	19.8	37.6	24.3	31.5	14.1	24.8	22.5	11.9	5.9	24.2	18.8	20.2	13.6	14.7	11.8	18.5	21.3	21.8	23.9	22.1	10.6	18.5	10.1	11.8	17.9	13.9	18.7	20.2	34.5	14.2	35.6	28.0	20.7	63.7	30.1	31.9	26.9	30.7	32.6	30.8	25.2	54.7	30.9	47.3	22.9	9.8	64.9	11.7	85.4	25.8	13.3	27.5	23.4	40.0	13.8	22.4	31.8	22.7	29.0	23.5	24.7	30.3	16.9	11.8	23.7	27.4	46.0	11.9	17.1	13.9	17.7	50.0	24.1	10.3	27.8	20.6	29.6	12.5	14.4	15.0	29.8	27.6	11.3	19.4	16.3	23.5	34.0	19.5	22.6	30.6	29.5	14.9	18.4	28.8	33.0	31.8	16.8	16.7	9.7	14.0	19.7	12.6	14.4	12.8	12.2	19.3	18.4	11.4	11.3	1.3	11.1	19.4	15.2	9.2	10.9	21.1	20.1	20.6	25.5	20.1	21.8	24.8	25.1	24.8	18.5	22.1	18.7	16.3	3.2	5.6	5.2	24.5	6.6	15.4	27.8	15.9	12.1	16.5	19.3	6.9	12.8	15.8	16.5	4.2	43.8	16.4	13.8	7.9	34.1	13.9	12.5	17.8	15.6	14.5	8.2	4.3	38.9	132.4	21.2	8.2	13.5	10.2	30.0	10.8	15.9	31.7	11.8	6.0	22.2	8.2	17.8	8.9	9.8	14.0	18.8	21.4	3.7	25.6	13.7	13.4	3.0	3.4	34.0	12.4	18.4	52.8	30.7	17.4	19.6	9.3	16.1	0.0	13.9	16.4	14.3	11.3	13.9	8.8	43.9	12.8	33.4	23.3	16.3
CERK	"dA59H18.2, dA59H18.3, DKFZp434E0211, FLJ21430, FLJ23239, hCERK, KIAA1646, LK4"	ENSG00000100422	"Ceramide kinase"	Q8TCT0	22	46684410-46738252	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064699			Approved	Vesicles		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 12: NES - Nervous system development"	"Cluster 24: Non-specific - Transcription regulation"	Vesicles		"HPA064699: AB_2685327"	"unprognostic (2.93e-2)"	"unprognostic (1.93e-1)"	"unprognostic (6.52e-2)"	"prognostic unfavorable (4.75e-4)"	"unprognostic (2.67e-2)"	"unprognostic (1.49e-3)"	"unprognostic (8.55e-2)"	"unprognostic (3.60e-2)"	"unprognostic (3.87e-1)"	"unprognostic (1.35e-2)"	"prognostic favorable (2.35e-4)"	"unprognostic (2.26e-1)"	"unprognostic (1.50e-3)"	"unprognostic (1.27e-1)"	"unprognostic (4.78e-1)"	"unprognostic (3.38e-1)"	"prognostic unfavorable (1.58e-4)"	15.7	23.7	17.5	22.2	18.1	21.1	12.7	33.2	22.5	17.8	16.4	17.9	31.6	17.5	6.0	14.8	18.2	17.4	39.0	18.3	37.4	19.5	18.9	16.6	26.1	32.1	34.5	26.6	30.2	11.5	49.0	10.0	33.2	11.7	14.9	21.1	17.5	13.4	20.8	16.3	31.2	15.2	20.8	19.4	21.9	6.0	26.2	38.7	21.0	19.2	25.2	13.7	12.4	18.4	25.6	15.1	71.6	22.6	40.3	30.2	6.7	43.7	33.8	24.5	17.2	22.3	8.4	35.3	19.9	46.9	15.1	16.3	30.4	19.8	24.9	12.6	33.0	15.8	36.9	29.0	27.9	49.9	4.0	25.3	25.0	26.7	9.1	39.2	73.5	37.1	12.1	44.5	45.4	1.9	34.0	24.8	32.4	10.3	16.3	62.8	81.2	40.4	14.7	0.5	66.4	60.6	21.5	10.3	47.1	16.5	11.3	37.6	67.4	50.2	26.8	37.5	64.4	45.7	59.5	22.3	53.5	28.0	41.7	0.7	3.0	3.7	10.3	7.0	17.9	2.0	10.7	10.0	5.4	2.1	6.3	5.8	4.2	2.6	8.7	5.7	10.4	4.4	17.5	18.1	33.2	22.5	18.3	37.4	32.1	34.5	33.2	20.8	26.2	18.4	28.6	9.6	16.6	16.0	17.0	3.4	6.3	6.1	18.2	24.4	6.1	9.8	44.2	10.0	11.0	1.8	6.2	2.4	25.4	23.4	15.6	12.8	7.8	10.3	19.8	27.4	14.4	8.0	11.7	11.8	1.4	14.1	9.2	19.8	10.1	10.2	25.4	22.1	10.8	26.9	21.9	6.6	8.2	24.8	16.9	16.0	9.6	22.1	3.6	15.9	18.6	25.6	22.6	9.5	4.2	10.9	15.2	15.1	43.3	2.1	50.0	16.8	0.7	9.7	0.0	8.3	13.2	4.7	1.7	11.0	4.4	1.8	37.6	5.3	20.0	1.7
CERS1	"LAG1, LASS1, UOG1"	ENSG00000223802	"Ceramide synthase 1"	P27544	19	18868545-18896727	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism"	Transferase	"Disease variant, Epilepsy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 298.6;choroid plexus: 92.2"	"Cell type enriched"	"Detected in some"	5	"Late spermatids: 126.6"	"Group enriched"	"Detected in many"	5	"glioma: 13.5;melanoma: 4.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 32.1;HEK 293: 34.7;NB-4: 39.3;NTERA-2: 25.2"									HPA045724	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Endoplasmic reticulum"		"HPA045724: AB_10969762"	"unprognostic (8.25e-2)"	"unprognostic (8.91e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.59e-2)"	"unprognostic (6.47e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.02e-1)"	"unprognostic (7.04e-3)"	"unprognostic (3.52e-3)"	"unprognostic (1.92e-1)"	"unprognostic (4.59e-2)"	"unprognostic (2.99e-2)"	"unprognostic (3.15e-2)"	"unprognostic (9.15e-2)"	"unprognostic (3.49e-1)"	0.9	3.1	206.4	0.8	244.8	0.2	0.6	256.1	216.6	2.1	92.2	3.5	0.1	0.7	0.5	1.0	0.7	2.5	4.3	218.8	200.4	0.8	0.2	0.5	0.0	298.6	233.8	2.8	0.9	2.9	12.8	0.3	240.9	1.4	0.2	4.8	0.9	0.5	21.3	0.6	1.0	1.5	247.7	0.2	1.2	29.3	251.3	0.3	1.0	12.3	0.1	1.7	1.7	248.3	0.2	3.3	19.1	32.1	1.1	0.4	0.8	2.2	0.1	5.4	3.9	15.7	1.2	0.1	22.0	1.4	4.4	0.3	13.8	0.6	2.1	0.0	34.7	0.2	0.7	11.7	2.4	3.4	0.5	1.2	0.2	1.7	0.6	6.0	1.3	0.2	2.2	0.2	3.7	8.4	0.3	39.3	25.2	0.1	0.7	0.2	0.6	0.7	4.1	0.0	17.8	15.8	0.8	0.1	14.1	6.0	5.5	20.5	0.5	0.1	4.3	3.4	4.8	0.7	0.5	0.1	0.2	1.2	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	206.4	244.8	256.1	216.6	218.8	200.4	298.6	233.8	240.9	247.7	251.3	248.3	0.2	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	3.6	0.6	1.3	0.6	0.0	0.0	0.0	2.1	0.0	0.1	0.2	0.0	0.0	21.1	0.3	0.4	0.6	0.0	0.0	0.0	0.2	0.0	1.0	0.0	1.1	0.0	1.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.4	126.6	1.2	0.2	1.8	0.0	0.0	10.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.1	0.0	1.6	0.0	1.0	0.4	1.4	2.9	0.0	0.4	0.3	0.1	0.4	0.0	0.0
CERS2	"FLJ10243, LASS2, SP260"	ENSG00000143418	"Ceramide synthase 2"	Q96G23	1	150960583-150975003	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 732.2"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 200.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027262, HPA078737"	Approved		Supported	"Nuclear membrane,Endoplasmic reticulum"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 15: Liver - Metabolism"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 2: Hepatocytes - Metabolism"	"Nuclear membrane, Endoplasmic reticulum"		"HPA027262: AB_1852717, HPA078737: "	"unprognostic (1.01e-1)"	"unprognostic (2.70e-3)"	"unprognostic (3.72e-2)"	"unprognostic (1.29e-2)"	"unprognostic (8.23e-2)"	"unprognostic (2.03e-2)"	"unprognostic (7.05e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.34e-1)"	"unprognostic (4.05e-2)"	"unprognostic (8.17e-3)"	"unprognostic (1.11e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.21e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.85e-1)"	95.0	307.2	126.3	53.1	171.3	80.1	100.1	170.2	165.7	96.8	141.7	81.5	94.5	79.9	89.6	46.2	94.1	97.1	71.8	125.5	144.8	261.4	732.2	135.0	56.4	201.5	168.5	104.4	129.3	159.4	84.7	113.8	192.1	83.2	88.6	38.1	61.5	82.7	37.5	46.9	102.8	99.2	158.7	65.1	128.0	49.8	157.2	67.5	161.4	57.3	69.9	91.0	70.7	223.7	154.3	175.8	138.1	277.9	395.1	237.1	100.8	153.1	217.9	278.1	189.1	188.4	248.5	137.7	244.3	242.4	174.6	165.5	195.5	160.7	247.6	194.0	157.7	193.4	107.5	219.3	277.6	216.4	218.5	214.0	197.9	254.3	315.6	341.4	174.3	189.8	210.4	281.0	363.4	255.6	134.2	135.7	200.9	499.4	299.6	160.0	95.4	208.4	311.5	127.2	121.7	185.8	169.6	278.7	183.8	172.1	335.6	296.5	145.4	196.4	93.6	180.1	267.9	189.5	229.0	841.7	222.4	91.0	200.7	212.1	80.2	136.0	76.9	43.7	93.6	34.6	70.3	78.8	69.5	31.9	60.6	60.1	86.5	63.4	32.8	70.1	86.7	88.5	126.3	171.3	170.2	165.7	125.5	144.8	201.5	168.5	192.1	158.7	157.2	223.7	46.3	67.3	67.9	8.8	23.1	24.1	38.2	37.0	18.2	7.5	52.8	27.6	2.8	120.1	23.2	53.3	4.2	77.8	40.2	60.7	13.7	104.6	7.5	24.9	39.9	47.9	24.6	24.8	5.5	92.8	42.4	44.2	16.3	29.7	36.8	33.0	38.9	200.5	55.9	3.3	5.9	29.3	30.5	45.2	35.2	7.9	56.2	54.5	37.4	5.6	39.4	26.5	26.8	7.5	51.3	103.7	32.4	40.3	29.2	52.4	98.8	81.7	21.2	9.9	39.5	37.2	33.8	13.8	6.8	13.9	15.6	54.2	34.3	39.0	29.1	34.2
CERS3	"LASS3, MGC27091"	ENSG00000154227	"Ceramide synthase 3"	Q8IU89	15	100400395-100544995	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism"	Transferase	Ichthyosis	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 55.1;skin 1: 64.0;vagina: 30.3"	"Group enriched"	"Detected in some"	5	"Basal keratinocytes: 18.9;Basal squamous epithelial cells: 39.3;Early spermatids: 23.5;Late spermatids: 17.5;Spermatocytes: 28.2;Squamous epithelial cells: 48.3;Suprabasal keratinocytes: 50.2"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 14.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"hTCEpi: 65.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA006092, HPA024356"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm		"HPA006092: AB_1079236, HPA024356: AB_1852721"	"unprognostic (5.01e-3)"	"unprognostic (3.43e-2)"	"unprognostic (6.47e-4)"	"unprognostic (2.35e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.84e-3)"	"unprognostic (3.23e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.31e-5)"	"unprognostic (2.65e-1)"	"unprognostic (4.74e-4)"	"unprognostic (1.83e-1)"	"unprognostic (4.33e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.05e-3)"	0.1	0.0	0.1	0.0	0.2	0.2	3.3	0.3	0.2	15.1	0.0	0.0	0.0	0.0	0.5	55.1	0.7	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.4	0.0	0.1	0.6	0.0	0.1	8.4	0.1	0.6	64.0	0.1	0.0	0.0	0.1	0.1	18.3	0.2	0.4	0.1	0.0	16.0	0.3	30.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	65.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.3	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.0	0.0	1.3	0.0	18.9	5.0	3.9	39.3	0.4	0.1	0.3	0.5	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	23.5	0.2	0.0	0.2	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.0	2.1	17.5	0.6	0.1	0.0	0.0	0.0	0.2	0.0	2.0	1.4	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	28.2	0.7	48.3	50.2	0.0	0.1	0.0	0.0	6.0
CERS4	"FLJ12089, LASS4, Trh1"	ENSG00000090661	"Ceramide synthase 4"	Q9HA82	19	8206736-8262421	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatocytes: 71.3;Muller glia cells: 150.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 55.1;NB-4: 99.8;U-937: 61.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033734, HPA054729"	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 5: Muller glia cells - Visual perception"	"Nucleoplasm, Vesicles"		"CAB033734: AB_2132977, HPA054729: "	"unprognostic (5.96e-2)"	"prognostic favorable (2.71e-4)"	"unprognostic (2.46e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.30e-1)"	"prognostic favorable (7.83e-4)"	"unprognostic (1.74e-1)"	"prognostic favorable (3.45e-5)"	"unprognostic (1.48e-2)"	"unprognostic (3.32e-1)"	"prognostic favorable (8.05e-4)"	"unprognostic (1.77e-1)"	"prognostic favorable (9.63e-5)"	"unprognostic (6.08e-3)"	"unprognostic (2.69e-2)"	"unprognostic (2.91e-2)"	"unprognostic (8.08e-3)"	13.6	13.0	31.8	10.0	38.9	3.4	31.1	26.6	37.1	35.9	18.7	17.7	6.3	21.5	61.5	64.3	21.3	11.2	14.8	35.3	25.2	27.8	57.7	19.4	19.9	36.9	30.5	22.0	89.1	29.0	22.2	1.9	30.8	32.9	3.9	36.9	55.0	17.6	3.1	47.7	15.2	12.0	26.8	17.7	26.8	11.5	30.7	13.1	51.9	5.3	20.4	18.4	32.7	44.0	0.4	2.1	2.1	25.0	0.8	0.2	1.7	3.1	8.4	3.7	1.7	19.5	1.7	40.0	27.4	0.0	9.6	13.6	16.4	0.4	1.7	35.5	12.4	7.6	0.1	55.1	31.6	0.0	21.3	12.3	20.7	8.8	18.9	10.5	0.3	17.7	5.9	1.2	0.0	0.8	2.6	99.8	25.4	0.2	8.7	49.1	0.8	3.0	6.3	0.0	9.3	12.2	4.3	0.7	14.5	16.7	18.8	8.8	0.2	2.9	7.8	18.6	0.1	24.5	21.1	32.0	0.1	61.9	2.8	12.3	7.1	27.4	7.5	3.9	5.7	19.8	4.3	4.6	4.1	17.7	3.9	3.8	22.4	22.4	2.4	3.9	5.5	5.8	31.8	38.9	26.6	37.1	35.3	25.2	36.9	30.5	30.8	26.8	30.7	44.0	3.2	6.4	10.7	27.1	31.2	18.0	13.2	12.0	15.4	24.5	47.0	28.8	4.1	22.8	22.2	1.8	18.8	3.4	17.2	0.2	7.9	20.0	1.7	7.9	11.2	8.6	23.9	4.0	38.3	30.5	0.9	15.7	3.1	7.6	12.7	14.4	8.2	71.3	16.4	11.8	24.4	1.3	8.2	7.1	7.2	7.3	14.3	6.7	26.6	16.9	19.6	150.3	27.8	47.7	48.1	9.4	2.5	16.1	12.4	40.6	0.4	44.6	27.8	29.5	6.6	6.9	13.8	1.0	1.6	20.6	25.9	2.9	15.7	2.7	2.5	11.9
CERS5	"FLJ25304, LASS5, MGC45411, Trh4"	ENSG00000139624	"Ceramide synthase 5"	Q8N5B7	12	50129289-50167533	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Sphingolipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006780, HPA026589"	Approved		Approved	"Nuclear membrane,Endoplasmic reticulum"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Nuclear membrane, Endoplasmic reticulum"		"HPA006780: , HPA026589: AB_1852727"	"unprognostic (1.59e-2)"	"unprognostic (9.83e-2)"	"unprognostic (5.17e-2)"	"unprognostic (3.64e-2)"	"unprognostic (3.02e-1)"	"unprognostic (2.49e-3)"	"prognostic unfavorable (4.63e-5)"	"unprognostic (5.56e-2)"	"unprognostic (1.65e-2)"	"unprognostic (9.26e-2)"	"unprognostic (1.88e-3)"	"unprognostic (5.67e-2)"	"prognostic unfavorable (9.33e-11)"	"unprognostic (8.37e-2)"	"unprognostic (1.03e-1)"	"prognostic favorable (5.76e-5)"	"unprognostic (3.26e-1)"	26.2	22.3	27.6	4.8	28.5	5.1	26.6	29.7	48.1	37.2	27.4	24.1	3.0	30.5	12.0	24.0	28.2	6.9	16.2	27.7	29.6	44.1	14.2	22.9	6.1	28.3	28.6	35.1	22.9	9.1	42.3	5.5	28.9	31.2	2.9	5.5	21.5	3.5	5.5	34.1	20.6	4.6	27.5	29.2	21.6	13.8	29.5	7.6	24.8	2.3	3.7	29.5	29.2	29.0	12.1	13.2	17.1	3.5	6.5	3.9	10.6	23.3	6.6	8.0	7.4	36.2	13.9	10.6	20.2	24.4	7.7	7.9	6.1	4.4	6.7	23.4	12.7	6.1	11.2	23.2	16.5	8.0	12.4	19.4	13.9	11.6	6.3	18.7	11.9	10.0	6.1	10.8	8.6	18.7	15.4	45.6	8.2	4.1	7.0	10.7	4.3	12.7	28.7	17.7	5.2	6.9	10.3	9.4	33.6	10.7	13.0	9.9	10.6	17.6	10.2	11.6	8.0	8.1	14.3	11.6	12.8	5.9	8.4	36.3	23.0	42.4	37.0	37.4	28.7	22.0	28.6	28.6	26.8	30.6	20.1	28.9	41.2	39.6	55.1	36.0	37.1	37.1	27.6	28.5	29.7	48.1	27.7	29.6	28.3	28.6	28.9	27.5	29.5	29.0	14.9	19.2	18.4	22.5	17.7	17.3	20.9	29.1	12.0	41.0	11.5	9.8	6.8	14.3	16.5	14.7	20.9	32.9	23.1	8.1	7.9	21.2	0.9	7.7	16.7	17.2	15.6	9.1	47.7	14.0	65.2	21.9	10.7	11.8	15.2	15.0	18.2	4.6	19.0	32.0	56.1	7.9	28.5	17.9	18.3	2.2	16.8	14.3	12.4	20.6	26.6	21.3	24.7	40.2	34.8	19.0	6.8	17.3	12.7	15.5	14.2	7.7	8.6	44.3	32.9	18.2	20.8	7.6	8.1	9.3	14.3	33.7	22.1	15.7	6.7	14.7
CERS6	LASS6	ENSG00000172292	"Ceramide synthase 6"	Q6ZMG9	2	168456249-168775134	"Metabolic proteins, Predicted membrane proteins"	"Inflammatory response, Lipid biosynthesis, Lipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 271.7;Inhibitory neurons: 293.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"plasmacytoid DC: 5.4"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 5.4"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044683	Approved					NA	No			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 9: Intestine - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA044683: AB_10965059"	"unprognostic (2.17e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.92e-3)"	"prognostic unfavorable (7.31e-4)"	"unprognostic (3.24e-1)"	"unprognostic (2.61e-1)"	"prognostic unfavorable (1.10e-4)"	"unprognostic (1.28e-1)"	"unprognostic (1.11e-2)"	"unprognostic (9.80e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.93e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.41e-1)"	"unprognostic (4.80e-2)"	13.4	14.3	10.1	10.1	11.6	12.5	13.5	11.8	17.4	12.7	2.4	28.2	25.8	11.6	18.1	13.7	6.7	8.5	27.6	12.9	14.4	13.2	13.3	7.6	8.6	4.1	7.4	15.3	7.6	12.3	4.7	9.4	7.9	12.9	30.2	9.2	3.6	13.3	6.0	19.1	32.2	11.0	9.0	6.9	24.1	12.0	8.8	24.9	27.2	10.7	8.3	12.6	6.9	8.1	15.8	14.2	24.2	27.8	58.8	43.2	0.1	15.5	16.1	16.7	22.2	22.2	33.8	0.0	21.7	14.1	23.3	28.9	32.2	36.6	27.6	0.0	21.4	29.1	13.8	15.9	51.5	61.1	13.4	48.7	102.1	34.7	27.3	16.0	8.5	42.2	15.8	0.1	34.6	17.2	54.0	16.9	22.4	33.6	20.0	41.3	45.5	27.3	15.5	46.9	32.6	39.4	15.0	38.2	8.2	19.9	34.0	34.4	4.7	41.3	17.3	11.3	27.1	0.3	0.0	0.1	26.8	31.8	28.2	0.6	1.0	0.0	0.1	0.7	0.3	0.1	0.3	0.1	0.8	0.4	0.9	0.7	0.1	0.7	0.6	5.4	0.0	0.3	10.1	11.6	11.8	17.4	12.9	14.4	4.1	7.4	7.9	9.0	8.8	8.1	7.0	6.4	10.3	114.3	10.2	108.8	55.2	37.4	38.1	24.1	42.4	30.6	45.1	21.5	33.6	11.0	0.0	0.7	45.2	79.1	0.0	14.0	6.8	7.9	20.3	13.4	103.8	15.3	271.7	22.5	3.4	11.3	57.6	18.9	10.2	15.2	12.8	43.8	24.3	37.0	293.2	92.2	20.3	49.4	54.1	3.6	19.9	40.8	10.6	37.5	77.8	28.1	6.2	124.7	10.3	17.9	48.3	39.9	9.8	40.3	63.7	9.3	49.2	3.0	65.7	13.4	28.8	3.0	9.4	34.9	92.8	0.5	10.1	15.7	115.8	46.3
CTSA	"GSL, PPGB"	ENSG00000064601	"Cathepsin A"	P10619	20	45890144-45898824	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Protease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 368.3"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 445.6;Proximal enterocytes: 301.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 856.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB024930, HPA031068, HPA072487"	Enhanced		Enhanced	Vesicles	"Intracellular and membrane"	NA	NA		28000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 51: Myeloid cells - Hemostasis"	Vesicles		"CAB024930: , HPA031068: AB_10601205, HPA072487: "	"unprognostic (8.61e-2)"	"unprognostic (3.37e-1)"	"unprognostic (4.30e-2)"	"unprognostic (2.13e-1)"	"unprognostic (6.42e-2)"	"unprognostic (2.21e-1)"	"prognostic unfavorable (1.95e-4)"	"unprognostic (6.33e-2)"	"unprognostic (9.53e-3)"	"unprognostic (7.19e-2)"	"unprognostic (1.83e-1)"	"unprognostic (6.85e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.05e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.40e-2)"	80.4	368.3	56.8	75.3	58.1	75.6	61.9	63.6	65.6	47.6	96.0	178.6	100.9	55.1	39.0	60.4	39.3	89.7	97.2	59.7	63.8	188.1	95.7	90.9	61.6	62.6	59.1	62.2	52.9	104.4	43.8	76.4	61.4	38.5	170.4	44.0	61.3	48.4	56.0	95.2	109.2	67.3	59.4	108.5	63.3	33.5	70.2	23.0	47.4	61.7	58.8	82.8	49.2	68.4	111.9	114.1	17.6	89.2	856.5	438.6	47.0	150.3	424.0	169.6	217.5	214.4	291.8	24.1	176.2	299.9	638.1	168.6	55.9	105.6	95.7	47.6	53.6	54.3	53.4	375.9	187.3	98.0	240.9	349.0	123.6	107.9	22.5	421.9	190.1	28.2	61.0	355.1	186.9	232.1	25.8	82.4	19.4	172.6	272.1	37.8	107.3	135.7	138.2	96.7	36.9	37.8	263.2	450.3	444.4	51.5	108.5	141.8	172.5	335.0	76.2	178.9	123.7	162.1	238.5	15.7	599.3	128.6	142.4	480.7	305.9	530.5	44.9	168.8	185.5	42.0	75.6	78.3	102.4	25.7	26.6	39.8	152.4	81.2	120.1	40.6	155.4	378.1	56.8	58.1	63.6	65.6	59.7	63.8	62.6	59.1	61.4	59.4	70.2	68.4	53.7	35.3	32.6	26.1	38.2	24.2	38.9	88.8	17.6	58.4	18.4	15.9	12.6	65.8	64.1	71.7	60.5	104.1	27.5	445.6	39.2	246.0	3.3	22.3	39.5	56.0	54.0	22.1	20.4	166.4	109.2	86.8	29.6	62.4	9.5	50.8	102.1	67.9	297.1	47.1	25.2	74.5	95.6	177.1	25.1	4.8	32.9	273.1	112.1	12.2	135.6	86.6	37.0	7.1	10.2	135.0	216.0	27.4	41.9	18.6	301.8	245.8	34.2	46.1	26.3	33.7	54.5	15.3	31.9	24.0	22.9	144.1	49.1	91.3	113.9	36.2
DBP	DABP	ENSG00000105516	"D-box binding PAR bZIP transcription factor"	Q10586	19	48630030-48637379	"Metabolic proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 318.3;Horizontal cells: 215.4;Muller glia cells: 194.2;Rod photoreceptor cells: 108.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 61.7;NB-4: 235.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 56: Bipolar cells - Visual perception"				"unprognostic (1.49e-1)"	"unprognostic (3.68e-3)"	"unprognostic (2.16e-3)"	"unprognostic (1.40e-1)"	"unprognostic (4.67e-2)"	"prognostic favorable (5.49e-4)"	"unprognostic (2.00e-1)"	"prognostic favorable (1.16e-5)"	"unprognostic (3.32e-2)"	"unprognostic (2.39e-1)"	"unprognostic (4.24e-3)"	"unprognostic (4.75e-2)"	"prognostic favorable (2.41e-5)"	"unprognostic (2.23e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.46e-2)"	"unprognostic (3.61e-2)"	12.4	53.0	22.5	6.6	34.6	7.5	12.6	35.7	32.9	12.9	9.7	18.7	19.2	13.2	7.2	21.1	11.6	6.0	18.3	21.9	23.4	17.9	24.7	9.8	14.6	21.3	24.5	33.5	14.0	15.6	34.9	2.8	18.6	16.8	3.8	32.6	42.2	13.8	57.1	58.1	15.5	4.5	23.5	19.1	16.4	16.4	29.0	13.6	34.4	7.7	8.4	8.8	16.3	20.5	4.3	7.3	3.6	17.6	2.6	3.4	3.8	1.0	9.8	3.0	7.4	4.6	39.7	8.5	4.8	4.8	3.6	9.8	12.6	2.5	2.5	8.9	6.0	17.2	6.1	2.4	12.9	10.6	12.5	12.1	2.3	0.5	2.0	21.1	0.6	17.9	1.3	61.7	2.7	5.9	32.8	235.3	2.5	11.3	4.9	15.8	2.9	22.2	1.5	1.3	11.7	14.7	5.5	26.5	15.6	1.6	4.8	10.5	1.1	6.5	17.8	3.4	1.9	28.4	50.7	15.6	3.1	15.0	3.9	3.3	3.0	4.9	1.9	3.5	3.9	2.7	3.2	1.6	4.1	1.7	2.5	3.1	0.1	0.7	1.9	3.5	3.7	1.1	22.5	34.6	35.7	32.9	21.9	23.4	21.3	24.5	18.6	23.5	29.0	20.5	14.1	12.8	6.2	9.4	21.7	21.9	15.3	3.1	52.3	318.3	17.2	23.5	4.7	12.8	3.2	7.3	87.6	5.2	15.9	8.0	45.0	5.8	1.4	9.0	25.4	10.8	1.8	6.9	4.2	5.6	1.9	25.5	7.1	13.1	0.0	17.6	10.4	10.0	10.9	215.4	5.7	8.1	6.1	15.1	9.6	3.3	16.8	19.4	17.8	1.9	12.9	194.2	32.0	1.5	4.8	3.0	11.3	25.6	6.8	7.8	63.7	26.6	1.3	108.4	0.0	22.8	13.6	1.3	8.4	32.2	22.6	1.6	20.8	85.8	7.5	18.3
DEGS1	"DEGS-1, Des-1, DES1, FADS7, MLD"	ENSG00000143753	"Delta 4-desaturase, sphingolipid 1"	O15121	1	224175756-224193441	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Oxidoreductase	"Disease variant, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"skin 1: 535.6"	"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 246.0;Cytotrophoblasts: 281.8;Suprabasal keratinocytes: 320.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA076422			Supported	Mitochondria		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 61: Skin - Cornification"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 47: Cytotrophoblasts - Unknown function"	Mitochondria		"HPA076422: AB_2686799"	"unprognostic (2.34e-2)"	"unprognostic (6.91e-2)"	"unprognostic (2.48e-2)"	"prognostic unfavorable (7.74e-5)"	"unprognostic (1.50e-1)"	"unprognostic (2.74e-1)"	"prognostic unfavorable (4.29e-5)"	"unprognostic (7.70e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.20e-1)"	"unprognostic (3.63e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (6.83e-7)"	"unprognostic (2.87e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.86e-2)"	"prognostic unfavorable (2.53e-4)"	60.3	31.0	30.3	44.9	33.1	69.5	61.9	35.0	36.2	53.4	42.5	50.8	47.0	44.5	29.5	48.6	34.4	40.5	43.8	31.3	35.6	38.1	35.7	49.1	48.0	36.6	35.2	27.1	22.5	31.5	34.8	128.7	35.9	83.2	27.2	20.8	38.7	58.6	20.9	535.6	33.4	70.9	37.9	38.7	38.6	22.7	34.0	34.2	52.3	23.3	50.9	48.4	72.7	44.5	72.8	50.7	65.2	49.5	275.7	181.1	51.2	201.1	223.8	137.5	164.2	47.1	55.2	58.0	252.4	181.0	82.4	76.3	76.5	67.9	153.0	84.2	141.5	41.7	51.1	29.2	167.9	84.2	86.1	177.4	153.6	125.5	69.9	143.0	140.4	31.4	62.8	61.8	181.2	27.5	43.2	46.9	83.3	40.0	76.1	38.8	92.4	37.5	181.1	19.8	42.3	69.8	106.6	169.4	110.4	118.8	57.1	123.4	125.7	133.4	41.4	153.1	197.5	44.5	55.3	52.8	141.9	41.7	154.2	104.6	61.4	120.3	30.9	67.8	59.8	58.2	52.7	43.3	104.4	74.3	40.7	37.0	67.7	43.9	48.7	34.9	59.0	52.8	30.3	33.1	35.0	36.2	31.3	35.6	36.6	35.2	35.9	37.9	34.0	44.5	71.7	83.3	29.3	13.4	69.9	246.0	44.0	33.6	89.4	31.2	40.7	38.4	20.8	10.0	19.8	11.0	14.6	281.8	40.5	4.0	13.7	34.9	27.9	54.0	90.2	66.7	14.9	18.7	17.4	43.3	48.3	77.7	21.4	146.1	106.5	21.3	55.6	20.8	93.0	18.5	20.4	6.2	34.6	57.8	90.5	13.6	63.0	72.8	69.4	20.6	57.1	26.0	10.3	25.6	32.1	29.5	5.9	79.4	50.1	44.2	20.1	29.7	20.1	18.4	105.2	42.7	89.1	84.3	44.0	50.4	320.4	198.9	58.9	43.7	6.6	13.7
DEGS2	"C14orf66, DES2, FADS8"	ENSG00000168350	"Delta 4-desaturase, sphingolipid 2"	Q6QHC5	14	100143957-100159645	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 37.0;intestine: 34.8;skin 1: 54.2"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 82.8;Paneth cells: 77.0;Proximal enterocytes: 298.9;Respiratory ciliated cells: 144.8;Squamous epithelial cells: 86.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 3.5;eosinophil: 6.6;memory B-cell: 10.9;naive B-cell: 6.8"	"Group enriched"	"Detected in many"	5	"B-cells: 10.9;granulocytes: 6.6"	"Group enriched"	"Detected in some"	16	"OE19: 69.3;T-47d: 104.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046644			Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 31: Skin - Epidermis development"	"Cluster 6: T47d - Mammary gland"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Nucleoli"		"HPA046644: AB_2797231"	"unprognostic (8.18e-2)"	"unprognostic (3.83e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.32e-2)"	"unprognostic (3.55e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.38e-1)"	"prognostic favorable (7.94e-7)"	"unprognostic (1.03e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.14e-1)"	"prognostic favorable (1.66e-4)"	0.4	0.1	6.4	1.0	7.2	0.2	6.1	18.3	7.1	4.8	3.6	8.9	24.7	3.3	0.5	37.0	2.0	6.5	0.2	5.1	4.5	10.8	0.9	1.6	0.6	5.9	5.3	1.0	6.9	0.4	3.3	0.4	6.0	2.3	4.5	0.2	8.6	2.1	0.3	54.2	34.8	0.5	4.8	0.8	20.1	1.1	5.3	0.1	2.4	0.0	1.8	6.5	10.1	4.9	0.0	0.3	0.0	0.3	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.5	2.4	0.0	0.5	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.1	0.5	0.8	0.1	0.3	0.0	0.0	0.0	0.0	1.1	1.6	0.0	0.0	4.2	0.4	0.3	0.1	69.3	0.0	0.4	0.0	3.6	0.0	1.6	5.2	0.1	0.0	3.1	0.0	0.1	104.4	1.1	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	3.5	0.4	6.6	1.6	0.0	0.0	10.9	0.1	0.7	0.7	6.8	0.0	1.0	0.2	0.2	0.0	0.1	0.0	0.7	6.4	7.2	18.3	7.1	5.1	4.5	5.9	5.3	6.0	4.8	5.3	4.9	0.7	3.2	5.0	5.2	3.7	1.8	3.3	22.9	1.2	4.6	24.2	15.2	0.6	37.1	34.8	82.8	0.0	7.7	3.3	24.2	1.9	19.0	1.2	15.3	4.3	3.8	55.3	1.3	0.5	1.5	4.9	1.3	54.6	28.9	9.5	0.9	0.4	0.3	1.6	0.0	0.4	53.5	34.6	0.9	0.6	1.6	0.3	1.5	0.0	3.7	0.5	1.2	12.3	0.0	1.5	2.4	77.0	0.0	3.7	1.7	298.9	0.4	144.8	22.0	0.0	1.1	3.1	3.2	4.0	86.9	15.3	37.4	2.5	0.2	69.6	21.0
ENPP7	"alk-SMase, NPP7"	ENSG00000182156	"Ectonucleotide pyrophosphatase/phosphodiesterase 7"	Q6UWV6	17	79730943-79742219	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"intestine: 104.6"	"Group enriched"	"Detected in some"	7	"Hepatocytes: 9.1;Proximal enterocytes: 22.7;Proximal tubular cells: 9.7"	"Cancer enriched"	"Detected in some"	6	"liver cancer: 6.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"Hep G2: 1.2;Karpas-707: 2.1;U-266/70: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA024603	Approved				"Intracellular and membrane"	NA	NA		450000		"Cluster 56: Intestine - Transmembrane transport"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 45: Enterocytes - Digestion"			"HPA024603: AB_1848174"	"unprognostic (4.00e-2)"	"unprognostic (1.16e-2)"	"unprognostic (6.49e-2)"	"unprognostic (4.83e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.01e-1)"		"unprognostic (8.45e-4)"	"unprognostic (4.83e-2)"		"unprognostic (1.18e-2)"	"unprognostic (1.52e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.80e-2)"	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	11.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	104.6	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	9.1	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.7	9.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0
FUT1	"H, HSC"	ENSG00000174951	"Fucosyltransferase 1 (H blood group)"	P19526	19	48748011-48755390	"Blood group antigen proteins, Enzymes, Metabolic proteins, Predicted membrane proteins"		"Blood group antigen, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 27.5"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 13.8;Endothelial cells: 8.5;Langerhans cells: 41.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"CACO-2: 9.3;HEL: 11.5;RT4: 11.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA		15000	"Cluster 11: Basophils - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"				"unprognostic (2.90e-2)"	"unprognostic (3.09e-2)"	"unprognostic (8.05e-3)"	"unprognostic (4.65e-3)"	"unprognostic (2.92e-3)"	"unprognostic (8.73e-2)"	"unprognostic (2.58e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.38e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.29e-1)"	"prognostic favorable (3.99e-4)"	"unprognostic (1.33e-1)"	"unprognostic (3.22e-2)"	"unprognostic (8.67e-3)"	"unprognostic (3.98e-2)"	3.8	1.6	2.3	0.6	3.5	2.9	3.1	5.2	3.3	1.2	1.0	0.7	1.9	0.9	0.9	2.8	2.0	1.0	3.8	3.1	1.5	4.1	1.0	10.6	0.7	1.6	1.6	0.3	27.5	3.3	2.7	4.2	1.7	1.4	0.5	0.3	1.4	1.0	1.7	1.6	0.6	0.9	1.3	5.4	13.6	1.6	2.0	0.7	1.9	2.9	1.4	1.3	1.4	1.8	3.8	0.1	0.2	0.2	0.0	0.0	1.8	0.2	0.1	0.2	0.2	9.3	5.4	0.4	0.4	0.3	0.8	6.2	1.9	5.8	0.2	0.1	0.9	11.5	0.4	0.2	2.6	0.4	4.9	0.0	9.1	0.4	4.1	0.1	4.1	2.0	0.6	1.8	0.0	4.4	0.2	7.3	1.1	7.5	0.5	0.3	0.0	1.9	0.3	11.2	8.5	0.5	0.5	8.0	0.2	0.4	5.2	0.3	4.0	0.4	2.6	0.2	0.4	1.5	4.3	1.1	0.1	0.3	0.4	1.3	0.2	0.1	0.1	0.0	0.0	0.2	0.1	0.1	0.0	0.2	0.1	0.1	0.5	0.3	0.0	0.2	0.0	0.0	2.3	3.5	5.2	3.3	3.1	1.5	1.6	1.6	1.7	1.3	2.0	1.8	13.8	3.2	1.7	0.0	0.0	2.5	0.7	4.1	1.2	0.4	1.2	0.9	1.1	2.8	2.3	0.0	2.1	0.4	0.0	0.1	1.9	1.7	0.0	1.3	0.3	8.5	1.2	6.5	1.3	2.4	0.3	0.8	4.1	3.4	1.3	0.0	6.8	0.0	0.3	0.0	0.4	1.2	2.0	0.8	41.9	0.1	0.9	1.9	5.4	1.0	0.0	0.0	0.0	0.0	0.1	3.6	0.0	0.0	0.1	0.9	0.1	0.0	0.9	0.2	0.0	0.6	0.9	0.1	0.1	2.4	1.7	0.4	0.3	0.0	0.1	0.6
FUT10		ENSG00000172728	"Fucosyltransferase 10"	Q6P4F1	8	33370824-33473146	"Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Astrocytes: 140.0;Early spermatids: 248.8;Late spermatids: 334.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053970, HPA058655"	Uncertain		Approved	"Nucleoplasm,Endoplasmic reticulum,Golgi apparatus"	"Intracellular and membrane"	NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Endoplasmic reticulum, Golgi apparatus"		"HPA053970: AB_2682327, HPA058655: AB_2683789"	"unprognostic (6.02e-2)"	"unprognostic (4.61e-2)"	"unprognostic (2.85e-3)"	"unprognostic (6.24e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.80e-2)"	"unprognostic (5.40e-3)"	"unprognostic (6.07e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.23e-1)"	"unprognostic (9.10e-3)"	"unprognostic (2.76e-4)"	"unprognostic (3.06e-3)"	"unprognostic (1.58e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.87e-3)"	"unprognostic (6.01e-3)"	1.9	2.2	4.3	1.0	4.7	0.8	3.4	4.2	4.2	4.0	2.0	2.5	2.5	3.1	1.2	1.9	3.3	1.8	1.7	3.0	3.3	3.1	2.0	2.4	1.8	4.3	5.5	5.2	2.6	5.1	1.3	3.5	3.3	2.2	2.7	5.2	2.7	2.1	0.6	3.2	2.6	2.9	2.7	1.5	2.3	1.5	4.8	2.9	2.8	1.2	2.2	2.2	2.2	2.5	2.4	4.5	6.8	8.3	10.8	10.8	3.4	4.3	7.1	4.2	5.4	6.3	3.6	2.7	5.1	5.8	3.5	5.9	10.4	4.1	4.1	5.8	3.8	8.6	3.6	7.0	4.9	1.9	2.9	8.0	7.0	1.1	5.4	8.8	8.6	4.4	8.0	3.2	3.9	1.4	6.6	2.8	9.1	6.4	3.0	4.8	5.1	1.4	6.1	5.4	2.4	2.3	2.5	3.7	5.1	7.0	3.8	1.9	6.6	3.2	1.4	8.1	3.6	1.3	2.2	1.8	2.0	5.4	3.4	0.4	0.6	0.7	1.3	0.2	1.4	1.0	0.7	1.2	1.3	0.3	0.8	0.8	0.4	1.6	0.2	0.7	1.7	0.6	4.3	4.7	4.2	4.2	3.0	3.3	4.3	5.5	3.3	2.7	4.8	2.5	4.5	3.2	2.0	140.0	2.5	2.7	2.7	3.4	4.0	2.9	3.7	3.8	2.5	2.8	3.2	3.7	10.4	12.0	3.0	1.5	1.9	4.5	248.8	2.8	5.7	3.8	3.6	3.8	16.3	4.0	7.0	5.8	6.1	3.0	5.7	10.1	5.3	3.6	3.4	3.3	20.2	3.2	4.1	2.2	1.8	334.2	6.8	2.2	1.8	29.0	3.0	29.9	5.2	44.2	16.4	4.0	1.0	4.9	5.0	1.4	5.3	3.0	2.0	11.0	0.0	5.7	4.6	7.0	2.7	5.5	1.7	6.0	2.6	6.5	3.6	1.3
FUT11	MGC33202	ENSG00000196968	"Fucosyltransferase 11"	Q495W5	10	73772276-73780251	"Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 171.6;Late spermatids: 234.7;NK-cells: 69.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014033	Approved		Approved	"Nuclear membrane,Golgi apparatus"	"Intracellular and membrane"	NA	NA		1200000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 34: Spermatids - Unknown function"	"Nuclear membrane"	"Golgi apparatus"	"HPA014033: AB_1849192"	"prognostic unfavorable (6.78e-4)"	"prognostic unfavorable (2.39e-6)"	"unprognostic (1.47e-2)"	"unprognostic (2.42e-3)"	"unprognostic (3.27e-1)"	"unprognostic (7.64e-2)"	"unprognostic (2.29e-2)"	"unprognostic (3.50e-3)"	"unprognostic (1.51e-1)"	"unprognostic (9.30e-2)"	"unprognostic (9.77e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (3.67e-4)"	"unprognostic (2.59e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.61e-1)"	"unprognostic (2.66e-2)"	9.4	5.1	2.5	6.8	3.2	6.4	5.2	4.4	2.8	8.9	1.8	4.5	3.1	6.0	3.2	7.0	4.7	9.0	9.4	2.1	3.8	4.7	5.1	8.7	6.4	4.9	4.8	6.3	4.1	3.7	3.1	17.4	4.1	4.3	3.8	10.0	4.1	6.4	4.1	4.5	3.7	8.3	4.1	10.2	4.9	10.2	5.0	4.3	7.0	4.8	6.2	7.0	4.8	4.9	26.4	14.2	9.9	20.8	19.2	22.2	2.9	13.1	31.3	16.3	31.7	4.7	13.8	6.1	9.3	21.7	5.5	10.9	5.2	13.3	18.1	14.4	10.9	8.1	11.4	7.6	7.5	11.6	24.5	14.8	3.0	15.5	15.9	50.3	30.1	2.7	8.1	10.5	16.4	3.2	2.0	6.0	4.7	2.5	35.1	2.8	6.1	7.2	5.9	4.7	3.0	9.6	11.5	12.0	7.5	8.4	8.2	5.0	31.3	21.1	9.0	10.6	16.4	13.8	5.1	1.4	29.6	10.2	7.0	5.4	1.4	1.4	20.0	1.6	14.2	2.1	5.9	14.3	1.7	1.8	4.3	8.9	0.3	10.9	1.8	3.5	2.6	6.9	2.5	3.2	4.4	2.8	2.1	3.8	4.9	4.8	4.1	4.1	5.0	4.9	22.4	16.0	13.1	6.2	12.1	13.6	5.6	22.7	5.2	14.6	6.1	6.1	12.2	7.2	9.8	11.0	14.6	10.7	23.1	4.9	0.0	13.3	171.6	6.7	12.0	28.0	4.8	15.8	6.0	6.8	25.2	15.8	2.6	10.5	14.0	7.1	38.2	5.2	12.5	20.2	5.7	4.6	2.0	18.1	16.7	234.7	16.1	11.0	17.8	11.2	11.4	8.3	69.0	5.0	6.5	10.3	5.2	14.7	10.2	8.9	2.6	3.4	9.8	13.0	6.6	14.3	11.7	20.7	19.0	5.5	11.5	9.7	19.9	6.8	3.1	6.4
FUT2	"SE, Se2, SEC2, sej"	ENSG00000176920	"Fucosyltransferase 2"	Q10981	19	48695971-48705951	"Blood group antigen proteins, Enzymes, Metabolic proteins, Predicted membrane proteins"		"Blood group antigen, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 44.5;salivary gland: 66.2;stomach 1: 28.9"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 56.4;Club cells: 69.4;Distal enterocytes: 110.0;Gastric mucus-secreting cells: 83.6;Ionocytes: 57.0;Paneth cells: 75.5;Proximal enterocytes: 182.4;Undifferentiated cells: 62.9"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	4	"cerebellum: 5.5"	"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	7	"CAPAN-2: 63.6;OE19: 76.1"	"Region enhanced"	"Detected in some"		"cerebellum: 2.3"	"Low region specificity"	"Detected in all"			HPA014402	Uncertain		Uncertain	"Plasma membrane,Cytosol"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Plasma membrane, Cytosol"		"HPA014402: AB_1849194"	"unprognostic (2.95e-2)"	"unprognostic (6.07e-2)"	"unprognostic (2.80e-3)"	"unprognostic (4.63e-3)"	"unprognostic (2.63e-1)"	"prognostic favorable (5.83e-4)"	"unprognostic (6.30e-3)"	"unprognostic (6.55e-3)"	"unprognostic (1.58e-1)"	"unprognostic (8.44e-2)"	"unprognostic (7.89e-2)"	"unprognostic (5.11e-1)"	"unprognostic (4.04e-2)"	"unprognostic (6.52e-3)"	"unprognostic (1.73e-1)"	"unprognostic (3.12e-1)"	"unprognostic (2.87e-1)"	0.2	0.6	0.8	6.2	0.9	0.3	1.7	5.5	1.2	16.0	0.0	23.5	44.5	1.1	0.1	26.0	2.6	13.5	0.5	0.9	0.0	1.0	0.3	0.9	0.5	0.2	0.1	1.1	5.2	0.1	2.0	0.1	0.3	1.4	19.8	0.9	66.2	2.9	0.7	4.8	21.9	0.8	0.0	0.6	28.9	0.8	0.4	0.6	0.7	0.0	6.6	6.3	9.7	0.6	2.0	1.5	0.3	0.9	0.0	0.0	0.2	0.2	0.0	0.0	0.0	7.2	63.6	0.7	0.5	0.0	0.3	10.6	0.0	0.0	0.0	0.5	0.5	0.6	0.6	0.3	0.0	0.1	0.6	0.0	0.1	0.0	0.0	1.0	0.0	1.2	0.1	0.8	0.1	0.5	0.7	1.5	0.4	76.1	0.3	0.5	0.2	3.0	0.0	0.6	3.4	0.5	0.3	0.6	0.1	0.4	9.5	0.1	0.3	0.4	0.4	0.5	0.2	0.7	0.5	0.1	0.3	0.4	0.2	1.1	0.1	0.1	0.4	0.1	0.2	0.3	0.5	0.2	0.1	0.3	0.4	0.1	0.5	0.2	0.1	0.4	0.6	0.2	0.8	0.9	5.5	1.2	0.9	0.0	0.2	0.1	0.3	0.0	0.4	0.6	0.5	0.0	0.6	0.7	0.6	0.9	2.3	56.4	5.7	2.5	6.1	3.0	0.8	32.9	69.4	20.2	2.1	0.1	0.4	110.0	1.9	4.7	0.5	8.4	2.7	0.7	11.4	0.0	2.3	46.5	0.0	0.5	83.6	23.9	0.0	0.1	0.0	0.1	0.1	0.0	1.4	42.1	57.0	0.3	0.3	0.2	0.0	0.3	1.8	0.0	0.3	0.5	2.1	0.5	1.2	31.8	75.5	0.0	0.2	2.9	182.4	0.1	37.8	4.2	0.0	1.2	2.4	0.3	0.2	9.9	1.4	0.1	0.8	0.3	62.9	19.4
FUT4	"CD15, ELFT, FCT3A, FUC-TIV"	ENSG00000196371	"Fucosyltransferase 4"	P22083	11	94543840-94549898	"Metabolic proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"bone marrow: 100.8"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 22.8;Ductal cells: 19.3;Gastric mucus-secreting cells: 21.9;Intestinal goblet cells: 23.7;Pancreatic endocrine cells: 22.5"	"Cancer enhanced"	"Detected in all"		"colorectal cancer: 11.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HL-60: 37.4;NB-4: 24.2;THP-1: 46.6;U-937: 32.9"	"Low region specificity"	"Detected in single"							"CAB000014, CAB016129"	Enhanced		Approved	Vesicles		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 27: Mucus-secreting cells - Mucin production"	Vesicles		"CAB000014: , CAB016129: AB_626918"	"unprognostic (6.36e-2)"	"unprognostic (7.53e-2)"	"unprognostic (4.70e-3)"	"unprognostic (2.46e-3)"	"unprognostic (1.46e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.66e-2)"	"prognostic unfavorable (3.64e-4)"	"unprognostic (7.26e-2)"	"unprognostic (4.14e-1)"	"unprognostic (4.81e-3)"	"unprognostic (1.27e-1)"	"unprognostic (9.08e-3)"	"unprognostic (8.17e-2)"	"unprognostic (1.37e-1)"	"unprognostic (4.04e-1)"	"unprognostic (3.10e-3)"	3.7	1.2	1.3	4.7	1.1	100.8	2.5	1.2	1.4	2.3	0.2	9.2	12.3	2.8	1.2	1.8	2.1	3.7	1.7	1.6	1.1	1.9	1.5	2.1	3.7	1.3	1.0	2.9	6.7	0.5	1.3	3.1	1.3	1.6	8.7	1.6	6.8	2.2	0.9	0.8	10.8	2.5	1.6	3.6	10.8	1.3	1.4	3.7	1.2	1.1	2.8	2.1	1.3	1.9	2.9	1.4	1.7	0.0	5.3	4.8	8.9	2.6	1.3	2.3	2.5	12.5	4.0	0.0	6.1	4.4	1.2	1.4	2.9	0.3	2.1	19.1	2.9	9.4	2.2	0.3	2.7	37.4	8.0	4.1	0.1	2.9	0.0	0.5	3.6	8.3	9.7	0.0	2.7	1.4	7.9	24.2	3.4	11.6	3.4	6.9	0.0	0.0	2.4	1.9	2.4	0.9	1.5	3.7	1.5	5.1	2.1	46.6	3.3	1.8	4.9	0.0	1.0	1.1	0.6	0.0	1.6	32.9	1.1	0.5	0.8	0.7	0.2	0.4	0.1	0.1	0.2	0.3	0.4	0.1	0.2	0.1	0.3	0.2	1.2	0.5	0.5	0.2	1.3	1.1	1.2	1.4	1.6	1.1	1.3	1.0	1.3	1.6	1.4	1.9	2.9	0.0	0.0	1.3	1.8	1.7	3.0	0.9	1.2	1.0	1.8	1.8	0.9	22.8	1.9	1.8	4.2	15.6	2.6	12.1	0.0	19.3	0.3	1.1	2.8	2.3	10.2	3.4	1.5	17.9	3.2	6.0	21.9	3.3	0.0	2.6	3.9	1.0	9.0	0.0	1.9	23.7	0.0	12.9	3.5	0.8	4.4	5.2	3.6	3.7	13.6	0.4	0.0	3.0	3.4	22.5	5.8	1.2	0.5	2.9	11.6	2.4	1.7	7.9	0.0	3.1	2.6	1.7	3.5	2.1	0.6	2.2	3.1	2.0	17.9	1.4
FUT7		ENSG00000180549	"Fucosyltransferase 7"	Q11130	9	137030174-137032088	"Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"bone marrow: 3.9;brain: 2.5;lymphoid tissue: 6.1"	"Group enriched"	"Detected in some"	8	"dendritic cells: 66.9;Langerhans cells: 38.7;monocytes: 20.7;NK-cells: 28.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 210.0"	"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"NB-4: 23.7;THP-1: 24.0;U-937: 14.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA042780			Approved	"Golgi apparatus"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 2: Immune cells - Immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Golgi apparatus"		"HPA042780: AB_2678162"	"unprognostic (1.33e-2)"	"unprognostic (4.20e-4)"	"unprognostic (2.36e-1)"	"unprognostic (1.39e-2)"	"unprognostic (5.42e-2)"	"unprognostic (5.01e-6)"	"unprognostic (2.50e-1)"	"unprognostic (2.35e-2)"	"unprognostic (6.75e-4)"	"unprognostic (4.68e-1)"	"unprognostic (1.72e-2)"	"unprognostic (3.20e-1)"	"unprognostic (6.69e-6)"	"unprognostic (3.99e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.75e-2)"	0.3	0.1	0.6	1.7	1.7	3.9	0.1	1.0	1.3	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.3	0.2	0.1	0.7	1.2	0.1	0.1	0.9	4.6	1.9	1.2	0.0	0.0	0.0	0.2	0.1	1.1	0.1	0.0	0.0	0.2	0.0	0.0	0.4	0.4	0.1	0.7	6.1	0.3	0.2	1.2	1.0	0.2	0.4	3.2	0.3	0.1	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.1	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	23.7	0.0	0.2	0.0	1.2	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	24.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.3	0.0	2.0	7.5	1.5	10.4	1.6	52.5	20.1	52.1	28.9	21.7	5.5	0.9	4.3	91.6	127.1	0.2	210.0	90.2	15.4	0.6	1.7	1.0	1.3	0.7	1.2	1.9	1.2	1.1	0.7	1.2	2.5	0.1	0.0	0.0	0.0	3.7	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	66.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.1	0.2	0.0	3.7	38.7	0.0	0.0	2.7	0.0	0.0	20.7	0.0	28.8	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	4.6	0.0	0.7	0.0
FUT9	Fuc-TIX	ENSG00000172461	"Fucosyltransferase 9"	Q9Y231	6	96015974-96215612	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 18.9;stomach 1: 23.2"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 776.4;Excitatory neurons: 333.5;Inhibitory neurons: 238.2;Oligodendrocyte precursor cells: 168.9;Oligodendrocytes: 224.7"	"Cancer enhanced"	"Detected in some"		"glioma: 1.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MCF7: 2.9;OE19: 2.8;RT4: 6.5;SCLC-21H: 6.3;SK-BR-3: 3.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070923			Approved	"Nucleoplasm,Microtubules,Cytokinetic bridge,Cytosol"		Yes	No				"Cluster 22: Non-specific - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm	"Microtubules, Cytokinetic bridge, Cytosol"	"HPA070923: AB_2686323"	"unprognostic (1.60e-1)"	"unprognostic (2.48e-1)"		"unprognostic (5.99e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.40e-1)"		"unprognostic (2.97e-1)"		"unprognostic (1.35e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.43e-3)"	"unprognostic (5.60e-2)"	"unprognostic (1.65e-2)"	"unprognostic (3.03e-2)"	0.0	0.4	10.5	0.0	12.6	0.0	0.6	14.5	11.7	0.0	0.0	0.1	2.1	0.2	0.0	0.0	0.2	0.0	0.0	11.8	13.6	0.2	0.0	0.0	0.0	3.4	18.9	0.0	4.8	0.0	0.4	0.4	3.2	0.2	0.0	0.5	0.0	0.2	0.1	0.1	0.0	0.0	5.5	0.0	23.2	0.0	15.3	0.0	0.1	0.0	0.0	0.9	0.0	6.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	1.4	2.8	0.0	0.0	0.0	0.0	0.0	6.5	6.3	0.1	0.0	3.6	0.0	0.1	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	12.6	14.5	11.7	11.8	13.6	3.4	18.9	3.2	5.5	15.3	6.4	0.0	0.0	0.0	776.4	0.2	0.0	0.6	0.0	0.0	4.2	1.4	1.7	0.8	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.3	0.5	0.1	1.3	0.0	0.0	333.5	2.0	0.0	0.1	56.1	1.4	0.0	0.4	0.0	0.0	0.1	0.0	238.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.1	0.0	0.2	0.0	168.9	224.7	0.5	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.2
GAL3ST1	CST	ENSG00000128242	"Galactose-3-O-sulfotransferase 1"	Q99999	22	30554635-30574665	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid metabolism, Sphingolipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 51.6;intestine: 24.4;kidney: 18.4"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 30.0;Muller glia cells: 35.3;Oligodendrocyte precursor cells: 26.7;Oligodendrocytes: 53.6;Proximal enterocytes: 48.1;Proximal tubular cells: 24.6"	"Cancer enriched"	"Detected in many"	6	"renal cancer: 38.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 27.6;CACO-2: 7.7;EFO-21: 14.6;K-562: 6.6;OE19: 10.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001220, HPA077138"	Approved		Uncertain	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 45: Intestine - Brush border"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Vesicles	Nucleoplasm	"HPA001220: AB_1078933, HPA077138: "	"unprognostic (2.69e-2)"	"unprognostic (3.12e-4)"	"unprognostic (5.93e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.32e-1)"	"unprognostic (6.50e-3)"	"unprognostic (1.53e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.89e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.43e-2)"	"prognostic unfavorable (1.79e-4)"	"unprognostic (2.33e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.56e-2)"	1.3	0.2	14.8	0.4	33.3	0.8	1.1	27.7	25.8	2.7	0.3	5.2	23.0	2.4	1.7	0.5	3.1	5.2	1.1	14.6	18.3	18.4	4.0	1.9	0.7	32.9	29.0	2.3	6.9	0.7	1.5	0.9	31.0	3.1	2.4	2.3	0.5	1.4	3.1	1.6	24.4	0.3	23.2	0.3	8.2	5.0	29.1	0.1	0.2	0.3	0.0	1.6	1.8	51.6	0.0	27.6	0.5	0.2	0.0	0.0	2.0	0.0	0.2	0.0	0.0	7.7	3.8	0.4	14.6	0.0	0.5	0.1	0.0	0.0	0.0	0.3	0.7	0.4	0.4	5.7	0.6	0.2	0.2	0.2	0.0	0.1	0.2	0.0	0.0	0.4	6.6	0.6	0.0	0.2	0.3	1.1	3.9	10.6	0.4	0.2	0.0	0.7	1.1	0.1	0.3	1.8	0.0	0.4	0.2	0.7	0.2	0.2	0.8	0.2	0.2	0.3	0.0	2.4	1.2	0.3	0.1	0.1	0.2	0.2	0.1	0.0	0.0	0.1	0.1	0.4	0.1	0.1	0.0	0.3	0.1	0.1	0.5	0.0	0.0	0.6	0.0	0.0	14.8	33.3	27.7	25.8	14.6	18.3	32.9	29.0	31.0	23.2	29.1	51.6	0.5	0.0	0.0	2.3	0.3	0.4	0.1	0.0	0.0	0.8	0.6	3.3	0.6	30.0	0.0	3.7	0.0	0.1	0.0	14.0	15.6	7.0	1.1	1.1	0.3	0.3	10.9	2.7	2.0	11.1	0.1	0.3	5.1	2.4	0.0	0.9	0.0	1.6	0.1	0.0	1.9	5.7	0.0	0.3	0.3	0.8	1.5	0.2	0.0	0.0	0.0	35.3	0.0	26.7	53.6	5.0	8.8	2.2	0.1	0.4	48.1	24.6	0.1	1.3	0.0	2.1	0.3	12.4	14.3	0.0	0.3	0.3	0.2	0.0	7.6	0.1
GALC		ENSG00000054983	Galactosylceramidase	P54803	14	87837820-87993665	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid degradation, Lipid metabolism, Sphingolipid metabolism"	"Glycosidase, Hydrolase"	"Disease variant, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"granulocytes: 68.4;Kupffer cells: 72.1;Late spermatids: 77.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 84.3;HMC-1: 78.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB022196	Approved				"Intracellular and membrane"	NA	NA		53000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"			"CAB022196: "	"unprognostic (1.27e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.16e-2)"	"unprognostic (9.39e-2)"	"unprognostic (3.08e-1)"	"unprognostic (9.70e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.56e-2)"	"unprognostic (8.44e-3)"	"unprognostic (8.08e-2)"	"unprognostic (1.84e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.13e-1)"	"unprognostic (6.80e-2)"	"unprognostic (2.72e-2)"	15.0	17.2	20.0	14.9	23.3	23.2	13.3	22.1	26.1	12.0	20.8	15.1	33.3	11.1	12.2	6.6	20.7	18.4	13.5	18.5	21.6	21.3	12.1	23.9	11.7	23.0	22.6	15.8	10.8	9.4	9.8	16.8	23.9	14.3	17.3	18.4	8.1	9.3	8.0	9.1	34.4	9.6	22.3	15.4	16.4	24.0	20.8	9.7	24.5	12.9	7.9	13.6	7.5	30.6	0.0	19.5	7.2	0.0	23.8	21.3	0.0	9.1	17.9	8.3	9.9	10.8	84.3	5.3	26.4	8.7	0.0	1.3	0.0	1.0	10.2	2.7	0.6	29.8	0.7	0.0	19.5	0.1	78.4	20.7	6.6	5.6	0.0	3.4	22.6	0.0	10.0	3.9	14.4	1.9	0.0	4.5	6.5	35.4	2.2	0.0	0.5	0.3	13.4	7.8	6.7	15.6	24.6	4.0	0.2	17.2	20.4	20.5	19.7	0.0	12.9	5.6	0.2	4.2	8.0	0.0	2.3	6.8	19.2	25.3	15.2	34.2	11.1	16.6	24.0	2.5	8.3	10.8	8.9	1.2	6.0	7.0	11.9	16.3	13.4	1.6	5.3	11.7	20.0	23.3	22.1	26.1	18.5	21.6	23.0	22.6	23.9	22.3	20.8	30.6	11.3	25.6	19.0	26.8	8.0	8.4	5.6	9.4	3.4	10.1	9.1	5.2	9.2	10.0	8.9	14.7	12.5	6.2	27.6	15.3	3.9	9.8	51.6	17.3	10.9	11.4	6.1	13.7	17.8	11.4	12.7	15.2	7.7	5.8	68.4	15.9	18.2	6.1	26.6	3.3	21.2	10.2	4.1	72.1	11.8	77.9	16.1	25.0	10.6	8.4	26.7	7.3	40.2	33.2	42.6	14.1	20.0	10.1	9.3	6.1	15.9	6.7	22.1	10.4	0.0	9.8	10.6	14.9	10.0	3.5	11.5	6.6	21.2	12.9	16.7	7.9
GALNS	"GALNAC6S, GAS"	ENSG00000141012	"Galactosamine (N-acetyl)-6-sulfatase"	P34059	16	88813734-88856970	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease variant, Dwarfism, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 51.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"dendritic cells: 11.3;granulocytes: 31.3;monocytes: 17.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026404, HPA042433, HPA074225"	Supported		Approved	Cytosol	"Intracellular and membrane"	NA	NA		2000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 18: U-2197 - ECM organization"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Cytosol		"CAB026404: , HPA042433: AB_2732499, HPA074225: "	"unprognostic (3.16e-1)"	"unprognostic (9.98e-2)"	"unprognostic (4.03e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.11e-1)"	"unprognostic (8.08e-3)"	"prognostic unfavorable (3.66e-4)"	"unprognostic (4.15e-3)"	"unprognostic (1.32e-1)"	"unprognostic (4.84e-3)"	"unprognostic (2.00e-1)"	"unprognostic (3.53e-2)"	"unprognostic (4.12e-3)"	"unprognostic (4.24e-2)"	"unprognostic (5.54e-2)"	"unprognostic (3.59e-2)"	"unprognostic (6.84e-2)"	9.2	12.8	9.4	9.3	10.0	22.2	6.3	10.0	11.5	9.1	22.1	10.0	10.6	7.4	14.5	8.8	11.4	9.7	11.0	10.6	12.0	8.6	8.1	10.4	7.4	12.6	16.4	6.7	5.0	8.6	11.9	8.6	12.0	7.7	6.1	3.3	8.3	4.7	6.4	8.4	10.6	7.1	10.8	9.1	8.1	26.3	11.3	4.8	9.1	3.6	5.6	9.0	9.1	12.0	5.7	42.7	6.2	43.4	47.1	22.4	41.9	17.9	27.3	19.1	14.7	22.7	36.8	7.1	37.1	29.2	28.8	33.0	9.0	14.2	11.4	4.7	13.8	4.5	17.0	13.2	31.5	3.6	28.5	31.4	26.9	21.4	6.0	27.0	16.4	7.8	9.9	4.1	11.3	33.3	9.2	15.0	14.2	14.3	19.6	19.6	5.4	12.1	11.9	13.2	15.8	12.2	42.4	4.0	21.9	14.4	27.3	32.5	31.3	41.8	31.5	43.2	10.0	4.3	4.5	12.6	45.2	29.7	25.4	1.4	17.4	31.3	4.5	12.5	3.9	3.0	2.5	4.0	11.3	1.3	2.5	3.1	21.7	4.0	9.6	4.7	4.6	8.5	9.4	10.0	10.0	11.5	10.6	12.0	12.6	16.4	12.0	10.8	11.3	12.0	4.8	16.0	4.8	9.4	5.9	6.5	7.3	27.7	9.1	5.0	6.8	5.0	8.4	4.3	11.0	3.7	6.2	9.9	8.5	16.8	3.9	5.7	21.0	27.2	9.6	7.2	12.0	1.3	7.6	3.7	14.0	13.8	6.1	8.9	1.3	11.9	7.5	6.4	18.7	25.2	10.4	6.8	8.2	13.2	6.3	37.3	7.2	11.3	7.2	2.8	18.2	8.8	14.4	4.0	9.8	5.6	13.6	6.8	9.9	6.7	17.3	5.9	35.1	10.0	6.6	9.4	9.0	51.3	42.8	6.3	5.7	15.9	7.9	16.5	10.1	6.8
GALNT7	GALNAC-T7	ENSG00000109586	"Polypeptide N-acetylgalactosaminyltransferase 7"	Q86SF2	4	173168811-173323967	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 143.4;Inhibitory neurons: 172.0;Intestinal goblet cells: 126.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064243, HPA065317"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA		6200000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Golgi apparatus"	Nucleoplasm	"HPA064243: AB_2685223, HPA065317: AB_2685465"	"unprognostic (1.81e-1)"	"unprognostic (2.11e-1)"	"prognostic favorable (4.53e-4)"	"unprognostic (1.37e-3)"	"unprognostic (1.48e-1)"	"unprognostic (6.86e-3)"	"unprognostic (2.72e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.85e-2)"	"unprognostic (2.25e-1)"	"prognostic unfavorable (7.65e-4)"	"unprognostic (1.33e-1)"	"unprognostic (4.66e-3)"	"unprognostic (3.05e-1)"	"unprognostic (3.19e-1)"	"unprognostic (2.34e-3)"	"unprognostic (5.97e-2)"	6.4	6.4	6.4	16.3	8.8	11.5	23.3	34.2	8.3	25.1	3.5	47.8	29.1	16.9	7.0	14.9	9.8	15.6	5.9	6.6	7.8	7.8	2.9	9.6	12.2	12.6	8.3	11.2	22.2	8.7	5.2	13.0	11.7	39.7	52.8	22.4	27.4	8.1	1.4	3.9	33.7	16.7	10.1	11.0	65.7	11.9	8.4	60.0	13.5	3.9	9.8	17.0	5.9	16.0	71.1	37.2	35.0	11.2	18.6	27.1	50.3	18.1	20.5	16.7	23.0	11.5	109.9	39.4	13.3	16.6	45.2	59.2	15.0	32.0	22.7	154.3	29.1	47.8	72.2	0.4	12.2	71.6	32.8	17.5	28.3	37.6	18.9	63.4	112.3	28.2	32.6	59.3	86.0	23.5	52.7	39.4	34.8	70.2	24.0	52.1	32.4	10.2	123.2	32.8	28.2	21.5	8.5	50.4	25.4	45.3	20.2	21.0	135.6	11.9	52.3	0.6	40.0	17.2	0.2	20.8	48.6	42.3	43.6	13.2	14.3	18.9	5.1	7.5	7.2	6.2	5.7	5.3	12.4	3.3	4.4	3.3	21.3	7.5	8.0	5.0	9.2	6.4	6.4	8.8	34.2	8.3	6.6	7.8	12.6	8.3	11.7	10.1	8.4	16.0	10.0	6.4	38.0	72.8	12.1	1.8	9.0	12.3	4.0	47.9	41.1	19.8	9.6	8.6	36.0	20.2	2.1	1.4	16.4	143.4	0.0	14.4	2.5	28.3	13.3	11.3	22.8	12.0	74.4	48.9	3.7	12.1	102.4	52.9	24.1	14.8	12.1	0.2	10.3	10.1	172.0	126.8	24.4	17.9	6.2	4.2	9.3	17.2	8.8	62.8	16.3	8.1	5.2	71.4	54.1	39.9	50.0	5.3	6.6	52.8	63.7	10.0	17.4	25.5	13.1	16.1	11.7	3.8	5.5	14.9	1.1	0.8	9.9	13.1	48.6	19.4
GALNTL5	"GalNAc-T5L, GALNT15"	ENSG00000106648	"Polypeptide N-acetylgalactosaminyltransferase like 5"	Q7Z4T8	7	151956379-152019929	"Disease related genes, Metabolic proteins, Predicted membrane proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	7	"testis: 10.8"	"Group enriched"	"Detected in some"	77	"Early spermatids: 432.4;Late spermatids: 500.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA011140	Enhanced					NA	NA				"Cluster 78: Testis - Spermatogenesis"		"Cluster 25: Spermatids - Spermatogenesis"			"HPA011140: AB_1078944"					"unprognostic (2.33e-2)"									"unprognostic (2.09e-1)"	"unprognostic (1.55e-1)"			0.0	0.0	0.6	0.0	0.7	0.0	0.0	0.6	1.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.6	0.0	0.0	0.0	0.0	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	10.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.6	1.6	0.8	0.6	0.6	0.6	0.6	0.6	0.6	0.8	0.0	3.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	432.4	0.0	0.0	0.9	0.0	0.0	1.8	0.0	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	500.9	3.1	0.3	0.0	1.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	6.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GBA	"GBA1, GLUC"	ENSG00000177628	"Glucosylceramidase beta"	P04062	1	155234452-155244699	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cholesterol metabolism, Lipid metabolism, Sphingolipid metabolism, Steroid metabolism, Sterol metabolism"	"Glycosidase, Glycosyltransferase, Hydrolase, Transferase"	"Disease variant, Gaucher disease, Ichthyosis, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 65.2;Syncytiotrophoblasts: 59.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006667, CAB037171, CAB037289"	Supported				"Intracellular and membrane"	NA	NA		470000	"Cluster 14: Monocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 10: Non-specific - Unknown function"			"CAB037171: AB_1078958, CAB037289: AB_1078957, HPA006667: AB_1078979"	"unprognostic (6.03e-2)"	"unprognostic (6.02e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.42e-1)"	"unprognostic (6.00e-3)"	"unprognostic (2.97e-1)"	"unprognostic (1.04e-3)"	"unprognostic (4.76e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.02e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.04e-2)"	"unprognostic (3.15e-1)"	"unprognostic (2.94e-2)"	23.9	37.9	22.5	24.8	24.4	41.7	25.1	25.9	24.3	26.7	27.4	35.1	23.9	22.9	50.2	27.6	20.5	28.3	19.1	26.1	27.7	33.6	33.7	28.3	19.9	27.3	28.0	16.9	33.4	103.1	43.8	39.2	36.2	23.3	39.8	12.4	26.8	33.6	9.1	33.4	22.5	29.7	25.0	29.0	22.7	8.8	29.2	19.7	37.7	13.6	28.0	27.1	21.9	29.5	38.0	72.2	25.1	34.2	254.8	55.8	29.3	65.4	230.4	95.3	119.0	43.2	135.7	26.3	70.4	153.7	152.0	76.2	35.9	46.4	50.3	55.5	25.1	21.8	45.1	23.2	73.6	25.8	87.0	73.4	38.2	199.7	30.2	100.2	85.6	22.2	23.4	42.9	113.5	82.6	32.5	11.9	16.3	61.9	51.2	26.8	41.9	108.1	63.9	29.0	23.9	33.5	57.4	136.4	145.3	45.6	102.6	63.3	65.7	71.7	31.7	91.9	53.7	86.2	78.6	20.4	126.6	23.4	56.4	21.4	36.0	15.3	20.8	35.8	13.2	11.1	15.7	13.8	22.4	7.8	11.0	11.7	28.9	11.6	37.2	12.5	23.4	23.3	22.5	24.4	25.9	24.3	26.1	27.7	27.3	28.0	36.2	25.0	29.2	29.5	6.8	3.2	5.1	3.3	8.8	6.0	5.8	9.5	4.6	4.0	12.7	6.5	8.8	17.2	8.1	12.9	2.1	30.7	6.2	36.1	3.9	30.5	1.4	12.3	9.7	12.2	14.6	7.4	3.4	32.4	27.9	18.6	20.9	17.9	7.0	7.9	17.2	23.2	65.2	5.0	2.7	11.6	4.1	33.3	9.9	2.8	9.9	26.8	26.6	1.0	22.8	11.7	12.3	0.5	3.3	29.5	15.8	9.1	19.8	6.7	28.6	20.6	8.5	6.0	0.0	9.4	21.6	22.5	12.5	8.6	4.4	59.4	8.5	6.0	10.4	6.5
GBA2	"AD035, DKFZp762K054, KIAA1605, SPG46"	ENSG00000070610	"Glucosylceramidase beta 2"	Q9HCG7	9	35736866-35749228	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cholesterol metabolism, Lipid metabolism, Sphingolipid metabolism, Steroid metabolism, Sterol metabolism"	"Glycosidase, Glycosyltransferase, Hydrolase, Transferase"	"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 114.7;Rod photoreceptor cells: 102.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024026	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Golgi apparatus"	Cytosol	"HPA024026: AB_1849530"	"unprognostic (3.34e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.83e-3)"	"unprognostic (2.20e-2)"	"unprognostic (2.09e-2)"	"unprognostic (3.99e-2)"	"unprognostic (8.69e-2)"	"prognostic favorable (6.00e-4)"	"unprognostic (9.01e-3)"	"prognostic favorable (1.24e-11)"	"unprognostic (7.62e-3)"	"unprognostic (2.94e-1)"	"unprognostic (7.69e-2)"	"prognostic favorable (6.60e-4)"	39.3	45.7	48.5	23.2	47.5	16.3	39.9	52.8	53.7	46.4	63.3	83.5	54.2	44.6	26.9	36.3	44.2	26.3	83.3	47.2	54.2	84.4	65.9	54.1	24.6	54.1	56.2	39.8	54.1	37.2	65.5	24.7	56.1	60.2	41.0	71.1	50.0	27.7	75.8	39.3	89.7	22.9	45.1	58.5	63.9	30.8	58.9	18.3	61.7	43.7	21.6	53.0	40.9	48.7	18.1	29.3	39.6	38.4	18.8	11.4	40.0	24.1	18.8	23.9	25.0	32.8	14.1	19.3	17.1	14.7	51.5	18.4	38.2	16.2	12.0	27.5	26.2	20.8	87.8	35.6	20.8	31.2	49.4	19.8	29.8	20.3	21.1	57.9	63.4	18.9	20.7	36.0	22.6	18.0	8.5	32.0	41.2	36.6	45.7	15.5	16.0	16.3	33.3	41.9	32.2	43.0	13.5	33.3	24.5	48.1	22.8	27.8	44.6	25.8	30.9	22.4	29.9	24.2	16.5	16.0	32.3	11.3	20.5	11.1	2.9	2.0	3.8	3.9	2.5	3.7	3.7	4.7	2.8	4.7	2.2	1.9	3.2	2.4	2.5	4.4	2.8	2.2	48.5	47.5	52.8	53.7	47.2	54.2	54.1	56.2	56.1	45.1	58.9	48.7	12.7	12.8	8.0	45.1	11.2	7.4	18.2	9.4	6.2	77.5	15.0	10.8	13.7	17.2	14.5	27.6	114.7	11.1	16.6	71.7	21.5	10.5	14.1	10.0	8.1	16.0	35.8	17.2	23.5	12.0	10.2	8.0	46.4	13.8	14.0	18.7	30.7	20.1	9.2	52.2	26.4	35.8	16.2	12.8	10.7	24.3	12.5	10.7	12.4	8.4	13.3	16.2	12.3	18.1	20.2	15.1	57.6	9.8	11.7	15.8	87.4	17.8	17.9	102.9	13.1	12.2	12.2	9.2	5.7	8.8	9.9	22.2	9.4	11.3	41.4	26.3
GBGT1	"A3GALNT, FS, MGC44848, UDP-GalNAc"	ENSG00000148288	"Globoside alpha-1,3-N-acetylgalactosaminyltransferase 1 (FORS blood group)"	Q8N5D6	9	133152948-133163933	"Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 16.4;Hofbauer cells: 21.3;Kupffer cells: 31.9;Macrophages: 22.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 64.1;HMC-1: 57.1;HUVEC TERT2: 24.0;NB-4: 29.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA051298	Approved				"Intracellular and membrane"	NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"			"HPA051298: AB_2681428"	"unprognostic (4.63e-3)"	"unprognostic (8.03e-2)"	"prognostic unfavorable (6.22e-4)"	"unprognostic (2.70e-1)"	"unprognostic (8.87e-2)"	"unprognostic (4.38e-1)"	"unprognostic (2.97e-2)"	"unprognostic (7.43e-2)"	"unprognostic (9.04e-2)"	"unprognostic (2.27e-3)"	"unprognostic (2.35e-1)"	"unprognostic (9.50e-2)"	"prognostic unfavorable (3.46e-5)"	"unprognostic (2.92e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.41e-2)"	"unprognostic (6.35e-2)"	9.9	10.5	6.3	11.0	5.9	9.9	6.5	11.8	7.0	5.4	11.8	5.3	3.3	6.7	2.7	3.6	7.4	7.5	6.7	5.9	8.2	5.6	1.3	9.7	9.7	13.5	11.2	12.5	3.4	4.8	4.2	12.8	13.8	6.1	3.2	1.0	4.8	4.2	2.2	3.5	6.7	6.7	7.7	8.9	22.2	1.3	11.5	2.7	6.7	2.9	8.1	6.0	6.3	8.5	0.1	1.6	1.5	0.0	1.0	1.1	0.5	4.7	3.8	2.6	0.1	0.0	0.9	1.2	15.5	4.7	1.7	17.3	10.5	1.0	0.1	0.0	0.5	64.1	1.1	0.0	12.4	2.4	57.1	5.3	1.7	0.6	0.1	10.5	24.0	0.8	18.7	0.2	1.0	0.3	0.2	29.0	4.9	0.5	0.4	4.5	0.4	1.7	1.6	0.2	0.4	1.8	0.0	2.6	0.1	2.0	0.1	14.0	14.8	0.0	2.0	1.9	0.1	0.0	0.0	0.1	0.3	10.2	0.8	6.2	10.7	5.2	0.2	7.2	0.4	1.8	0.3	0.0	3.0	2.7	0.1	0.1	1.7	0.2	6.4	2.2	0.2	2.5	6.3	5.9	11.8	7.0	5.9	8.2	13.5	11.2	13.8	7.7	11.5	8.5	1.6	0.0	1.7	4.9	4.9	0.8	2.2	0.6	2.8	0.3	4.1	2.7	2.6	1.5	0.7	1.8	0.0	2.4	0.0	0.6	0.0	3.2	0.0	0.5	1.8	1.8	0.0	16.4	2.4	0.6	1.1	7.3	2.6	0.3	11.4	3.6	0.7	0.0	21.3	0.0	1.9	0.3	0.0	31.9	3.1	0.0	7.5	22.0	0.0	5.6	11.1	2.4	0.0	1.5	0.0	0.8	12.1	1.9	0.7	1.5	0.1	1.6	0.0	0.2	0.0	3.9	6.2	0.1	0.1	1.4	1.1	3.6	2.0	0.5	1.2	1.7
GCNT7	"C20orf105, dJ1153D9.2"	ENSG00000124091	"Glucosaminyl (N-acetyl) transferase family member 7"	Q6ZNI0	20	56491492-56525925	"Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	4	"bone marrow: 4.4"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 2.2;Excitatory neurons: 1.4;Inhibitory neurons: 1.2;Late spermatids: 1.0;Oligodendrocyte precursor cells: 3.0;Oligodendrocytes: 1.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA052617, HPA059403"	Uncertain		Approved	"Nuclear bodies,Vesicles,Cytosol"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 67: Neutrophils - Humoral immune response"		"Cluster 43: Cardiomyocytes - Nuclear processes"	"Nuclear bodies, Vesicles"	Cytosol	"HPA052617: AB_2681886, HPA059403: "	"unprognostic (3.57e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.74e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.96e-2)"	"unprognostic (9.08e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.13e-2)"	"unprognostic (4.38e-2)"	"unprognostic (2.38e-1)"	"unprognostic (9.69e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.16e-3)"	"unprognostic (1.84e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.96e-1)"	"unprognostic (8.69e-2)"	0.0	0.1	0.1	0.3	0.2	4.4	0.0	0.6	0.2	0.0	0.3	0.0	0.1	0.1	0.0	0.1	0.0	0.2	0.1	0.1	0.2	0.0	0.0	0.0	0.2	0.3	0.2	0.0	0.2	0.0	0.0	0.0	0.3	0.1	0.0	0.4	0.1	0.0	0.2	0.4	0.1	0.0	0.1	0.2	0.1	0.2	0.4	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.1	0.2	0.1	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.3	0.0	0.2	0.1	0.3	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.2	0.1	0.2	0.2	0.0	0.1	0.1	0.0	0.0	0.4	0.0	0.1	0.1	0.3	0.0	0.1	0.0	0.1	0.1	0.2	0.1	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.1	0.9	0.0	0.1	0.2	0.2	0.0	0.1	0.2	0.6	0.2	0.1	0.2	0.3	0.2	0.3	0.1	0.4	1.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.2	0.0	0.2	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
GLA	GALA	ENSG00000102393	"Galactosidase alpha"	P06280	X	101393273-101408012	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 229.9;Plasma cells: 171.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 328.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000237, HPA000966"	Enhanced				"Intracellular and membrane"	NA	NA		1300000	"Cluster 7: Monocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 7: Non-specific - Mitochondria"			"HPA000237: AB_1078968, HPA000966: AB_1078969"	"unprognostic (7.27e-3)"	"unprognostic (1.47e-2)"	"unprognostic (1.57e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.15e-2)"	"prognostic unfavorable (5.62e-5)"	"unprognostic (2.53e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.97e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.73e-2)"	"prognostic favorable (6.16e-4)"	"unprognostic (1.13e-1)"	"unprognostic (5.44e-2)"	"unprognostic (2.21e-1)"	15.6	21.5	5.2	12.7	5.4	25.1	26.7	6.6	6.9	13.8	6.2	13.0	22.4	10.9	17.5	9.3	15.2	11.8	9.9	5.6	6.2	15.6	12.7	17.2	13.2	7.0	7.3	9.2	6.7	31.7	9.9	22.1	7.3	7.9	15.3	6.9	10.0	39.3	6.2	9.2	13.5	15.4	6.5	13.2	9.3	3.8	6.9	12.0	7.9	6.5	15.6	14.7	9.1	8.1	30.5	117.9	30.8	31.9	68.9	26.8	13.8	34.1	51.9	63.5	176.3	64.7	45.9	33.6	70.0	35.3	151.8	70.3	65.9	38.3	53.8	19.3	47.1	18.3	87.9	78.4	19.2	26.7	328.1	24.3	11.3	72.9	21.6	17.4	50.9	18.2	28.6	71.2	60.8	52.3	24.4	53.7	48.2	72.5	46.4	18.2	39.5	81.5	95.1	61.9	11.5	19.4	78.6	34.6	30.9	54.4	15.2	51.2	29.9	20.7	23.8	52.6	27.0	23.0	26.3	25.4	36.9	39.9	23.1	22.5	37.3	11.9	6.9	38.5	9.0	8.8	5.6	8.8	29.8	9.0	5.6	6.9	21.6	5.6	40.6	10.9	7.3	20.4	5.2	5.4	6.6	6.9	5.6	6.2	7.0	7.3	7.3	6.5	6.9	8.1	31.5	16.0	10.2	3.3	65.8	30.2	32.6	23.7	45.5	4.0	34.0	23.2	7.7	4.3	19.3	11.0	6.2	38.4	25.5	26.5	17.6	22.5	3.9	57.6	19.5	30.8	33.9	12.6	3.2	18.7	26.3	66.1	39.8	97.6	31.0	9.6	8.9	7.1	93.0	8.4	3.9	15.9	20.3	28.5	229.9	0.9	11.1	115.7	88.9	4.7	30.3	17.5	14.4	3.0	3.9	14.4	25.3	18.0	171.4	20.5	30.9	9.5	29.9	5.3	6.6	22.6	70.8	6.4	5.8	31.0	23.7	75.5	33.2	19.8	19.2	27.9
GLB1	"EBP, ELNR1"	ENSG00000170266	"Galactosidase beta 1"	P16278	3	32996609-33097202	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease variant, Gangliosidosis, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 857.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008382, HPA040610, HPA069503"	Enhanced		Supported	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA		2700000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 4: Macrophages - Innate immune response"	Vesicles	"Golgi apparatus"	"CAB008382: AB_590642, HPA040610: AB_2677039, HPA069503: AB_2686142"	"unprognostic (1.51e-2)"	"unprognostic (3.66e-2)"	"unprognostic (5.02e-3)"	"unprognostic (9.66e-3)"	"unprognostic (9.61e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.31e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.08e-1)"	"prognostic favorable (1.14e-5)"	"unprognostic (3.05e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.20e-1)"	"unprognostic (5.85e-2)"	22.0	36.1	12.1	27.8	13.0	21.9	20.5	12.5	14.8	33.4	16.0	43.5	43.0	21.9	103.6	15.4	28.2	32.0	15.5	12.5	14.8	46.0	48.2	42.7	25.8	14.3	12.9	21.4	30.8	59.4	18.5	53.8	15.4	23.2	45.6	14.9	25.3	29.3	7.7	15.8	31.0	30.6	12.4	24.4	35.5	13.5	13.5	17.5	52.8	10.8	23.0	31.8	16.2	15.1	37.4	63.6	39.8	48.3	241.9	123.7	857.2	59.1	157.6	73.7	95.1	91.3	86.5	17.9	50.9	120.9	53.9	35.1	38.1	75.5	53.7	104.9	33.0	69.9	35.3	47.4	124.3	50.5	69.9	144.9	70.2	67.0	39.2	144.1	116.5	24.7	64.3	67.0	81.8	44.6	29.6	31.6	26.4	78.0	27.0	24.7	26.4	86.6	78.4	54.4	12.0	40.3	75.0	120.2	74.4	69.3	80.3	130.2	67.7	46.8	32.2	65.2	50.1	53.2	87.9	5.9	99.6	71.2	36.7	43.9	146.2	86.4	29.2	125.8	40.4	37.9	34.3	31.8	166.5	35.6	17.9	21.8	56.6	26.0	92.1	35.1	77.1	91.9	12.1	13.0	12.5	14.8	12.5	14.8	14.3	12.9	15.4	12.4	13.5	15.1	8.7	19.2	25.3	39.2	18.6	6.0	13.6	60.1	10.8	11.3	11.5	7.5	9.1	34.3	43.3	27.6	6.2	100.1	14.1	41.9	27.4	53.5	24.8	18.7	16.0	17.4	16.9	20.6	46.7	35.4	55.3	29.2	26.0	27.1	26.6	20.6	19.6	39.7	79.5	5.0	46.0	23.5	40.7	43.9	13.9	5.0	15.2	41.7	14.2	23.4	64.6	16.5	10.3	27.2	24.2	28.1	43.4	21.1	19.8	9.9	36.2	33.1	31.0	16.2	13.1	12.9	16.3	1.0	6.6	10.1	3.4	49.1	18.7	51.0	32.0	12.1
GLB1L	MGC10771	ENSG00000163521	"Galactosidase beta 1 like"	Q6UWU2	2	219236598-219245478	"Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 52.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 41.5;Spermatocytes: 117.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 19.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA043058	Enhanced				"Secreted - unknown location"	NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA043058: AB_10806375"	"unprognostic (4.30e-2)"	"unprognostic (6.93e-2)"	"unprognostic (2.68e-2)"	"unprognostic (2.08e-3)"	"unprognostic (4.35e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.67e-3)"	"unprognostic (3.32e-2)"	"unprognostic (4.77e-1)"	"unprognostic (2.39e-1)"	"unprognostic (8.48e-3)"	"unprognostic (3.27e-1)"	"unprognostic (3.62e-1)"	"unprognostic (1.28e-1)"	"unprognostic (9.23e-3)"	"unprognostic (1.33e-1)"	"unprognostic (8.50e-2)"	4.6	4.8	3.1	4.0	3.4	4.5	5.3	3.3	3.0	5.3	14.7	3.1	3.1	5.9	11.4	2.5	23.1	9.0	2.2	3.0	3.7	13.6	3.1	5.3	3.0	5.5	7.0	7.1	3.1	14.4	6.8	8.5	4.5	5.6	3.7	8.0	4.5	4.8	0.9	4.6	4.1	5.8	4.4	4.9	2.8	52.3	3.7	3.4	8.4	1.0	3.4	5.9	2.1	5.6	2.8	4.8	7.4	5.9	8.0	9.8	3.7	4.6	9.7	5.7	5.3	1.9	7.7	0.9	4.1	4.1	4.3	1.5	1.9	4.6	4.5	2.6	3.6	2.9	6.9	4.5	19.7	1.1	4.4	11.4	2.9	5.4	3.3	13.5	5.3	4.3	1.8	5.3	5.4	4.0	2.5	2.7	1.3	1.0	1.3	2.5	4.1	4.0	11.5	1.6	4.7	4.2	3.9	5.3	4.3	4.9	8.4	2.6	4.1	4.7	5.8	2.8	2.6	5.0	1.7	1.5	8.8	1.2	12.3	1.9	5.1	0.3	0.7	6.4	0.4	0.4	0.5	0.7	2.1	1.0	1.1	0.7	2.1	1.0	5.4	0.9	0.2	1.7	3.1	3.4	3.3	3.0	3.0	3.7	5.5	7.0	4.5	4.4	3.7	5.6	3.2	3.2	5.1	3.3	1.3	1.8	2.6	3.6	0.6	4.7	4.9	5.6	1.9	1.5	6.3	3.7	12.5	3.4	1.9	1.1	3.9	3.8	41.5	15.7	3.9	4.2	4.9	1.3	0.9	1.8	2.2	8.4	1.1	2.2	0.0	2.7	8.6	1.3	14.5	3.3	1.1	3.2	2.0	5.6	2.4	25.6	10.8	4.4	8.8	1.9	2.7	5.0	3.1	1.0	0.5	2.1	3.3	6.4	1.8	2.7	6.5	16.5	23.9	10.2	6.6	3.8	2.2	117.4	9.7	1.8	1.7	1.4	2.0	7.0	2.4	1.7
GLT6D1	GLTDC1	ENSG00000204007	"Glycosyltransferase 6 domain containing 1"	Q7Z4J2	9	135623648-135639540	"Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in single"	12	"testis: 4.7"	"Group enriched"	"Detected in some"	39	"Early spermatids: 26.8;Late spermatids: 12.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA023424	Uncertain				"Intracellular and membrane"	NA	NA				"Cluster 78: Testis - Spermatogenesis"		"Cluster 29: Early spermatids - Spermatogenesis"			"HPA023424: AB_1849729"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0
GLT8D1	"AD-017, FLJ14611"	ENSG00000016864	"Glycosyltransferase 8 domain containing 1"	Q68CQ7	3	52694486-52706032	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 149.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010588	Approved		Approved	Mitochondria		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 66: Spermatocytes - Spermatogenesis"	Mitochondria		"HPA010588: AB_1078098"	"unprognostic (1.37e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.38e-2)"	"prognostic favorable (2.76e-4)"	"unprognostic (3.17e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.82e-3)"	"unprognostic (7.12e-2)"	"unprognostic (9.81e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.07e-1)"	"unprognostic (5.82e-3)"	"unprognostic (2.42e-3)"	"unprognostic (3.97e-1)"	"unprognostic (3.34e-2)"	"unprognostic (6.21e-2)"	33.1	39.8	25.4	22.5	26.6	9.3	35.6	25.2	29.3	47.5	35.6	27.7	25.9	35.0	41.3	18.3	54.4	29.8	32.6	26.2	26.7	40.4	69.5	29.6	25.3	24.0	26.9	53.8	35.7	46.0	64.8	48.2	25.5	30.5	32.3	32.2	29.9	32.7	20.8	22.6	23.4	32.2	25.9	24.6	28.9	64.5	26.4	29.2	64.0	24.6	26.8	31.6	28.6	28.6	28.7	33.2	65.7	52.0	142.6	179.8	36.8	70.3	107.8	60.6	69.1	15.5	52.6	24.0	19.7	122.7	73.3	31.9	42.1	72.0	79.5	43.5	30.6	22.8	61.4	71.7	68.3	34.0	68.5	104.1	62.9	52.1	66.8	139.8	91.3	40.6	29.4	53.6	80.6	29.2	23.4	51.8	33.8	49.8	61.5	17.4	37.3	81.9	71.3	30.8	26.9	46.5	58.6	27.9	48.9	61.2	47.7	44.2	67.1	43.7	33.9	63.9	39.6	60.2	73.7	26.4	76.0	53.2	56.2	38.4	13.0	21.8	19.1	8.5	18.3	14.1	22.2	20.0	11.8	9.8	22.3	15.6	6.9	30.3	9.3	23.1	16.8	10.9	25.4	26.6	25.2	29.3	26.2	26.7	24.0	26.9	25.5	25.9	26.4	28.6	25.8	0.0	9.6	16.0	16.0	12.1	16.1	40.3	13.6	41.5	18.1	19.7	15.3	17.2	23.8	18.4	12.5	58.4	26.5	9.4	23.5	34.4	71.4	38.5	38.4	22.7	18.6	8.6	17.9	27.1	63.5	59.2	14.8	15.2	5.7	35.6	34.2	38.2	26.9	21.9	16.8	21.1	30.5	13.6	12.0	23.0	53.7	12.3	24.9	8.4	26.5	37.0	34.0	15.6	14.6	23.3	16.9	48.5	39.1	14.7	22.8	21.5	44.4	21.3	26.3	31.6	25.2	149.5	50.0	10.3	8.0	26.1	21.4	74.2	17.3	10.0
GLT8D2	FLJ31494	ENSG00000120820	"Glycosyltransferase 8 domain containing 2"	Q9H1C3	12	103988987-104064183	"Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 26.3;Early spermatids: 41.2;Fibroblasts: 55.9;Leydig cells: 55.9;Peritubular cells: 51.9;Skeletal myocytes: 25.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 69.3;BJ hTERT+: 89.4;HSkMC: 63.2;hTERT-RPE1: 51.9;RPTEC TERT1: 45.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA012740, HPA026904, HPA070791"	Approved		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus, Vesicles"		"HPA012740: , HPA026904: AB_1849731, HPA070791: "	"unprognostic (4.02e-1)"	"prognostic unfavorable (7.37e-4)"	"unprognostic (9.53e-2)"	"unprognostic (4.56e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.34e-3)"	"unprognostic (2.57e-1)"	"unprognostic (1.25e-1)"	"unprognostic (7.55e-2)"	"unprognostic (5.03e-2)"	"unprognostic (8.87e-2)"	"prognostic unfavorable (1.58e-6)"	"prognostic unfavorable (7.92e-4)"	"unprognostic (7.15e-2)"	"unprognostic (7.70e-3)"	"unprognostic (7.03e-3)"	16.9	10.9	4.2	5.2	4.9	1.5	19.5	2.6	5.1	29.6	11.2	17.6	5.8	27.4	21.6	7.5	22.3	35.8	15.4	4.8	3.7	4.3	2.7	10.2	6.0	2.9	3.1	41.6	4.5	6.6	9.6	9.4	3.1	13.3	11.4	1.0	7.7	16.0	3.2	4.1	7.7	21.8	2.8	1.6	8.4	6.8	3.7	2.2	26.3	11.5	5.8	20.8	18.9	4.4	0.3	0.6	0.7	22.2	28.3	69.3	0.5	32.0	89.4	8.3	10.5	0.4	0.2	0.9	1.8	37.5	0.4	0.1	0.4	11.9	7.0	1.6	10.0	0.6	11.2	0.2	12.7	0.9	0.5	63.2	0.7	10.0	13.8	51.9	4.4	0.6	0.4	1.3	36.5	0.3	0.8	0.5	2.7	0.1	6.7	1.0	33.6	0.2	45.5	0.4	1.3	1.7	33.5	0.8	0.4	2.4	6.0	0.5	0.7	13.2	6.2	1.3	1.9	3.9	0.8	0.3	1.0	0.7	1.1	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.2	4.9	2.6	5.1	4.8	3.7	2.9	3.1	3.1	2.8	3.7	4.4	8.0	0.0	4.6	2.9	0.3	2.8	4.2	2.4	0.0	0.8	1.0	26.3	3.9	1.5	0.1	0.0	2.1	4.1	0.4	0.0	0.0	0.1	41.2	0.6	8.3	7.5	1.8	0.0	10.2	0.0	0.8	55.9	1.1	0.4	0.0	0.1	20.7	0.3	0.6	0.0	10.5	1.3	0.0	0.6	2.8	11.5	55.9	0.4	3.6	4.7	0.6	0.5	0.0	1.0	2.6	0.3	0.0	51.9	1.2	1.4	0.0	0.0	0.1	0.5	6.6	25.2	18.0	1.1	1.1	0.2	2.4	1.4	0.6	10.7	0.0	0.1
GM2A	SAP-3	ENSG00000196743	"GM2 ganglioside activator"	P17900	5	151212150-151270440	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Lipid metabolism, Sphingolipid metabolism"	Hydrolase	"Disease variant, Gangliosidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 224.7;Hofbauer cells: 100.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"B-cells: 30.9;dendritic cells: 39.6;monocytes: 40.4"	"Cell line enhanced"	"Detected in all"		"BEWO: 207.1;HBEC3-KT: 291.8;hTCEpi: 287.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008063	Enhanced		Approved	Vesicles,Cytosol	"Intracellular and membrane"	NA	NA		19000000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Vesicles, Cytosol"		"HPA008063: AB_1849842"	"unprognostic (4.33e-2)"	"unprognostic (8.97e-3)"	"unprognostic (2.27e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.70e-1)"	"prognostic unfavorable (1.77e-5)"	"unprognostic (1.22e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.50e-2)"	"unprognostic (5.33e-3)"	"unprognostic (9.81e-2)"	"unprognostic (4.24e-2)"	"unprognostic (4.42e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.65e-1)"	17.4	20.5	29.3	30.0	39.7	20.6	28.0	38.9	31.1	30.8	17.9	19.7	15.8	15.1	30.8	56.2	15.4	23.4	26.2	27.1	34.3	11.4	24.8	39.0	61.4	42.6	37.9	21.3	14.9	28.3	6.6	57.9	44.3	21.1	26.3	11.7	17.0	17.9	7.2	81.8	16.3	20.0	39.0	36.0	15.8	11.6	36.2	72.3	13.0	10.5	77.9	40.3	49.5	46.7	22.3	14.8	15.1	71.7	98.0	48.2	207.1	35.0	75.1	19.0	25.6	30.3	26.1	71.9	35.1	26.9	51.1	60.0	16.7	291.8	27.2	41.4	10.5	11.7	16.8	37.9	23.7	19.1	117.1	65.4	287.0	24.4	16.4	26.0	27.6	85.1	11.4	30.7	30.1	9.6	38.4	18.0	10.2	11.4	32.3	17.7	7.1	46.3	18.4	43.3	3.9	13.4	29.1	133.0	58.3	52.0	30.7	22.5	24.6	46.0	17.6	38.3	10.6	75.2	96.8	187.0	53.1	30.1	19.4	7.6	40.4	2.4	3.7	13.6	2.7	30.9	4.3	3.9	39.6	29.8	6.1	4.8	8.7	4.4	3.4	28.0	5.4	18.6	29.3	39.7	38.9	31.1	27.1	34.3	42.6	37.9	44.3	39.0	36.2	46.7	5.8	16.0	23.0	5.5	25.0	14.9	18.5	63.2	26.7	5.8	5.4	15.5	30.9	0.0	29.7	18.4	2.1	53.6	8.3	4.4	1.9	7.2	0.5	5.7	6.8	7.3	3.6	5.0	2.2	8.1	224.7	10.2	10.7	7.7	69.6	16.3	8.6	24.2	100.8	6.7	2.7	5.4	10.2	55.7	32.5	1.6	8.1	67.8	8.8	2.8	52.5	8.0	7.2	3.5	9.5	6.0	4.7	13.9	28.8	6.7	6.2	5.4	19.9	3.7	0.0	7.9	6.9	1.8	4.2	45.6	23.9	52.5	5.6	6.4	6.7	36.5
HEXA		ENSG00000213614	"Hexosaminidase subunit alpha"	P06865	15	72340924-72376420	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease variant, Gangliosidosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 234.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018082, HPA054583"	Supported		Supported	Vesicles,Cytosol	"Intracellular and membrane"	NA	NA		20000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 4: Macrophages - Innate immune response"	Vesicles	Cytosol	"HPA018082: , HPA054583: AB_2682531"	"unprognostic (1.51e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.41e-1)"	"prognostic favorable (5.63e-8)"	"unprognostic (6.58e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.82e-2)"	"unprognostic (3.75e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.59e-2)"	"unprognostic (9.98e-2)"	"unprognostic (3.98e-1)"	"unprognostic (7.05e-3)"	"unprognostic (3.02e-2)"	"unprognostic (4.73e-2)"	"unprognostic (8.69e-2)"	49.8	56.1	18.3	37.6	21.1	110.0	58.5	20.4	21.6	73.8	28.5	55.1	49.8	42.6	164.6	24.8	47.8	76.7	54.3	19.9	20.1	90.1	79.4	84.2	54.2	23.0	21.3	39.3	30.6	54.0	26.3	102.0	24.6	45.3	67.0	32.1	45.0	53.3	22.1	21.8	41.2	59.5	21.7	54.7	45.1	35.6	27.0	38.1	76.5	33.2	42.4	71.6	19.7	29.9	39.8	66.4	27.8	53.8	223.6	253.1	39.7	54.8	274.1	115.3	182.8	34.6	282.7	32.9	50.9	110.0	59.9	77.1	74.5	34.6	72.5	26.5	30.0	41.4	60.4	60.9	172.9	99.9	113.1	216.7	101.3	50.4	89.3	210.3	107.4	48.4	65.1	197.6	156.0	33.9	21.7	50.0	16.0	128.9	0.3	22.3	60.6	75.3	129.1	61.6	23.8	26.4	136.5	126.6	307.3	56.1	23.4	123.9	54.1	171.9	70.7	160.1	59.3	104.7	151.8	33.4	62.1	130.4	85.3	24.2	84.6	60.1	43.8	35.7	38.7	41.1	28.8	38.9	98.0	38.0	22.5	33.2	8.1	51.3	13.3	37.3	28.2	63.0	18.3	21.1	20.4	21.6	19.9	20.1	23.0	21.3	24.6	21.7	27.0	29.9	68.9	64.1	62.4	19.9	46.3	22.2	33.3	94.3	19.4	42.4	28.6	30.4	26.9	30.0	68.0	66.2	106.3	150.2	54.2	36.6	60.7	88.3	20.6	27.2	30.2	50.8	47.2	19.1	22.7	38.0	68.0	78.7	42.8	40.6	29.9	49.9	43.5	42.9	234.3	26.9	24.7	46.3	81.4	92.8	75.0	13.7	74.3	118.1	94.3	24.4	60.3	38.4	82.4	20.6	26.7	39.1	74.6	44.8	37.7	33.0	68.5	66.7	37.5	56.9	46.0	24.5	31.7	24.3	32.3	13.5	15.6	157.6	36.7	45.2	50.6	27.5
HEXB		ENSG00000049860	"Hexosaminidase subunit beta"	P07686	5	74640023-74722647	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease variant, Gangliosidosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 466.5;Hofbauer cells: 340.2;Syncytiotrophoblasts: 493.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 746.0;GAMG: 646.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055409, HPA056010"	Enhanced				"Intracellular and membrane"	NA	NA		40000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"			"HPA055409: AB_2682808, HPA056010: AB_2683008"	"unprognostic (3.45e-1)"	"unprognostic (5.84e-2)"	"unprognostic (1.85e-2)"	"unprognostic (8.72e-2)"	"unprognostic (1.12e-2)"	"unprognostic (6.44e-3)"	"prognostic unfavorable (3.36e-8)"	"unprognostic (2.21e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.58e-3)"	"unprognostic (6.45e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.31e-2)"	"unprognostic (9.67e-2)"	"unprognostic (1.64e-2)"	92.2	72.0	22.1	59.7	25.3	59.9	83.0	22.3	32.5	97.6	39.4	105.0	99.0	71.5	321.4	38.5	66.7	99.0	84.3	23.1	26.2	81.6	137.5	111.3	47.0	23.8	22.9	62.4	103.6	94.2	46.6	319.4	24.7	98.7	116.9	33.6	123.4	54.0	43.3	54.3	75.4	76.1	23.2	64.7	88.4	19.6	28.2	29.1	89.6	38.4	40.4	94.6	64.1	30.4	147.3	111.0	39.4	131.8	746.0	232.3	122.3	173.5	590.4	175.0	375.2	130.6	194.5	0.0	133.0	152.2	646.3	115.2	43.2	185.2	228.7	79.2	72.6	19.1	101.4	101.5	216.5	16.2	152.3	206.7	108.0	180.7	121.3	275.9	204.5	47.3	54.3	236.9	194.9	145.7	19.8	36.6	36.8	142.7	47.8	43.9	56.2	191.8	119.8	130.4	24.5	30.4	134.2	92.6	180.0	68.8	99.1	108.6	118.5	112.1	26.6	207.8	165.6	102.6	191.3	0.9	257.9	143.6	209.8	86.2	343.2	99.1	69.3	129.9	80.7	45.2	56.1	64.0	310.8	28.1	52.6	51.3	125.2	42.4	82.5	93.4	73.2	269.0	22.1	25.3	22.3	32.5	23.1	26.2	23.8	22.9	24.7	23.2	28.2	30.4	49.6	41.7	38.4	5.9	31.5	44.0	82.8	103.2	21.6	10.2	26.3	27.6	19.8	82.9	63.8	29.5	8.4	466.5	32.8	68.2	19.6	151.3	1.3	21.0	21.4	56.2	22.8	23.1	32.2	125.6	175.4	107.2	33.6	26.9	69.8	19.8	74.3	70.1	340.2	10.1	24.3	56.7	107.8	127.3	134.3	3.4	85.1	168.8	72.9	17.8	114.2	35.4	29.9	22.6	13.3	65.8	54.8	72.2	71.5	74.2	99.5	79.6	36.3	16.3	46.0	32.6	49.5	0.3	1.4	23.8	32.5	493.6	35.3	31.4	81.8	71.0
KDSR	"DHSR, FVT1, SDR35C1"	ENSG00000119537	"3-ketodihydrosphingosine reductase"	Q06136	18	63327726-63367228	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	Oxidoreductase	"Cancer-related genes, Disease variant, Palmoplantar keratoderma, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/70: 90.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003673, HPA044884"	Approved					NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 22: Epithelial cell types - Mixed function"			"CAB003673: AB_425440, HPA044884: AB_2679131"	"unprognostic (4.44e-2)"	"unprognostic (8.57e-2)"	"unprognostic (2.52e-2)"	"unprognostic (4.56e-2)"	"unprognostic (5.88e-3)"	"unprognostic (7.50e-3)"	"unprognostic (1.80e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.70e-2)"	"unprognostic (6.81e-2)"	"prognostic favorable (9.53e-6)"	"unprognostic (3.32e-2)"	"unprognostic (5.77e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.16e-3)"	32.3	22.4	12.8	8.1	19.9	4.8	25.4	19.5	16.7	26.9	12.3	24.6	7.0	22.7	20.8	22.4	18.9	12.6	20.7	12.7	16.4	20.1	36.7	21.5	7.0	20.6	17.7	21.3	15.7	13.1	12.1	8.5	20.0	16.3	7.4	7.0	22.8	11.6	16.7	44.5	15.1	13.3	17.6	8.4	16.4	6.1	16.6	7.1	17.2	8.9	6.8	23.9	23.4	22.4	14.9	6.5	6.7	7.5	52.6	39.0	13.0	48.8	29.7	10.5	13.9	2.7	10.0	15.1	20.3	19.1	17.4	64.6	8.7	27.3	12.8	28.6	14.5	11.6	8.7	3.4	40.1	22.0	7.8	37.4	50.7	16.8	47.9	19.3	10.5	9.9	9.5	21.0	28.1	6.2	23.6	9.7	8.0	3.7	23.5	15.5	19.7	21.9	29.0	9.6	8.5	16.4	23.4	11.3	21.9	8.8	6.1	12.1	24.9	44.0	10.6	14.8	21.3	90.4	44.9	8.7	33.2	13.0	13.4	0.1	5.2	0.5	6.5	8.1	26.6	5.7	13.6	10.2	8.0	4.7	9.3	6.1	1.3	14.2	3.9	3.8	19.1	5.3	12.8	19.9	19.5	16.7	12.7	16.4	20.6	17.7	20.0	17.6	16.6	22.4	53.1	35.3	49.1	21.9	30.1	158.6	131.7	47.0	122.3	37.4	63.4	63.6	27.7	62.9	43.5	38.6	27.1	58.8	15.6	34.6	15.6	50.7	1.0	43.9	53.0	48.1	20.4	17.4	19.1	36.7	70.4	82.0	26.5	64.9	26.0	52.3	51.8	88.3	36.4	40.4	24.2	31.8	42.7	32.2	47.7	6.5	71.1	39.9	56.9	14.0	31.5	56.5	13.4	21.6	57.0	47.4	44.6	70.7	24.5	104.3	43.4	39.6	41.2	41.1	32.9	73.7	48.4	1.3	5.2	89.7	143.1	91.4	37.7	51.1	40.3	94.7
LCT		ENSG00000115850	Lactase	P09848	2	135787850-135837184	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"Glycosidase, Hydrolase, Multifunctional enzyme"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	187	"intestine: 225.5"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 1.4;Breast myoepithelial cells: 3.3;Early spermatids: 1.3;Proximal enterocytes: 2.8;Undifferentiated cells: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"JURKAT: 2.5;MOLT-4: 4.9;RPMI-8226: 9.7"	"Region enriched"	"Detected in some"	15	"hippocampal formation: 15.7"	"Not detected"	"Not detected"									NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 45: Enterocytes - Digestion"				"unprognostic (2.21e-2)"	"unprognostic (1.65e-4)"	"unprognostic (2.54e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.39e-2)"	"unprognostic (8.03e-4)"	"unprognostic (3.55e-3)"	"unprognostic (6.71e-3)"	"unprognostic (1.89e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.69e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.64e-4)"	"unprognostic (4.90e-2)"	"unprognostic (8.92e-2)"	"unprognostic (8.97e-2)"	"unprognostic (1.02e-1)"	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	225.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	136.3	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.5	0.0	0.0	4.9	0.8	0.0	0.0	0.0	1.1	0.0	9.7	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.4	3.3	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0
LPIN1	KIAA0188	ENSG00000134324	"Lipin 1"	Q14693	2	11677595-11827409	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism, Transcription, Transcription regulation"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 193.5;tongue: 137.2"	"Cell type enriched"	"Detected in all"	5	"Late spermatids: 1705.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024591, HPA038021"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol	"Plasma membrane"	"HPA024591: , HPA038021: AB_10669514"	"unprognostic (1.97e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.87e-2)"	"unprognostic (9.17e-2)"	"unprognostic (2.69e-2)"	"unprognostic (8.20e-2)"	"unprognostic (5.28e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.45e-3)"	"unprognostic (2.55e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.58e-3)"	"unprognostic (1.25e-1)"	"unprognostic (9.60e-2)"	"unprognostic (4.02e-1)"	36.2	15.0	29.0	14.9	30.6	8.6	36.7	24.2	24.9	25.1	21.9	16.7	11.9	16.6	19.0	40.5	15.6	13.0	20.1	21.0	32.1	14.9	27.0	16.1	22.3	31.8	38.2	31.5	9.9	23.1	34.2	11.7	35.3	13.7	8.5	14.8	27.3	14.1	193.5	13.4	19.7	13.0	14.1	14.8	14.9	57.4	35.0	16.1	14.6	137.2	26.3	19.9	23.1	18.8	16.2	18.0	15.9	34.9	71.4	77.9	7.8	22.2	38.7	14.0	24.3	6.9	15.4	8.2	2.9	18.6	41.6	17.3	17.4	49.2	12.8	32.9	9.8	20.3	11.5	9.7	25.1	14.1	90.1	71.1	21.7	57.9	22.6	41.7	28.0	19.6	27.4	68.3	10.4	6.4	13.5	12.0	16.2	5.5	18.9	18.1	28.6	52.0	36.9	10.0	42.8	33.6	8.0	19.7	51.9	15.0	4.9	7.9	19.5	22.1	19.9	14.4	19.0	108.0	92.0	15.2	31.3	24.7	16.6	11.2	2.9	13.4	10.3	2.3	11.2	7.3	9.9	10.1	2.7	5.1	8.6	7.2	1.1	9.5	2.3	10.3	12.2	3.7	29.0	30.6	24.2	24.9	21.0	32.1	31.8	38.2	35.3	14.1	35.0	18.8	15.6	22.4	56.8	167.8	46.1	19.1	45.1	12.6	18.8	48.6	32.8	22.9	59.6	31.5	43.9	11.0	85.5	8.7	68.0	21.2	7.9	23.0	338.4	27.8	44.4	25.8	36.2	9.7	55.7	28.0	6.0	28.8	19.4	76.5	35.4	13.1	17.5	48.7	8.9	48.8	71.7	25.2	22.4	15.7	39.4	1705.8	119.0	25.5	17.8	21.5	15.4	14.7	66.9	41.7	43.5	36.5	29.7	179.8	76.0	34.9	5.4	4.8	52.0	49.0	32.9	32.4	18.4	20.6	19.7	5.5	11.9	12.3	73.2	26.6	16.3	31.3
LPIN2	KIAA0249	ENSG00000101577	"Lipin 2"	Q92539	18	2916994-3013144	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism, Transcription, Transcription regulation"	Hydrolase	"Congenital dyserythropoietic anemia, Disease variant, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 165.8"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 154.4;Granulosa cells: 323.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	7	"granulocytes: 23.4;NK-cells: 12.5;T-cells: 12.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015223, HPA017857, HPA030550"	Enhanced		Approved	"Plasma membrane,Actin filaments,Cytosol"		Yes	No			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol	"Plasma membrane, Actin filaments"	"CAB015223: , HPA017857: AB_1852904, HPA030550: AB_2673519"	"unprognostic (7.03e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.20e-1)"	"prognostic favorable (8.01e-4)"	"unprognostic (9.85e-3)"	"unprognostic (1.89e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.44e-3)"	"unprognostic (3.19e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.15e-3)"	"unprognostic (4.66e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.49e-1)"	"unprognostic (7.11e-2)"	9.7	9.3	17.9	21.2	19.9	19.8	9.8	14.6	17.4	9.7	16.6	13.9	62.8	9.8	6.7	10.0	9.5	25.7	7.2	16.1	24.2	26.4	165.8	21.2	24.3	22.7	22.0	13.2	16.4	13.5	10.9	15.7	24.2	9.0	12.5	10.7	7.4	8.0	2.7	3.6	39.9	9.6	15.6	20.3	28.1	22.0	28.8	18.9	12.1	3.0	19.2	9.9	6.0	14.3	8.7	12.0	17.1	6.6	31.7	27.4	10.5	17.4	22.8	18.9	16.9	16.7	7.1	5.4	10.8	30.2	30.2	0.2	13.8	6.3	13.2	11.2	2.7	13.3	10.0	19.4	27.2	11.2	17.0	27.4	4.6	18.5	17.2	28.2	23.4	14.8	12.8	3.5	28.2	7.2	15.0	12.0	5.7	13.7	13.1	26.7	14.0	23.2	17.6	20.0	14.4	10.2	18.4	9.1	6.8	10.7	0.0	18.0	31.2	25.3	28.7	31.7	14.6	5.0	7.9	12.3	22.1	12.2	8.1	8.7	2.4	7.8	11.8	1.5	12.1	1.0	9.2	7.2	1.0	1.7	9.1	6.3	23.4	12.5	0.8	1.5	9.2	3.2	17.9	19.9	14.6	17.4	16.1	24.2	22.7	22.0	24.2	15.6	28.8	14.3	17.7	67.3	44.0	55.2	20.4	5.6	9.8	8.5	5.7	35.7	12.1	11.2	11.2	154.4	23.9	38.6	14.6	25.2	41.9	45.3	17.6	11.8	3.3	48.2	33.3	18.9	14.9	138.1	26.3	19.0	11.3	25.4	103.0	64.4	12.6	323.0	19.2	131.1	23.1	116.1	65.6	36.8	16.2	26.8	8.9	11.0	22.7	31.1	8.8	79.6	31.2	16.7	59.8	37.7	21.0	22.2	21.6	31.2	16.1	21.2	92.4	54.9	17.1	16.7	6.6	16.6	20.1	26.5	73.0	0.6	2.0	49.5	58.9	20.3	14.0	14.1
LPIN3	"LIPN3L, SMP2"	ENSG00000132793	"Lipin 3"	Q9BQK8	20	41340821-41360582	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 214.9;Proximal enterocytes: 76.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"NK-cell: 2.3"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"HPA051466, HPA052667, HPA070640"	Approved		Supported	Cytosol		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol		"HPA051466: , HPA052667: AB_2681908, HPA070640: AB_2686288"	"unprognostic (2.31e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.68e-1)"	"prognostic unfavorable (9.74e-4)"	"unprognostic (1.88e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.91e-3)"	"unprognostic (4.26e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (1.74e-4)"	"unprognostic (4.29e-2)"	"unprognostic (7.79e-2)"	"prognostic unfavorable (1.14e-5)"	"unprognostic (5.60e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.37e-3)"	19.1	7.3	5.6	3.7	5.4	0.3	18.0	4.6	6.8	19.4	8.4	24.0	41.6	14.1	13.1	32.2	17.7	5.8	17.9	5.6	5.2	31.5	30.0	9.1	2.1	6.1	5.2	14.5	15.1	10.3	12.6	3.6	5.4	19.7	13.2	1.3	16.9	9.6	3.3	40.6	32.4	5.9	5.3	5.7	12.3	3.3	6.2	2.0	26.9	2.5	3.2	13.3	26.2	6.1	12.4	12.0	0.7	7.1	18.6	28.8	9.1	7.5	10.3	9.0	12.1	22.3	10.7	0.6	9.1	16.7	9.5	30.6	3.6	19.6	5.6	0.3	6.9	0.6	19.8	11.5	3.0	0.0	8.1	20.8	24.3	15.3	5.9	10.4	2.3	0.3	3.2	0.4	11.3	26.5	0.1	0.3	1.0	7.6	12.1	0.1	0.2	0.9	30.9	15.5	0.9	0.2	10.0	12.6	6.4	5.6	14.8	6.2	0.7	0.6	2.9	10.1	0.1	5.8	3.3	0.1	0.2	0.1	0.6	0.8	0.1	0.2	0.1	0.1	0.2	0.2	0.2	0.1	0.1	0.3	0.2	0.2	0.6	2.3	0.3	0.2	0.1	0.1	5.6	5.4	4.6	6.8	5.6	5.2	6.1	5.2	5.4	5.3	6.2	6.1	7.2	6.4	12.3	12.1	0.8	14.4	8.2	10.0	3.4	0.0	12.7	11.3	0.8	10.0	6.0	11.0	0.0	2.8	0.2	44.4	5.9	8.7	21.6	10.0	12.5	3.2	14.9	2.7	1.0	3.8	3.5	9.4	19.9	33.1	1.3	16.2	5.0	44.1	3.3	0.0	0.3	21.9	4.1	2.2	6.0	214.9	3.1	1.0	10.6	8.4	0.0	5.2	0.0	1.0	0.2	6.4	28.4	2.6	0.1	3.8	76.9	11.8	4.2	0.5	32.9	8.8	8.2	1.0	2.7	4.7	12.6	2.6	1.0	5.2	23.2	4.8
MGAT4D	GnT1IP	ENSG00000205301	"MGAT4 family member D"	A6NG13	4	140442262-140498377	"Metabolic proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	37	"testis: 22.7"	"Group enriched"	"Detected in some"	19	"Early spermatids: 19.5;Late spermatids: 26.7;Spermatocytes: 64.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA036523	Enhanced					NA	NA				"Cluster 83: Testis - Spermatogenesis"		"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA036523: AB_10670110"										"unprognostic (2.70e-1)"		"unprognostic (3.16e-2)"						0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	19.5	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	26.7	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	64.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MGAT5B	"FLJ25132, GnT-IX, GnT-VB"	ENSG00000167889	"Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B"	Q3V5L5	17	76868404-76950393	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"brain: 12.0"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 16.0;Early spermatids: 7.3;Excitatory neurons: 26.2;Inhibitory neurons: 21.9;Late spermatids: 8.1"	"Group enriched"	"Detected in many"	5	"glioma: 2.6;melanoma: 7.1;testis cancer: 2.4"	"Region enhanced"	"Detected in many"		"cerebral cortex: 12.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 32.1;SCLC-21H: 15.9;U-138 MG: 19.2;U-2 OS: 20.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011082			Approved	"Nucleoplasm,Cytokinetic bridge,Mitotic spindle"		Yes	No				"Cluster 10: Brain - Neuronal signaling"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Mitotic spindle"	"Cytokinetic bridge"	"HPA011082: AB_2668423"	"unprognostic (6.37e-2)"	"unprognostic (9.16e-3)"	"unprognostic (8.51e-2)"	"unprognostic (1.43e-3)"	"unprognostic (5.68e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.28e-3)"	"unprognostic (1.52e-3)"	"unprognostic (5.30e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.68e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.46e-7)"	"unprognostic (1.66e-1)"	"unprognostic (8.09e-3)"	"unprognostic (1.04e-1)"	"unprognostic (3.01e-1)"	0.2	0.2	2.4	0.2	2.1	0.1	0.1	0.0	12.0	0.2	0.0	0.1	0.0	0.2	0.0	0.1	0.1	0.1	0.0	5.2	0.0	0.2	0.0	0.3	0.1	0.3	0.0	0.2	0.0	0.2	0.9	0.2	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.1	1.2	0.0	0.2	0.2	0.1	0.0	0.1	0.1	0.0	3.7	32.1	6.4	3.4	0.0	0.0	3.7	0.4	1.3	11.7	6.9	0.1	0.7	0.0	2.5	1.5	13.7	0.2	1.6	0.2	3.0	0.1	0.5	0.0	1.7	0.1	0.0	0.0	0.2	0.1	0.2	0.0	1.8	5.2	2.0	0.7	0.2	0.0	0.0	1.5	0.1	0.0	1.8	0.8	3.5	4.8	5.6	7.1	8.9	0.1	15.9	6.1	5.5	2.4	5.0	0.4	0.2	0.2	5.8	19.2	20.9	0.3	6.3	0.0	0.0	0.7	0.6	0.0	14.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	2.1	0.0	12.0	5.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	16.0	0.1	0.1	0.1	0.0	0.0	5.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.1	0.1	0.8	0.0	0.0	26.2	0.0	3.2	0.2	0.0	0.2	0.0	0.6	0.7	0.0	0.1	0.0	21.9	0.0	0.0	0.0	0.0	8.1	0.6	0.0	0.0	2.8	0.0	0.2	0.0	5.0	1.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	1.8	0.0	0.0	0.1	1.1	2.4	0.0	0.0	0.1	0.1	0.2	0.0	0.0
NAGA	D22S674	ENSG00000198951	Alpha-N-acetylgalactosaminidase	P17050	22	42058334-42070842	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Cancer-related genes, Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 65.0;Hofbauer cells: 91.6;Kupffer cells: 64.4;monocytes: 65.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"classical monocyte: 202.5;intermediate monocyte: 249.1;myeloid DC: 195.2;non-classical monocyte: 257.9;plasmacytoid DC: 119.8"	"Group enriched"	"Detected in all"	6	"dendritic cells: 195.2;monocytes: 257.9"	"Cell line enhanced"	"Detected in all"		"HMC-1: 190.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000649	Enhanced				"Intracellular and membrane"	NA	NA		2200000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"			"HPA000649: AB_1079448"	"unprognostic (3.74e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.45e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.02e-2)"	"unprognostic (4.27e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.64e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.92e-3)"	"unprognostic (8.95e-2)"	"unprognostic (2.53e-1)"	21.4	12.7	9.3	32.3	10.4	20.1	13.4	10.3	10.1	20.6	17.0	26.1	20.4	17.2	12.4	17.2	20.0	22.1	16.0	8.9	11.5	14.9	31.9	27.1	20.8	13.9	10.8	17.0	11.4	39.2	11.7	42.8	12.6	18.2	26.7	7.7	17.3	18.6	7.7	13.4	24.2	28.3	12.2	20.3	16.6	9.0	12.0	13.9	15.1	12.3	19.0	24.8	13.7	14.4	27.8	14.0	21.7	38.9	37.0	41.9	15.9	22.4	45.7	37.9	39.2	31.4	39.9	13.5	13.5	49.1	22.9	19.2	16.7	27.4	22.3	31.0	21.2	33.5	20.1	21.5	21.5	28.1	190.4	28.9	23.8	34.0	14.4	19.5	63.4	11.6	12.4	56.0	30.2	32.3	10.4	11.5	5.8	25.3	18.5	23.0	11.0	24.2	29.4	32.7	6.7	7.7	29.8	27.0	29.3	19.1	40.4	50.9	34.4	26.6	31.8	17.1	20.7	30.9	33.3	10.9	28.3	52.7	33.4	36.5	202.5	25.1	13.6	249.1	13.8	10.5	14.1	12.7	195.2	6.9	9.2	8.4	9.9	18.8	257.9	119.8	18.3	121.0	9.3	10.4	10.3	10.1	8.9	11.5	13.9	10.8	12.6	12.2	12.0	14.4	6.5	9.6	6.7	4.6	8.2	3.3	9.4	10.9	5.7	2.8	6.7	6.2	4.2	4.3	11.3	7.3	8.4	46.1	11.0	27.3	3.9	15.4	15.8	5.6	8.8	11.2	6.0	12.4	1.1	8.1	65.0	13.8	6.1	10.2	9.5	3.2	9.3	33.6	91.6	0.0	2.0	15.0	6.1	64.4	36.3	17.9	7.2	52.5	19.6	12.2	65.8	5.9	6.2	0.5	2.0	13.0	23.9	6.8	22.2	6.0	40.0	9.8	15.7	6.4	19.7	6.1	10.0	10.7	5.2	7.1	3.4	58.3	6.9	6.5	15.4	10.0
NEU1	NEU	ENSG00000204386	"Neuraminidase 1"	Q99519	6	31857659-31862905	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Lipid degradation, Lipid metabolism"	"Glycosidase, Hydrolase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 197.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 3.0"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 3.0"	"Cell line enhanced"	"Detected in some"		"GAMG: 5.4;U-266/84: 9.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015634, HPA021506"	Approved		Supported	"Vesicles,Cell Junctions"		NA	NA		180000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 16: U-266 - Nucleosome"	"Cluster 7: Non-specific - Mitochondria"	Vesicles	"Cell Junctions"	"HPA015634: AB_1854386, HPA021506: AB_1854385"	"unprognostic (3.84e-2)"	"unprognostic (7.47e-2)"	"unprognostic (9.64e-2)"	"unprognostic (4.65e-2)"	"unprognostic (3.00e-1)"	"unprognostic (4.42e-3)"	"unprognostic (1.38e-3)"	"unprognostic (8.58e-3)"	"unprognostic (7.49e-2)"	"unprognostic (5.21e-2)"	"unprognostic (4.44e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.70e-2)"	"unprognostic (6.22e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.13e-3)"	23.9	57.2	0.7	0.4	0.8	0.0	22.4	2.5	1.2	21.2	1.2	25.1	0.7	19.5	0.0	14.9	16.8	1.0	22.5	0.7	0.6	43.7	29.9	28.9	0.3	0.8	0.5	20.3	35.9	0.3	33.0	0.2	0.8	26.5	0.0	1.6	38.6	0.0	21.3	20.1	24.3	0.1	0.3	25.3	29.8	8.2	1.0	0.0	31.8	0.0	0.0	23.2	16.2	1.7	0.3	0.2	0.8	1.4	1.8	0.4	0.7	0.2	0.2	0.3	0.3	1.5	0.6	0.7	0.4	0.1	5.4	0.3	2.2	0.0	0.4	2.5	0.3	0.6	0.9	1.2	1.4	0.9	1.8	1.0	0.2	1.4	0.7	0.2	0.6	0.9	1.1	1.2	0.5	0.3	0.6	0.0	0.6	0.5	0.4	0.9	0.4	0.9	1.0	0.4	0.7	0.4	0.2	0.3	0.7	0.9	0.9	0.5	0.7	1.1	0.8	0.7	0.6	3.7	9.6	0.9	1.7	0.4	0.4	1.3	0.3	0.4	0.2	0.3	0.1	0.2	0.2	0.1	0.2	0.6	0.2	0.3	3.0	0.3	0.2	0.3	0.2	0.1	0.7	0.8	2.5	1.2	0.7	0.6	0.8	0.5	0.8	0.3	1.0	1.7	65.7	25.6	46.3	5.2	57.0	34.3	48.5	45.0	39.9	26.4	87.7	55.8	29.0	51.5	54.8	47.8	25.0	62.8	100.5	83.7	9.8	114.2	0.8	29.3	53.5	42.8	113.5	4.6	6.3	59.6	57.8	73.8	32.6	60.8	67.9	17.4	30.7	34.5	170.9	10.1	7.6	39.9	79.3	63.0	65.9	1.4	27.7	93.0	71.2	9.4	25.8	48.8	9.2	5.0	4.0	34.4	88.1	23.3	81.7	89.0	115.0	59.9	29.2	32.7	26.3	60.8	43.7	5.4	10.0	29.3	41.6	197.0	81.7	40.3	41.1	34.6
NEU2	SIAL2	ENSG00000115488	"Neuraminidase 2"	Q9Y3R4	2	233032672-233035057	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Lipid degradation, Lipid metabolism"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	15	"skin 1: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in single"		"cerebral cortex: 1.8"	CAB022336	Uncertain					NA	NA		25000		"Cluster 61: Skin - Cornification"					"CAB022336: "						"unprognostic (1.30e-1)"												0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NEU3		ENSG00000162139	"Neuraminidase 3"	Q9UQ49	11	74988279-75018893	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Lipid degradation, Lipid metabolism"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 62.6;Spermatocytes: 32.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038729, HPA070381"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	Vesicles	"HPA038729: AB_2676179, HPA070381: "	"unprognostic (1.67e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.13e-3)"	"unprognostic (2.95e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.63e-1)"	"unprognostic (5.11e-2)"	"unprognostic (3.91e-3)"	"unprognostic (8.50e-2)"	"prognostic favorable (5.98e-4)"	"unprognostic (3.57e-3)"	"unprognostic (3.80e-2)"	"unprognostic (3.79e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.73e-1)"	"unprognostic (1.84e-1)"	3.2	12.7	8.1	6.4	9.7	23.7	6.5	5.1	10.8	3.8	2.9	4.2	4.3	4.9	5.2	2.6	4.2	4.5	6.2	5.3	5.0	5.1	8.2	5.1	8.3	4.1	4.0	8.0	6.1	10.4	5.7	3.9	5.4	11.5	6.4	10.4	4.2	3.2	26.4	8.0	4.3	4.8	1.1	6.2	4.8	13.9	5.1	12.3	8.1	22.6	7.8	3.5	2.5	7.5	9.1	8.2	6.7	11.7	5.2	4.4	7.1	8.7	5.7	9.4	7.7	24.3	7.2	25.7	8.5	7.2	12.9	8.1	16.1	11.4	14.7	13.2	7.9	21.8	14.4	10.8	5.6	34.7	19.3	5.5	9.4	9.9	15.0	6.5	7.2	37.3	35.1	17.5	11.2	9.7	33.1	16.8	8.0	18.5	10.3	27.0	17.5	22.2	12.8	9.3	12.0	7.2	13.7	8.4	37.0	8.0	18.9	8.2	10.4	11.6	11.7	8.0	9.1	15.5	15.8	51.8	3.6	17.2	9.8	1.2	2.6	2.4	1.5	1.4	1.1	1.0	1.2	1.5	1.5	1.2	1.2	1.5	1.5	0.5	1.8	1.1	0.9	0.9	8.1	9.7	5.1	10.8	5.3	5.0	4.1	4.0	5.4	1.1	5.1	7.5	1.4	3.2	4.6	4.6	5.3	0.5	2.0	0.4	0.6	8.6	3.5	3.9	7.7	2.8	2.7	1.8	62.6	2.1	4.1	1.0	0.0	1.2	9.2	2.2	2.3	2.3	7.2	5.0	12.5	3.1	1.4	2.1	3.1	2.7	1.3	3.7	3.6	6.9	5.4	11.8	10.3	2.9	2.0	10.1	1.1	7.6	1.5	6.2	0.0	8.4	6.8	3.4	3.1	9.5	9.9	2.6	1.0	1.9	5.8	3.0	1.6	3.7	1.6	6.4	0.0	5.8	1.8	32.0	2.2	1.6	0.6	1.4	3.9	3.8	2.8	0.6
OGT	"FLJ23071, HRNT1, MGC22921, O-GLCNAC, OGT1"	ENSG00000147162	"O-linked N-acetylglucosamine (GlcNAc) transferase"	O15294	X	71533104-71575892	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Biological rhythms, Host-virus interaction, Ubl conjugation pathway"	"Chromatin regulator, Glycosyltransferase, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030751, HPA030752, HPA030753, HPA030754, CAB034099"	Approved		Supported	"Nucleoplasm,Plasma membrane"		Yes	No			"Cluster 39: Non-specific - mRNA processing"	"Cluster 50: Non-specific - Ribosome"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	"Plasma membrane"	"CAB034099: AB_2157067, HPA030751: AB_10600217, HPA030752: AB_10601445, HPA030753: AB_2673594, HPA030754: AB_2673595"	"unprognostic (1.37e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.32e-2)"	"prognostic unfavorable (8.33e-4)"	"unprognostic (3.40e-2)"	"prognostic favorable (1.97e-4)"	"unprognostic (9.56e-3)"	"unprognostic (1.96e-3)"	"unprognostic (5.58e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.06e-1)"	"unprognostic (9.74e-3)"	"prognostic unfavorable (2.36e-6)"	"unprognostic (2.99e-3)"	"unprognostic (2.28e-1)"	"unprognostic (8.03e-3)"	"prognostic favorable (6.85e-7)"	59.3	55.9	39.7	38.3	42.4	61.5	62.7	43.3	51.6	72.7	40.1	62.5	30.6	56.0	62.2	52.8	76.4	26.4	55.5	43.9	35.5	61.6	45.8	70.7	71.9	36.1	35.8	85.5	102.4	24.3	46.9	26.4	37.9	75.4	39.6	36.9	64.1	27.1	62.8	68.6	86.4	24.5	36.1	122.8	67.4	19.0	36.2	57.2	70.7	39.2	57.8	55.7	67.4	44.3	40.5	37.0	47.1	41.5	49.6	45.6	31.6	30.3	54.3	32.1	49.1	39.3	45.4	47.9	20.7	37.3	33.3	49.1	52.0	29.5	39.4	41.1	53.4	30.4	98.6	28.5	37.6	62.9	48.1	43.6	59.2	35.1	65.7	55.5	30.5	100.7	31.1	160.4	31.1	34.3	48.9	75.2	31.6	35.5	49.8	47.8	52.7	62.1	50.0	45.9	24.1	21.2	46.9	30.9	30.2	35.5	22.8	42.4	35.5	34.6	27.9	36.6	17.9	43.5	33.5	56.5	24.4	65.0	21.6	2.8	4.6	2.0	7.5	5.7	6.8	7.4	6.3	6.2	6.1	6.2	7.2	7.4	1.9	10.4	5.7	6.2	6.2	5.6	39.7	42.4	43.3	51.6	43.9	35.5	36.1	35.8	37.9	36.1	36.2	44.3	31.1	35.3	85.2	52.9	67.2	88.1	37.9	23.5	58.6	26.5	49.6	34.0	42.8	20.0	31.1	49.7	8.4	15.8	130.7	31.1	9.8	14.4	2.4	32.1	49.8	39.8	34.9	51.3	110.7	14.4	8.5	47.5	54.6	53.3	27.8	26.4	45.7	27.5	16.1	40.4	94.6	37.3	22.4	60.9	69.7	4.8	53.4	45.8	35.6	71.2	51.6	11.3	51.5	92.0	97.9	17.6	34.9	29.7	147.2	53.8	34.8	15.1	28.0	21.8	32.9	44.8	42.2	2.5	6.1	63.3	84.1	10.9	82.1	62.0	34.0	50.8
PIGB		ENSG00000069943	"Phosphatidylinositol glycan anchor biosynthesis class B"	Q92521	15	55318960-55355648	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"	"Glycosyltransferase, Transferase"	Epilepsy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039929	Uncertain		Uncertain	"Plasma membrane,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 32: U-937 - Innate immune response"	"Cluster 57: B-cells - Immune response"	"Plasma membrane, Cytosol"		"HPA039929: AB_10673539"	"unprognostic (1.91e-2)"	"unprognostic (7.45e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.03e-2)"	"unprognostic (2.96e-2)"	"unprognostic (4.65e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.37e-3)"	"unprognostic (7.52e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.56e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.86e-1)"	"unprognostic (5.93e-2)"	"unprognostic (4.24e-2)"	6.4	4.8	2.3	5.8	2.6	9.1	9.0	2.8	2.6	5.5	3.1	7.0	7.5	6.4	11.0	5.7	7.8	6.3	2.8	2.5	3.3	10.3	9.4	6.3	8.2	2.8	2.7	4.7	5.7	10.6	3.9	4.8	2.6	7.7	7.8	7.9	4.3	6.8	1.5	6.1	5.8	5.6	2.7	6.1	7.6	6.5	2.7	6.3	13.3	1.8	8.6	7.5	3.7	3.1	10.5	12.2	5.8	4.1	6.6	13.2	7.8	9.0	19.9	10.4	17.8	5.1	10.3	10.9	10.4	12.9	15.6	18.3	3.3	9.5	8.6	10.4	6.4	10.9	13.6	6.7	11.9	30.8	8.7	12.5	11.4	7.9	10.7	13.8	13.6	9.2	12.2	6.9	15.0	9.1	3.4	12.8	3.1	7.9	4.8	4.9	5.6	24.1	18.4	12.4	2.5	6.2	8.1	12.2	17.3	5.4	11.7	22.2	9.5	13.6	4.3	3.7	18.6	8.1	15.9	8.6	12.4	34.5	10.2	13.6	7.7	3.3	6.2	9.7	7.0	6.0	6.1	6.9	7.0	3.9	4.8	5.5	14.5	5.3	11.4	5.4	6.5	5.5	2.3	2.6	2.8	2.6	2.5	3.3	2.8	2.7	2.6	2.7	2.7	3.1	3.5	9.6	9.5	17.6	27.5	4.6	9.5	14.9	4.6	3.3	5.6	4.2	3.4	1.5	14.9	0.0	12.5	12.4	11.2	4.8	1.9	7.4	26.8	4.3	3.2	4.7	6.6	8.2	18.3	10.9	12.0	6.0	6.1	6.4	8.2	4.6	6.8	4.4	8.6	1.7	17.7	4.1	4.1	7.5	6.7	5.1	1.5	8.8	3.6	12.2	8.4	2.7	11.3	17.1	14.6	6.9	4.0	1.5	3.8	3.4	6.4	9.7	7.9	9.4	6.6	4.8	4.2	5.9	3.8	5.7	4.0	6.6	12.5	4.2	4.0	7.4
PIGM	GPI-MT-I	ENSG00000143315	"Phosphatidylinositol glycan anchor biosynthesis class M"	Q9H3S5	1	160024953-160031990	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA047418	Uncertain					NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 5: Muller glia cells - Visual perception"			"HPA047418: AB_2680039"	"unprognostic (1.55e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.58e-1)"	"unprognostic (9.89e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.69e-3)"	"unprognostic (1.52e-1)"	"unprognostic (3.85e-2)"	"prognostic favorable (3.27e-4)"	"unprognostic (2.63e-2)"	"unprognostic (2.77e-2)"	"unprognostic (3.01e-2)"	"unprognostic (8.55e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.50e-1)"	3.2	4.2	3.0	4.0	4.8	1.8	5.2	4.6	3.7	4.1	3.3	3.8	4.4	3.6	6.0	3.4	3.9	3.3	2.6	3.2	4.0	4.0	5.2	3.6	4.3	5.7	4.3	4.0	7.8	6.7	3.6	3.4	5.3	6.1	4.3	8.1	6.3	4.1	1.4	5.5	4.8	3.2	4.7	4.2	4.6	3.5	4.4	4.9	6.1	1.7	4.0	3.0	2.6	8.6	5.8	5.2	6.1	9.1	8.0	6.5	2.0	8.6	5.4	5.6	5.1	2.8	10.3	4.1	6.9	5.6	4.8	11.5	6.9	6.9	7.0	8.7	7.2	9.3	6.8	4.2	4.9	12.1	7.0	6.0	4.5	6.6	5.0	4.8	4.7	8.9	5.1	7.5	6.5	9.8	7.9	6.4	6.5	10.9	7.4	2.3	6.4	18.0	6.1	7.9	8.7	13.5	9.4	11.0	6.9	5.8	20.7	14.4	6.7	7.3	6.4	11.1	5.3	13.5	16.0	0.2	6.7	6.1	8.3	8.9	12.4	5.3	6.7	10.4	6.9	5.1	6.7	5.3	7.7	4.8	8.4	6.7	2.2	8.9	13.8	9.1	7.8	7.3	3.0	4.8	4.6	3.7	3.2	4.0	5.7	4.3	5.3	4.7	4.4	8.6	10.0	12.8	19.8	7.5	7.7	4.2	4.7	6.4	17.1	16.1	14.1	9.0	5.3	17.2	13.2	16.5	10.4	7.6	5.0	7.3	1.9	13.3	6.7	5.5	12.5	10.0	12.6	14.1	5.7	18.5	3.2	11.9	7.1	8.1	5.1	9.6	15.4	22.2	7.3	16.8	5.5	12.8	2.0	14.5	5.0	3.9	8.4	9.2	8.8	4.7	12.3	27.9	9.2	12.5	23.1	12.0	5.3	9.1	11.2	8.1	10.1	6.6	10.2	13.6	19.7	10.7	8.6	29.3	8.1	17.0	4.5	1.8	7.3	11.0	12.1	3.7
PIGV	FLJ20477	ENSG00000060642	"Phosphatidylinositol glycan anchor biosynthesis class V"	Q9NUD9	1	26787054-26800659	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"	"Glycosyltransferase, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 50.8;Late spermatids: 96.0;Spermatocytes: 80.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTCEpi: 43.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054181			Approved	"Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol	"Endoplasmic reticulum"	"HPA054181: "	"unprognostic (2.08e-1)"	"unprognostic (6.53e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.96e-2)"	"unprognostic (2.02e-2)"	"unprognostic (5.76e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.56e-1)"	"unprognostic (8.40e-2)"	"unprognostic (4.44e-2)"	"prognostic favorable (7.60e-7)"	"unprognostic (1.71e-1)"	"unprognostic (4.24e-1)"	"unprognostic (8.92e-2)"	"unprognostic (5.96e-3)"	6.6	13.9	4.6	3.4	5.3	3.0	7.6	5.1	4.8	9.5	4.1	8.1	6.5	8.1	13.8	9.0	10.2	6.2	4.4	4.2	4.7	10.9	24.1	6.2	4.2	6.1	5.2	7.9	10.3	13.9	10.0	6.2	5.5	8.4	8.4	3.7	10.0	8.0	4.4	11.3	7.3	6.7	5.2	6.9	8.9	30.0	5.1	6.7	10.6	4.8	6.4	8.5	8.3	5.4	10.6	4.4	4.1	4.7	7.3	10.8	5.8	6.7	14.0	7.6	7.9	2.3	25.9	6.7	7.3	7.7	8.2	20.3	4.2	8.6	8.6	11.5	2.5	5.6	5.1	5.1	10.3	7.7	10.0	11.8	43.8	9.8	12.2	12.0	5.1	9.4	10.0	12.2	14.0	3.9	3.7	3.0	9.9	20.9	3.0	3.8	6.2	15.0	11.0	1.0	7.6	3.9	9.2	4.3	8.7	9.8	14.1	6.5	8.1	10.8	6.5	6.0	1.8	3.8	2.2	2.9	10.7	10.0	8.2	33.1	14.1	11.0	14.0	13.0	21.1	8.8	9.9	14.4	12.5	8.8	10.2	12.4	14.2	21.5	18.5	4.5	9.7	10.8	4.6	5.3	5.1	4.8	4.2	4.7	6.1	5.2	5.5	5.2	5.1	5.4	5.2	3.2	6.0	7.5	6.0	4.2	11.0	27.5	6.2	3.3	10.0	7.6	1.9	4.3	12.7	7.3	8.4	27.4	10.6	5.0	7.9	7.2	50.8	6.7	4.7	4.6	3.5	13.5	2.8	4.6	14.8	8.8	6.1	6.4	0.0	6.8	6.4	16.6	9.2	8.4	3.2	6.5	12.2	5.2	3.2	96.0	7.2	4.2	7.2	2.8	8.2	11.1	7.2	0.0	5.5	4.9	4.8	9.8	6.5	7.6	12.1	10.2	16.3	2.7	0.0	5.7	4.9	80.8	15.1	7.3	4.1	14.1	8.2	12.1	9.2	8.4
PIGZ	"FLJ12768, MGC52163, SMP3"	ENSG00000119227	"Phosphatidylinositol glycan anchor biosynthesis class Z"	Q86VD9	3	196946356-196969060	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"	"Glycosyltransferase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"intestine: 39.1"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 205.1;Intestinal goblet cells: 61.3;Paneth cells: 129.7;Proximal enterocytes: 50.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"											"HPA058599, HPA059920"	Approved					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA058599: AB_2683771, HPA059920: AB_2684162"	"unprognostic (1.46e-1)"	"unprognostic (3.18e-3)"	"unprognostic (1.06e-2)"	"unprognostic (3.31e-2)"	"unprognostic (3.90e-2)"	"unprognostic (8.16e-2)"	"unprognostic (4.25e-3)"	"unprognostic (4.19e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.31e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (5.60e-5)"	"unprognostic (1.02e-1)"	"unprognostic (3.93e-2)"	"unprognostic (8.38e-5)"	"unprognostic (5.02e-3)"	6.7	1.6	8.2	2.0	8.5	1.0	5.4	8.6	9.6	4.3	4.4	39.1	1.6	3.4	0.7	4.2	3.4	2.0	6.9	8.1	9.2	2.1	2.6	3.7	1.1	7.6	8.6	0.8	2.7	3.0	4.1	1.0	10.0	6.1	16.7	3.1	4.7	2.6	7.4	4.7	11.7	2.7	5.3	1.9	4.6	1.6	8.6	1.2	1.9	3.2	0.5	10.4	4.6	7.7	1.8	1.2	0.7	2.8	7.7	3.7	0.7	2.6	7.3	2.0	1.6	1.7	1.5	0.3	5.1	5.9	1.3	3.0	0.1	0.4	0.5	0.5	0.3	0.8	0.6	6.5	3.6	0.0	2.9	3.7	5.6	0.3	0.9	2.2	2.4	4.7	0.2	2.2	1.9	3.2	0.3	1.5	0.1	2.2	0.9	0.4	0.1	0.6	3.0	3.3	1.1	1.2	3.7	0.3	1.5	0.3	7.2	2.6	6.0	1.6	0.4	4.7	0.9	1.0	0.1	0.1	0.4	1.1	0.6	0.0	0.3	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.3	0.1	0.0	0.1	8.2	8.5	8.6	9.6	8.1	9.2	7.6	8.6	10.0	5.3	8.6	7.7	8.9	0.0	1.1	20.5	1.7	7.8	9.1	3.8	6.8	7.1	22.6	33.9	8.0	1.5	2.8	9.2	2.1	0.0	2.8	205.1	5.9	2.3	2.1	5.1	3.0	5.5	13.8	3.0	31.3	3.6	0.0	5.0	1.5	6.5	5.7	0.3	12.1	10.3	1.8	15.2	21.9	61.3	10.2	4.4	3.4	5.0	4.1	2.2	8.8	5.6	4.1	4.6	2.1	12.5	2.7	3.2	129.7	6.4	1.9	7.4	50.0	5.4	2.7	7.0	0.0	7.7	6.5	1.2	0.2	11.5	5.1	0.1	1.7	0.0	44.4	14.7
PLPP1	"LPP1, PAP-2a, PPAP2A"	ENSG00000067113	"Phospholipid phosphatase 1"	O14494	5	55424854-55534969	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 359.1;Endometrial stromal cells: 206.7;Hepatic stellate cells: 267.0;Leydig cells: 219.3;Prostatic glandular cells: 182.0"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 200.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 445.7;fHDF/TERT166: 142.8;HMC-1: 235.8;HSkMC: 171.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033331, HPA047815"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"		"CAB033331: AB_2168044, HPA047815: AB_2680164"	"unprognostic (1.22e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.55e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.36e-1)"	"prognostic favorable (6.06e-4)"	"unprognostic (2.81e-1)"	"unprognostic (2.20e-1)"	"unprognostic (4.05e-3)"	"unprognostic (2.43e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.37e-3)"	"prognostic unfavorable (5.77e-4)"	"unprognostic (3.94e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.11e-2)"	172.3	78.1	51.5	42.3	59.9	0.9	140.7	63.7	59.4	88.7	59.6	118.3	47.4	119.5	39.8	42.4	73.4	167.5	117.1	49.9	56.8	104.0	67.7	56.2	32.2	62.1	56.2	29.4	35.6	49.0	27.8	37.6	64.2	254.1	65.8	9.7	32.9	61.3	70.0	57.9	79.1	108.9	62.5	31.1	70.9	21.0	58.6	15.8	112.9	81.5	24.2	128.8	63.8	72.9	9.8	24.4	7.0	14.2	445.7	51.8	9.6	21.8	61.4	11.9	27.9	16.7	17.7	10.2	20.0	142.8	31.9	6.5	25.2	12.6	13.5	6.8	20.1	1.1	9.6	21.3	70.5	2.5	235.8	171.3	25.7	17.6	10.9	23.3	19.9	9.1	0.2	27.0	24.1	6.0	6.8	5.5	15.5	1.1	20.0	2.0	11.7	0.9	46.3	79.8	8.4	5.8	21.5	4.2	13.4	28.8	15.6	1.6	24.0	4.0	6.9	17.8	15.5	16.6	7.4	11.8	15.7	1.3	19.5	0.0	0.4	4.0	1.6	0.5	1.7	6.7	5.3	3.4	2.0	3.3	9.5	7.7	0.3	3.0	0.9	15.0	2.6	1.8	51.5	59.9	63.7	59.4	49.9	56.8	62.1	56.2	64.2	62.5	58.6	72.9	359.1	6.4	9.4	0.0	9.8	0.0	51.0	0.0	10.2	4.0	8.4	45.7	0.0	21.5	5.6	29.5	2.1	3.3	5.4	61.0	5.9	25.2	44.4	10.7	206.7	112.3	1.2	5.7	0.0	28.5	11.1	115.5	11.2	18.5	27.8	4.0	267.0	48.3	12.8	1.7	0.0	20.2	0.0	12.0	0.0	21.0	219.3	8.1	0.0	0.0	4.5	16.6	1.0	0.0	0.0	30.0	24.6	88.4	13.0	182.0	49.4	29.3	2.2	5.6	59.2	89.7	49.7	54.4	17.7	10.0	0.0	4.9	11.3	3.1	12.1	42.8
PLPP2	"LPP2, PAP-2c, PPAP2C"	ENSG00000141934	"Phospholipid phosphatase 2"	O43688	19	281040-291403	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 204.5;Ductal cells: 352.1;Proximal enterocytes: 209.8;Rod photoreceptor cells: 234.9;Urothelial cells: 205.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"gdT-cell: 3.2;MAIT T-cell: 6.6"	"Lineage enriched"	"Detected in single"	41	"T-cells: 6.6"	"Cell line enhanced"	"Detected in many"		"A549: 144.1;CAPAN-2: 154.6;OE19: 255.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055540, HPA058428"	Uncertain		Supported	"Plasma membrane"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane"		"HPA055540: AB_2682839, HPA058428: "	"prognostic unfavorable (4.55e-4)"	"unprognostic (8.91e-3)"	"unprognostic (1.06e-1)"	"prognostic favorable (3.21e-8)"	"unprognostic (2.95e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.83e-3)"	"unprognostic (5.48e-2)"	"unprognostic (1.59e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.18e-3)"	"unprognostic (3.85e-1)"	"unprognostic (3.53e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.30e-3)"	"unprognostic (1.36e-3)"	4.8	13.2	37.7	8.5	61.6	0.0	36.9	57.1	50.0	63.4	26.2	40.5	62.7	16.8	8.4	27.2	81.8	52.4	1.7	38.8	43.5	11.5	3.7	8.3	1.4	57.3	53.6	2.7	37.3	19.5	11.8	3.6	56.2	31.7	32.1	29.6	105.7	32.9	0.6	53.2	51.0	6.4	44.8	4.7	50.3	7.6	49.2	5.2	5.7	0.5	6.0	36.5	14.2	83.9	85.5	144.1	2.1	0.1	0.0	0.3	0.2	8.2	0.0	25.3	18.9	41.7	154.6	0.0	88.3	11.9	0.1	45.3	0.0	17.6	11.1	0.8	2.6	0.0	55.9	0.0	28.6	0.0	5.5	5.2	7.6	12.7	16.7	53.4	4.2	0.0	0.7	0.1	0.0	98.5	0.4	0.1	61.5	255.8	0.0	0.0	0.0	2.4	62.1	13.7	17.4	40.9	23.3	38.3	60.3	5.8	50.0	2.5	4.5	55.7	36.5	0.5	61.9	0.8	101.7	70.4	15.5	0.0	46.9	0.0	0.0	0.0	3.2	0.0	6.6	0.0	1.3	1.6	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.3	37.7	61.6	57.1	50.0	38.8	43.5	57.3	53.6	56.2	44.8	49.2	83.9	17.0	6.4	7.5	0.0	1.5	0.0	134.2	0.0	8.0	19.7	137.1	149.9	0.0	204.5	35.3	22.0	10.4	0.5	2.7	77.0	3.9	352.1	0.3	115.2	9.2	15.2	8.5	0.0	0.0	139.5	15.1	3.0	91.3	90.1	1.3	0.0	0.0	0.5	0.9	16.8	0.0	38.8	0.0	1.0	0.0	1.6	0.0	1.9	0.0	0.0	2.6	21.7	0.0	0.0	0.0	128.8	85.2	0.0	1.6	97.4	209.8	1.4	91.1	234.9	0.0	0.8	2.7	0.6	35.1	20.3	0.0	0.8	3.5	0.1	87.2	205.8
PLPP3	"LPP3, PAP-2b, PPAP2B"	ENSG00000162407	"Phospholipid phosphatase 3"	O14495	1	56494761-56645301	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Fibroblasts: 392.7;Hepatic stellate cells: 779.6;Leydig cells: 1092.6;Peritubular cells: 398.7"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 168.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"memory B-cell: 2.4;naive B-cell: 2.3"	"Lineage enriched"	"Detected in single"	6	"B-cells: 2.4"	"Cell line enhanced"	"Detected in many"		"ASC diff: 710.0;ASC TERT1: 351.8;HSkMC: 438.1;U-2197: 660.4"					"Low region specificity"	"Detected in all"			HPA072751	Approved		Supported	"Golgi apparatus"		NA	Yes			"Cluster 19: B-cells - Humoral immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus"		"HPA072751: AB_2686555"	"unprognostic (2.50e-2)"	"unprognostic (3.94e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.22e-3)"	"unprognostic (5.86e-3)"	"unprognostic (7.25e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.75e-2)"	"unprognostic (3.91e-2)"	"unprognostic (3.08e-1)"	"prognostic favorable (4.59e-4)"	"unprognostic (3.16e-2)"	"unprognostic (1.74e-1)"	"unprognostic (3.54e-2)"	"unprognostic (2.09e-1)"	168.4	53.0	93.9	33.6	94.2	13.1	139.8	87.3	105.9	294.6	50.7	56.7	24.0	107.2	56.2	51.3	122.5	66.3	84.6	88.3	90.6	91.4	182.0	87.0	22.4	107.5	108.1	81.9	36.8	130.2	23.1	225.5	87.7	102.8	41.8	19.0	76.2	169.7	50.9	82.1	45.8	65.6	86.8	23.3	66.0	37.3	113.2	29.8	327.6	63.0	19.9	139.2	142.8	88.6	3.3	10.8	14.1	1.5	710.0	351.8	34.5	39.3	39.7	35.5	17.4	31.8	6.2	5.2	4.6	59.3	39.4	5.9	2.1	0.8	7.4	0.0	9.4	1.3	4.4	44.5	17.3	0.1	0.0	438.1	3.0	34.2	28.6	25.1	34.1	0.4	2.9	0.1	39.0	3.2	0.1	0.5	43.3	9.2	42.6	0.1	0.1	1.7	6.1	32.6	0.4	28.1	12.4	16.1	4.2	42.6	5.2	0.0	21.6	176.2	14.4	660.4	1.8	0.0	0.0	0.0	31.0	1.7	12.7	0.0	0.1	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	2.3	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.1	93.9	94.2	87.3	105.9	88.3	90.6	107.5	108.1	87.7	86.8	113.2	88.6	148.5	25.6	18.9	0.0	7.2	0.0	19.8	0.0	35.3	3.9	12.2	31.2	0.0	44.3	13.0	22.0	0.0	127.0	1.1	8.1	21.5	21.5	7.9	13.9	139.4	148.3	2.4	8.0	0.0	9.2	9.8	392.7	5.6	16.3	3.8	8.1	779.6	132.6	38.8	0.0	0.0	8.5	0.0	35.2	0.0	28.3	1092.6	14.9	0.0	0.0	0.9	136.0	0.0	0.0	0.0	7.9	5.9	398.7	7.1	20.8	15.5	21.3	4.4	4.1	138.1	179.7	107.2	4.5	3.4	16.4	0.0	214.9	5.0	22.4	7.2	20.1
PLPP4	"DPPL2, PPAPDC1, PPAPDC1A"	ENSG00000203805	"Phospholipid phosphatase 4"	Q5VZY2	10	120457227-120592065	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	13	"brain: 12.2"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 11.5;Distal tubular cells: 7.9;Early spermatids: 10.9;Erythroid cells: 9.7;Late spermatids: 10.7;Leydig cells: 19.3;Peritubular cells: 7.9;Proximal tubular cells: 9.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"hTERT-RPE1: 14.2;U-251 MG: 10.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045188	Approved		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoli, Nucleoli rim"	Nucleoplasm	"HPA045188: AB_2679246"	"unprognostic (8.19e-2)"	"unprognostic (2.94e-2)"	"unprognostic (8.86e-2)"	"unprognostic (1.90e-3)"	"unprognostic (3.45e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.26e-3)"	"unprognostic (1.55e-1)"	"unprognostic (8.62e-3)"	"unprognostic (2.70e-3)"	"unprognostic (1.89e-1)"	"unprognostic (2.40e-3)"	"unprognostic (3.49e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.21e-3)"	0.0	0.0	2.9	0.1	3.5	0.4	0.1	6.4	2.8	0.2	0.5	0.3	0.0	0.1	0.0	0.0	0.0	0.6	0.0	5.3	8.9	0.8	0.1	0.0	0.0	11.0	5.3	0.0	0.0	0.0	0.0	0.0	12.2	0.2	0.0	0.1	0.0	0.2	0.1	0.2	0.1	0.1	4.3	0.0	0.0	0.9	3.7	0.1	0.0	0.0	0.0	0.0	0.1	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.3	0.2	0.0	0.3	0.1	0.0	1.7	1.4	0.0	0.1	0.1	0.1	0.1	0.5	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	14.2	1.3	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.6	0.0	0.3	0.0	0.1	0.0	0.1	0.9	0.2	0.0	2.8	1.7	1.2	0.1	10.4	0.0	0.0	0.0	2.3	0.0	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	2.9	3.5	6.4	2.8	5.3	8.9	11.0	5.3	12.2	4.3	3.7	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	11.5	0.0	3.7	0.0	0.0	0.0	0.0	7.9	0.3	10.9	0.1	2.5	0.0	0.0	9.7	0.0	0.2	0.1	0.3	0.0	0.1	0.0	0.2	1.8	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	10.7	19.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	7.9	0.0	0.5	0.0	9.0	0.0	0.0	0.0	0.0	4.9	1.5	2.1	0.0	0.0	0.0	0.1	0.0	0.0	0.4
PLPP5	"DPPL1, HTPAP, PPAPDC1B"	ENSG00000147535	"Phospholipid phosphatase 5"	Q8NEB5	8	38263130-38269243	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid metabolism"	Hydrolase	"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Plasma cells: 264.5;Prostatic glandular cells: 146.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	8	"basophil: 80.2;memory B-cell: 211.8;naive B-cell: 305.9"	"Group enriched"	"Detected in all"	7	"B-cells: 305.9;granulocytes: 80.2"	"Cell line enhanced"	"Detected in all"		"RPMI-8226: 140.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055777			Approved	Vesicles		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 25: Pancreas - Digestion"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Vesicles		"HPA055777: AB_2682915"	"unprognostic (4.54e-2)"	"unprognostic (2.51e-3)"	"unprognostic (3.66e-2)"	"prognostic favorable (1.48e-5)"	"unprognostic (1.80e-2)"	"unprognostic (1.27e-2)"	"unprognostic (5.58e-2)"	"prognostic favorable (8.72e-5)"	"unprognostic (9.79e-2)"	"prognostic favorable (2.42e-5)"	"unprognostic (1.50e-1)"	"unprognostic (5.08e-2)"	"prognostic unfavorable (8.33e-10)"	"unprognostic (3.82e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.59e-3)"	"unprognostic (1.57e-2)"	12.6	18.6	12.5	21.5	13.0	16.6	24.4	15.8	16.1	29.4	36.5	30.2	41.6	16.1	81.7	13.9	28.3	27.9	8.6	12.6	14.4	27.6	33.0	16.0	28.1	12.7	13.5	18.6	114.5	13.7	52.4	14.0	12.4	74.5	35.5	8.5	85.7	30.5	4.8	10.7	40.3	11.4	11.5	28.0	46.1	7.8	13.5	10.2	29.2	3.0	32.3	21.2	14.1	13.0	15.1	29.7	17.4	35.7	33.2	32.1	23.9	42.1	52.7	21.0	27.3	13.8	22.7	1.0	35.1	43.8	30.5	16.5	14.5	30.9	18.2	9.6	9.3	26.6	13.1	40.5	56.3	7.8	30.8	25.3	31.5	29.4	38.3	37.2	34.7	34.9	1.3	67.2	25.9	31.2	17.7	13.0	26.5	61.2	10.0	19.1	12.8	140.0	53.3	19.4	13.6	20.8	17.3	26.5	25.4	15.4	56.9	15.0	21.2	14.8	13.1	25.2	11.3	41.5	29.4	4.5	41.0	20.5	26.1	80.2	12.9	23.4	13.4	13.7	23.0	211.8	17.8	17.7	12.2	305.9	8.8	8.5	8.0	22.4	19.7	26.0	18.0	17.0	12.5	13.0	15.8	16.1	12.6	14.4	12.7	13.5	12.4	11.5	13.5	13.0	22.2	9.6	46.2	0.0	110.8	0.0	81.8	0.0	25.6	5.9	49.4	42.3	0.0	32.9	21.7	75.4	16.7	45.1	14.8	12.4	43.0	68.0	30.6	70.3	27.3	27.9	44.9	9.9	0.0	89.9	43.5	41.5	50.4	54.8	31.5	38.1	17.5	23.4	36.5	62.2	0.0	62.6	0.0	10.1	0.0	8.9	17.7	23.0	0.0	0.0	12.0	37.4	18.6	0.0	0.0	57.2	31.1	9.4	264.5	146.3	74.3	24.9	55.4	3.6	13.1	22.8	18.9	31.4	12.3	20.8	0.0	88.1	25.2	18.5	44.1	59.1
PLPPR2	"LPPR2, PRG-4"	ENSG00000105520	"Phospholipid phosphatase related 2"	Q96GM1	19	11355386-11365698	"Enzymes, Metabolic proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"neutrophil: 72.3"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 72.3"	"Cell line enhanced"	"Detected in many"		"U-2197: 95.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048973	Uncertain		Uncertain	Nucleoplasm		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	Nucleoplasm		"HPA048973: AB_2680580"	"unprognostic (1.29e-2)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (6.45e-4)"	"unprognostic (2.90e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.70e-2)"	"unprognostic (7.10e-2)"	"unprognostic (1.37e-1)"	"unprognostic (9.60e-2)"	"unprognostic (1.72e-1)"	"prognostic favorable (6.82e-4)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (7.46e-11)"	"unprognostic (1.99e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.37e-2)"	"unprognostic (1.17e-1)"	21.9	35.8	80.2	10.6	62.7	15.8	21.1	28.5	80.9	39.4	22.3	41.9	5.6	32.9	7.5	16.0	35.4	13.3	32.5	111.3	70.5	18.9	25.9	29.9	5.2	39.4	44.0	40.4	17.0	13.0	73.5	11.1	44.6	40.8	4.4	10.6	22.3	13.6	33.0	24.7	17.4	16.5	32.0	28.9	26.5	17.4	75.3	3.0	26.0	5.4	2.8	32.3	27.5	41.2	23.6	14.3	7.8	32.2	31.8	30.3	2.1	40.8	37.7	24.7	25.2	2.8	4.3	4.5	23.6	52.5	5.2	4.2	4.4	12.3	13.3	12.3	8.4	1.4	9.5	2.8	16.5	1.4	45.3	27.3	21.7	21.4	4.2	35.8	17.0	7.2	22.9	36.0	21.1	34.6	0.8	6.4	8.5	7.9	78.6	0.5	1.1	12.9	11.7	11.0	8.3	27.6	17.1	14.6	9.0	2.4	20.9	29.6	19.8	55.7	11.8	95.2	21.8	22.4	14.7	1.6	54.1	21.2	22.4	2.0	17.7	9.1	0.6	15.3	0.1	0.1	0.2	0.0	6.7	0.0	0.3	0.1	72.3	0.0	10.8	0.2	0.6	6.7	80.2	62.7	28.5	80.9	111.3	70.5	39.4	44.0	44.6	32.0	75.3	41.2	9.5	6.4	8.3	0.0	1.5	0.0	6.9	0.0	11.4	7.0	9.9	10.7	0.0	8.6	1.3	3.7	12.5	0.6	1.5	0.1	1.9	6.2	11.7	2.0	11.0	10.1	17.0	0.4	0.0	8.7	2.3	12.7	3.1	3.4	2.5	3.6	11.4	8.3	4.2	8.4	0.0	2.0	0.0	11.1	0.0	13.5	14.3	7.9	0.0	0.0	12.1	16.0	6.2	0.0	0.0	9.6	0.4	16.6	1.3	11.6	0.6	1.5	1.5	6.9	6.6	5.7	13.0	2.3	7.4	2.6	0.0	2.9	1.5	11.2	0.7	5.3
PLPPR3	"FLJ11535, LPPR3, PRG-2, PRG2"	ENSG00000129951	"Phospholipid phosphatase related 3"	Q6T4P5	19	812488-821955	"Enzymes, Metabolic proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"bone marrow: 9.8;brain: 21.1;fallopian tube: 11.1"	"Cell type enriched"	"Detected in some"	7	"Endometrial ciliated cells: 37.2"	"Cancer enhanced"	"Detected in many"		"testis cancer: 4.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"NB-4: 61.8;THP-1: 128.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052293, HPA057034"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 65: Brain - Ion transport"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA052293: AB_2681787, HPA057034: AB_2683316"	"unprognostic (7.65e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.33e-2)"	"unprognostic (3.66e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.59e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.32e-1)"	"unprognostic (4.51e-4)"	"unprognostic (8.06e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.72e-12)"	"unprognostic (1.21e-2)"	"unprognostic (6.82e-2)"	"unprognostic (8.50e-2)"	"unprognostic (2.91e-1)"	0.0	0.0	16.8	0.2	14.1	9.8	2.2	0.0	21.1	0.6	0.0	0.1	0.0	0.2	0.0	0.0	11.1	0.1	0.1	14.2	11.5	0.0	0.0	2.3	0.1	4.1	8.2	0.3	0.0	0.2	0.4	0.0	1.5	0.2	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	2.3	0.2	0.1	3.2	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	1.5	12.2	0.0	0.0	0.0	6.9	0.2	0.1	0.0	0.0	0.7	0.1	0.1	8.4	0.1	0.1	0.3	2.3	0.0	0.0	0.0	5.2	0.0	1.6	0.0	0.5	4.4	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.1	12.0	0.3	0.0	1.1	0.0	61.8	9.5	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.3	15.5	0.3	0.0	0.0	6.3	5.4	128.9	0.1	0.2	0.2	0.3	0.1	0.2	0.5	0.2	0.0	10.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.8	14.1	0.0	21.1	14.2	11.5	4.1	8.2	1.5	2.3	13.8	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	3.7	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	37.2	0.6	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.4	0.0	1.2	0.0	0.0	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.9	0.1	5.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0
PLPPR4	"KIAA0455, LPPR4, PHP1, PRG-1"	ENSG00000117600	"Phospholipid phosphatase related 4"	Q7Z2D5	1	99263953-99309590	"Enzymes, Metabolic proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 23.5"	"Cell type enhanced"	"Detected in some"		"Endometrial stromal cells: 10.9;Horizontal cells: 30.3;Muller glia cells: 21.4;Smooth muscle cells: 7.0"	"Group enriched"	"Detected in many"	4	"glioma: 7.2;melanoma: 2.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 14.1;BJ hTERT+ SV40 Large T+ RasG12V: 6.3;fHDF/TERT166: 6.0;SH-SY5Y: 11.4;U-138 MG: 6.7;U-87 MG: 10.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 5: Muller glia cells - Visual perception"				"unprognostic (4.32e-2)"	"unprognostic (4.92e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.17e-2)"	"unprognostic (9.09e-2)"	"unprognostic (9.70e-3)"	"unprognostic (3.36e-2)"	"unprognostic (2.21e-1)"	"unprognostic (7.25e-12)"	"unprognostic (1.67e-5)"	"unprognostic (3.47e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.16e-3)"	1.5	0.5	8.4	0.2	13.1	0.0	0.7	0.0	16.6	1.8	0.0	0.3	0.3	0.4	0.3	1.5	0.3	3.0	0.3	23.5	2.1	0.3	0.0	1.4	0.4	0.0	0.1	0.0	0.5	0.3	2.1	0.8	0.0	0.1	0.3	3.8	0.3	0.2	0.1	1.7	0.5	0.7	0.0	0.3	0.3	2.9	5.5	0.3	0.6	0.2	0.6	3.4	0.3	1.4	0.0	0.0	0.0	2.3	0.2	0.0	0.0	3.2	14.1	3.6	6.3	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.1	0.0	0.1	0.0	0.0	0.0	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	8.4	13.1	0.0	16.6	23.5	2.1	0.0	0.1	0.0	0.0	5.5	1.4	4.3	0.0	0.6	0.0	0.5	0.0	0.0	0.0	0.0	4.9	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.4	10.9	2.5	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.2	0.0	0.0	0.0	0.0	0.1	30.3	0.0	0.0	0.0	0.0	0.0	0.4	5.3	0.2	0.0	0.0	0.0	21.4	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	1.3	0.7	4.5	0.0	0.0	7.0	1.2	0.2	0.1	0.0	0.0	0.1	0.7	0.0	0.0
POGLUT1	"9630046K23Rik, C3orf9, hCLP46, KDELCL1, KTELC1, MDS010, MDSRP, MGC32995, Rumi"	ENSG00000163389	"Protein O-glucosyltransferase 1"	Q8NBL1	3	119468963-119494708	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	Gastrulation	"Developmental protein, Glycosyltransferase, Transferase"	"Disease variant, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 81.2;monocytes: 151.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037855, HPA037856"	Approved		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 3: Monocytes - Immune response regulation"	"Endoplasmic reticulum"		"HPA037855: AB_10672728, HPA037856: AB_2732477"	"unprognostic (2.43e-1)"	"unprognostic (5.94e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.83e-2)"	"unprognostic (5.62e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.38e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.52e-3)"	"unprognostic (1.31e-2)"	"prognostic unfavorable (7.02e-7)"	"unprognostic (3.08e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.23e-3)"	"prognostic favorable (2.23e-4)"	6.8	7.2	5.9	7.8	6.1	3.1	7.7	6.0	8.2	7.1	6.9	6.8	4.2	9.0	7.8	5.6	6.0	4.7	5.9	5.9	7.2	5.7	6.6	5.6	10.8	6.6	6.5	5.5	7.9	9.5	4.9	8.2	6.6	5.4	7.2	4.2	4.6	11.6	3.2	10.0	7.8	10.4	6.1	9.0	5.4	2.5	7.2	9.7	5.6	3.4	10.8	8.5	6.3	6.7	10.8	7.1	11.7	13.1	29.5	16.8	8.6	16.7	16.7	12.3	18.4	11.5	6.9	16.5	22.2	21.4	10.6	11.9	15.9	16.8	20.4	14.4	10.6	19.3	11.1	12.9	19.1	21.3	21.7	17.5	9.6	13.3	18.0	15.7	15.5	11.2	10.5	19.7	13.9	10.9	12.5	20.7	12.4	18.6	13.8	12.2	12.2	24.0	11.6	13.9	12.7	20.0	8.1	4.9	13.4	11.7	13.2	17.8	19.7	13.1	8.0	3.8	8.9	27.1	25.2	21.7	11.1	20.6	18.8	2.9	16.4	13.9	16.2	15.7	18.7	13.9	18.2	17.0	20.7	10.1	21.1	20.0	1.2	29.5	10.8	11.5	22.3	15.0	5.9	6.1	6.0	8.2	5.9	7.2	6.6	6.5	6.6	6.1	7.2	6.7	19.1	0.0	6.2	11.4	15.7	16.8	7.3	17.4	16.5	13.6	9.7	8.5	5.2	14.3	10.1	20.2	6.2	10.6	17.1	5.2	0.0	6.9	0.7	5.5	19.3	16.1	9.5	8.4	32.7	5.3	14.7	14.5	9.2	7.0	17.7	11.3	13.6	12.5	8.4	5.0	31.6	11.7	22.4	11.9	81.2	0.2	8.7	16.6	12.4	6.5	151.4	10.3	21.6	23.6	25.8	5.0	8.3	17.0	14.1	8.0	8.5	6.0	6.5	13.0	13.1	16.7	13.4	1.5	1.5	13.9	14.9	6.6	15.5	17.4	13.9	5.9
POMGNT1	"FLJ20277, LGMD2O, MEB, MGAT1.2"	ENSG00000085998	"Protein O-linked mannose N-acetylglucosaminyltransferase 1 (beta 1,2-)"	Q8WZA1	1	46188682-46220305	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital muscular dystrophy, Disease variant, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044518	Approved					NA	NA		17000000	"Cluster 15: NK-cells - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 22: Epithelial cell types - Mixed function"			"HPA044518: AB_10795985"	"unprognostic (4.59e-3)"	"unprognostic (1.59e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.20e-1)"	"prognostic unfavorable (3.52e-4)"	"unprognostic (1.82e-1)"	"unprognostic (5.74e-2)"	"unprognostic (5.37e-2)"	"prognostic favorable (4.27e-4)"	"unprognostic (5.86e-2)"	"unprognostic (4.39e-2)"	"unprognostic (4.99e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.16e-2)"	"unprognostic (2.36e-1)"	22.5	40.4	45.8	14.9	51.9	5.5	23.7	52.7	50.4	26.3	44.5	23.9	21.5	24.1	31.1	18.7	26.2	17.8	83.3	45.9	49.8	36.5	40.7	24.0	13.6	55.0	53.3	21.9	29.5	87.5	47.3	20.8	53.8	37.9	17.9	21.8	24.8	27.5	73.9	23.2	19.6	27.8	51.2	24.6	30.3	37.2	50.9	18.8	37.9	48.1	16.2	27.8	21.0	61.0	37.7	39.6	47.3	46.0	51.0	55.3	60.9	49.3	82.7	65.9	51.5	22.6	30.5	34.6	79.7	82.3	112.3	21.1	34.2	70.5	39.3	45.4	38.6	27.3	34.2	34.3	44.6	21.3	25.8	56.2	90.5	73.7	68.2	118.0	68.0	46.6	32.9	21.9	108.9	26.2	37.8	15.3	39.2	21.5	54.7	27.2	48.4	32.7	58.2	45.9	17.9	64.1	45.7	52.1	70.7	67.4	34.8	29.8	50.0	49.2	43.5	56.4	96.4	54.7	65.3	16.1	75.1	20.8	53.5	0.0	1.1	1.2	3.3	2.1	2.2	1.4	2.2	2.6	1.6	2.6	4.1	3.2	0.0	6.2	4.1	4.6	2.5	1.4	45.8	51.9	52.7	50.4	45.9	49.8	55.0	53.3	53.8	51.2	50.9	61.0	12.0	12.8	40.4	15.0	11.7	8.4	40.4	31.0	13.6	38.9	18.5	14.9	44.5	21.5	30.1	35.0	50.1	25.2	17.5	13.9	13.7	39.3	47.6	15.3	13.7	17.5	27.0	9.0	19.4	39.9	27.4	14.8	7.1	27.1	27.1	25.2	14.6	20.5	15.6	26.9	20.6	12.6	16.2	14.6	6.4	15.6	20.2	10.6	24.9	8.4	18.0	21.9	19.6	19.6	33.7	38.7	14.5	13.2	16.9	44.4	19.0	22.8	21.2	36.4	13.1	16.4	16.4	11.2	12.9	12.7	7.5	23.4	13.6	19.0	17.4	33.0
PSAP	"GLBA, SAP1, SAP2"	ENSG00000197746	Prosaposin	P07602	10	71816298-71851325	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Lipid metabolism, Sphingolipid metabolism"		"Disease variant, Gangliosidosis, Gaucher disease, Leukodystrophy, Metachromatic leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 2792.8;Kupffer cells: 2427.0;Macrophages: 1916.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"intermediate monocyte: 11615.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 5104.0;hTERT-RPE1: 6978.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004426, CAB004647"	Supported		Supported	Vesicles	"Intracellular and membrane"	NA	NA		88000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 4: Macrophages - Innate immune response"	Vesicles		"CAB004647: AB_425625, HPA004426: AB_1079701"	"unprognostic (4.43e-3)"	"unprognostic (2.69e-1)"	"unprognostic (1.64e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.36e-3)"	"unprognostic (2.79e-1)"	"unprognostic (3.31e-2)"	"unprognostic (3.25e-2)"	"unprognostic (2.30e-3)"	"unprognostic (2.00e-2)"	"unprognostic (3.62e-3)"	"unprognostic (6.47e-2)"	"unprognostic (4.42e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.06e-1)"	1068.6	1192.2	831.4	874.2	946.7	834.2	683.8	873.7	831.7	1073.9	1023.0	667.1	475.6	879.3	951.2	605.5	724.7	1115.6	1413.3	830.5	1081.8	860.4	906.4	1118.6	956.1	957.6	894.0	1106.9	544.7	1167.5	563.5	869.3	885.3	773.9	625.5	665.2	580.9	936.8	1409.5	544.4	487.7	1138.6	1025.9	1045.9	664.0	489.1	1048.8	672.3	875.9	987.5	560.4	941.2	578.3	1325.1	455.9	847.4	540.4	1121.0	5104.0	2910.1	1900.2	799.9	2368.3	620.8	735.9	795.4	1131.9	245.6	1608.1	1321.6	1038.9	964.1	207.5	659.1	434.8	481.4	381.8	288.9	352.3	459.6	1970.7	188.8	1596.0	1871.8	1479.1	625.7	1177.6	6978.9	1128.1	345.8	420.5	1158.1	777.0	294.9	843.8	290.1	249.5	575.4	404.0	172.9	301.3	696.7	730.3	764.4	584.4	515.8	751.1	2248.3	3122.2	700.4	454.4	431.1	1467.0	861.8	610.0	587.1	670.5	1289.0	1038.7	435.4	1375.5	374.4	650.0	863.2	10095.9	1127.5	424.2	11615.6	349.8	466.7	342.9	368.8	3481.1	425.5	370.1	350.6	2890.4	365.8	10148.2	1758.2	422.8	15009.0	831.4	946.7	873.7	831.7	830.5	1081.8	957.6	894.0	885.3	1025.9	1048.8	1325.1	263.2	253.2	339.0	136.8	173.9	228.3	253.4	487.0	108.1	193.8	254.6	158.7	664.1	253.1	318.9	476.3	127.2	891.6	260.2	434.8	70.5	1043.6	19.3	147.0	246.6	311.4	261.9	160.5	86.1	456.1	872.6	623.8	187.6	195.2	398.1	210.8	426.9	509.2	2792.8	333.1	93.7	242.2	343.8	2427.0	779.7	54.1	458.6	1916.9	663.5	105.9	1528.9	495.6	182.3	92.5	117.6	357.7	298.3	551.8	503.0	244.8	370.6	311.6	297.2	164.3	276.1	273.6	263.8	55.2	126.3	137.2	198.0	1073.2	138.9	624.1	228.3	223.9
SGMS1	"MGC17342, MOB, SMS1, TMEM23"	ENSG00000198964	"Sphingomyelin synthase 1"	Q86VZ5	10	50305586-50625163	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Lipid metabolism, Sphingolipid metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 153.1;Microglial cells: 229.5;Oligodendrocyte precursor cells: 313.1;Oligodendrocytes: 422.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 62.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045191	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	"Nucleoli fibrillar center, Golgi apparatus, Cytosol"	"HPA045191: AB_10959605"	"unprognostic (1.13e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.87e-1)"	"unprognostic (9.08e-2)"	"unprognostic (8.69e-3)"	"unprognostic (8.34e-2)"	"unprognostic (7.98e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.30e-2)"	"unprognostic (5.75e-2)"	"unprognostic (9.20e-2)"	"unprognostic (2.05e-1)"	"prognostic favorable (1.95e-7)"	"unprognostic (8.38e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.31e-1)"	"unprognostic (3.05e-1)"	15.8	19.3	19.8	10.7	27.4	24.0	14.5	21.5	20.3	16.9	33.9	10.1	13.5	11.9	19.9	15.3	16.6	15.4	13.2	17.2	23.0	20.2	27.9	21.9	14.9	29.5	24.1	18.6	13.3	52.9	6.4	24.6	28.5	19.5	11.7	20.2	18.0	16.8	9.9	25.3	16.0	15.8	23.6	11.7	14.3	11.3	23.4	12.0	24.7	10.5	14.5	20.9	13.1	41.3	30.2	14.0	4.0	9.0	14.2	18.6	18.8	19.6	19.7	13.5	12.6	11.7	30.3	22.1	11.3	25.9	12.2	18.7	9.5	20.6	14.0	19.4	10.2	32.7	17.9	9.0	16.5	7.5	7.6	12.1	23.6	18.0	21.7	8.7	19.3	7.9	62.6	32.2	14.6	12.7	3.3	4.2	9.2	13.7	13.7	5.5	18.4	8.8	19.7	31.2	6.2	4.9	14.4	14.2	7.5	11.3	21.4	2.7	27.1	14.6	17.8	14.1	14.6	11.0	9.5	6.3	18.2	12.0	12.1	3.4	9.3	28.4	4.6	4.9	10.3	7.0	6.2	6.8	5.2	6.5	8.2	5.4	16.7	10.1	4.0	3.2	15.6	6.3	19.8	27.4	21.5	20.3	17.2	23.0	29.5	24.1	28.5	23.6	23.4	41.3	17.1	44.8	40.0	106.7	19.9	54.4	28.9	15.6	23.9	20.1	15.8	8.9	26.3	10.0	30.0	29.5	4.2	10.9	15.6	6.2	15.6	17.6	17.0	20.9	10.5	19.6	14.9	32.0	153.1	21.6	7.7	19.8	30.5	32.4	20.8	12.1	17.9	16.0	29.0	5.0	117.2	11.1	4.1	46.5	17.6	30.6	16.1	34.5	12.4	229.5	12.4	17.4	10.3	313.1	422.0	10.7	6.4	10.5	13.7	32.3	18.4	9.3	25.1	36.4	0.0	20.5	27.1	12.8	2.3	18.7	83.4	4.9	20.0	11.8	12.4	25.4
SGMS2	"MGC26963, SMS2"	ENSG00000164023	"Sphingomyelin synthase 2"	Q8NHU3	4	107824563-107915047	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	"Kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 126.6;Basal prostatic cells: 167.4;Endometrial ciliated cells: 172.1;Glandular and luminal cells: 147.8;Urothelial cells: 159.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"classical monocyte: 3.7;eosinophil: 2.4;intermediate monocyte: 1.5;myeloid DC: 4.2;non-classical monocyte: 1.4"	"Group enriched"	"Detected in many"	35	"dendritic cells: 4.2;granulocytes: 2.4;monocytes: 3.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015076	Supported					NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 44: Endometrium - Transcription"			"HPA015076: AB_1857298"	"unprognostic (7.44e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.87e-2)"	"unprognostic (7.88e-3)"	"unprognostic (9.53e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.15e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.82e-3)"	"unprognostic (3.26e-1)"	"prognostic favorable (1.37e-4)"	"unprognostic (6.18e-2)"	"unprognostic (5.63e-2)"	"unprognostic (8.71e-2)"	"unprognostic (5.22e-3)"	8.6	3.0	5.2	9.0	15.3	4.6	5.2	10.1	7.8	12.7	36.7	12.3	19.5	8.8	4.6	16.4	12.5	39.6	9.1	3.3	6.5	14.5	20.4	27.8	1.1	13.9	14.3	1.1	11.7	3.6	4.7	5.1	13.0	9.6	10.6	0.8	9.2	4.6	2.5	3.6	16.5	29.1	10.2	1.1	13.8	9.6	10.6	0.8	18.0	3.4	2.9	13.9	4.2	21.6	20.8	7.7	1.1	5.8	12.9	29.9	0.4	25.0	18.8	11.6	12.1	3.5	42.1	1.5	9.7	40.0	10.1	7.6	14.5	22.1	20.7	5.9	5.7	0.9	16.5	1.2	14.8	14.2	0.1	10.4	15.1	22.7	27.4	24.2	26.1	0.3	0.2	0.5	18.6	6.9	0.5	0.1	0.7	12.1	8.6	0.5	9.9	2.9	30.7	10.0	2.0	0.1	19.1	26.9	3.3	3.0	14.5	0.4	44.7	13.9	21.9	20.1	11.7	1.4	0.5	0.8	18.7	3.4	5.9	0.0	3.7	2.4	0.0	1.5	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.3	0.0	1.4	0.0	0.0	1.0	5.2	15.3	10.1	7.8	3.3	6.5	13.9	14.3	13.0	10.2	10.6	21.6	3.4	86.6	126.6	7.2	1.0	56.0	167.4	12.8	18.2	0.5	20.9	10.4	17.8	28.6	88.0	16.5	0.0	1.0	2.9	32.3	3.9	19.8	71.4	172.1	13.5	10.7	8.9	0.0	8.0	19.5	0.9	26.6	58.1	147.8	10.1	2.8	11.4	25.0	5.5	1.7	10.0	26.0	14.2	22.1	43.0	11.1	2.5	28.2	8.8	1.9	23.3	0.2	2.1	0.5	18.5	37.9	60.5	0.4	0.4	96.9	33.5	12.4	104.0	0.1	0.0	46.1	22.0	0.9	3.1	38.1	72.9	13.8	3.3	0.1	21.8	159.7
SGPL1	SPL	ENSG00000166224	"Sphingosine-1-phosphate lyase 1"	O95470	10	70815948-70881184	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Lipid metabolism, Sphingolipid metabolism"	Lyase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RT4: 112.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021125, HPA023086"	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 37: Intestine - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Endoplasmic reticulum"		"HPA021125: AB_1856803, HPA023086: AB_1856804"	"unprognostic (1.14e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.34e-1)"	"unprognostic (7.60e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.12e-1)"	"unprognostic (9.52e-2)"	"unprognostic (3.42e-1)"	"unprognostic (2.14e-1)"	"unprognostic (9.21e-2)"	"unprognostic (4.68e-3)"	12.0	12.7	15.8	18.0	17.4	6.8	13.0	15.2	16.3	17.6	11.0	16.7	16.0	14.4	18.8	27.9	15.3	12.6	6.4	14.7	16.4	15.5	22.9	10.7	18.1	18.6	16.7	9.0	18.5	21.0	9.4	10.0	17.4	17.5	17.9	10.8	14.3	12.4	9.6	30.4	22.8	13.9	17.4	16.1	12.3	14.0	17.7	17.9	20.1	6.0	20.1	25.0	14.7	19.8	26.9	35.2	33.2	38.1	8.9	11.5	22.1	15.5	16.4	16.5	21.4	38.4	57.8	24.2	18.0	15.8	15.9	44.1	28.8	31.0	23.5	39.1	15.6	2.5	17.5	46.2	33.6	10.6	20.9	21.8	51.4	22.1	57.6	34.6	10.4	22.3	7.2	20.4	23.6	29.6	13.2	7.1	15.0	35.4	19.5	16.6	25.2	9.1	26.3	112.1	22.6	27.5	30.9	46.6	28.5	25.9	24.3	7.5	20.3	14.8	38.7	11.6	30.1	8.4	12.6	11.0	14.7	19.3	10.7	1.1	18.2	14.0	18.0	34.6	16.5	7.2	11.5	14.7	16.2	8.7	8.5	13.5	15.0	18.8	44.9	8.9	11.8	12.4	15.8	17.4	15.2	16.3	14.7	16.4	18.6	16.7	17.4	17.4	17.7	19.8	3.8	16.0	6.4	32.3	11.0	12.2	17.8	21.4	8.0	6.3	15.8	9.8	6.3	27.1	23.2	46.0	20.9	7.3	16.0	41.5	3.9	36.2	2.9	30.2	13.3	7.3	25.1	4.4	48.7	37.6	13.8	10.1	6.6	46.1	14.7	23.1	7.1	44.5	27.6	15.2	38.8	21.2	22.4	43.1	16.1	5.2	11.5	25.7	7.2	35.6	22.7	9.8	25.7	41.7	43.8	55.6	18.8	20.3	5.9	26.0	53.5	12.0	26.6	9.7	6.6	13.3	19.0	20.0	34.0	15.9	22.7	6.3	11.1	18.2	20.9	25.3
SGPP1		ENSG00000126821	"Sphingosine-1-phosphate phosphatase 1"	Q9BX95	14	63684216-63728065	"Metabolic proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Kupffer cells: 61.8;Oligodendrocytes: 60.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 6.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 43.8;U-698: 57.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053149, HPA064908"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	Nucleoplasm		"HPA053149: AB_2682057, HPA064908: AB_2797270"	"unprognostic (1.57e-2)"	"unprognostic (1.04e-2)"	"unprognostic (5.40e-3)"	"unprognostic (7.82e-2)"	"unprognostic (9.09e-2)"	"unprognostic (4.30e-2)"	"unprognostic (6.49e-3)"	"unprognostic (1.35e-2)"	"unprognostic (1.64e-1)"	"unprognostic (7.41e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.27e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.31e-3)"	7.9	10.6	5.3	6.0	6.0	3.0	6.4	5.8	7.9	6.4	3.6	7.0	3.8	7.4	6.2	4.9	5.7	5.5	4.9	5.3	5.9	15.9	19.5	6.9	13.3	6.6	6.2	5.8	12.7	10.2	5.6	12.0	6.6	7.4	5.3	4.1	4.8	4.0	4.2	3.8	8.8	4.8	7.3	9.3	5.5	5.4	5.8	5.8	5.8	2.6	12.9	5.8	6.8	8.0	19.7	6.2	3.0	8.6	10.7	9.9	35.9	15.7	10.9	9.6	10.7	2.7	10.9	43.8	4.5	8.0	8.0	20.3	4.8	9.3	15.3	17.3	5.7	4.0	3.4	4.4	13.1	7.3	12.2	7.3	14.7	8.4	13.2	9.7	4.6	8.2	2.3	1.2	14.1	7.3	8.6	0.1	2.1	3.2	13.1	2.1	8.4	3.5	15.2	9.7	1.8	5.0	11.0	10.2	8.4	9.2	13.3	2.6	5.2	13.2	9.1	9.5	7.9	10.1	6.5	57.4	9.7	0.0	5.8	6.9	0.2	1.7	0.5	1.4	0.5	1.8	0.5	0.3	0.3	0.4	0.8	0.6	0.2	0.3	2.1	0.1	1.3	0.3	5.3	6.0	5.8	7.9	5.3	5.9	6.6	6.2	6.6	7.3	5.8	8.0	5.3	12.8	16.2	22.2	22.6	9.7	6.1	4.1	8.0	4.0	9.4	5.2	3.8	24.3	3.2	51.5	0.0	23.4	10.9	11.9	0.0	6.0	2.4	6.3	12.1	6.5	18.6	9.7	32.6	9.1	27.0	12.8	3.1	10.1	11.4	5.0	6.1	43.6	23.7	10.1	38.5	10.2	2.0	61.8	20.1	1.2	6.2	18.6	17.8	21.5	6.8	8.2	2.1	31.7	60.0	13.2	13.5	17.0	5.7	8.1	3.2	22.7	2.6	5.4	6.6	8.1	11.3	7.4	3.5	4.6	13.5	33.0	10.4	10.3	10.3	5.6
SLC33A1	"ACATN, AT-1, AT1, SPG42"	ENSG00000169359	"Solute carrier family 33 member 1"	O00400	3	155821024-155854456	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Cataract, Deafness, Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042430	Uncertain		Approved	Vesicles,Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 55: Plasma cells - Humoral immune response"	"Vesicles, Cytosol"		"HPA042430: AB_10806238"	"unprognostic (5.12e-3)"	"unprognostic (7.78e-2)"	"unprognostic (1.13e-2)"	"unprognostic (7.21e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.73e-2)"	"unprognostic (9.57e-2)"	"unprognostic (5.65e-2)"	"unprognostic (6.61e-2)"	"unprognostic (4.36e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.92e-1)"	"unprognostic (4.73e-2)"	"unprognostic (5.74e-2)"	8.8	11.0	3.9	4.9	4.8	2.9	8.4	4.6	4.7	12.3	9.2	7.2	6.9	8.8	12.9	8.0	9.5	7.8	7.6	4.6	5.3	10.4	17.2	8.4	5.0	4.4	4.2	8.0	30.9	11.6	5.9	6.6	4.6	8.3	6.4	6.8	11.2	11.0	4.7	6.4	7.7	7.1	5.2	5.8	8.8	5.4	5.2	7.1	18.8	4.8	6.2	6.8	7.9	7.3	18.9	17.7	7.3	8.3	24.4	23.5	12.9	13.1	21.2	19.8	18.7	8.5	22.0	9.9	24.1	13.1	19.8	17.1	14.3	15.2	20.8	16.5	13.3	11.3	6.5	15.8	41.5	13.3	8.9	18.4	26.7	9.7	49.5	20.5	19.8	12.4	8.6	27.8	14.3	14.3	5.0	3.7	6.8	17.7	14.9	5.6	8.1	29.1	9.7	11.8	7.9	5.9	11.1	24.5	21.4	11.3	8.1	11.2	21.4	10.1	4.9	17.9	13.1	33.2	14.4	12.3	14.6	8.8	14.0	12.7	8.4	6.2	8.9	6.3	9.6	5.4	6.0	6.8	10.4	3.5	5.4	5.5	1.7	6.6	6.5	16.1	5.7	5.9	3.9	4.8	4.6	4.7	4.6	5.3	4.4	4.2	4.6	5.2	5.2	7.3	9.0	22.4	25.0	16.0	14.8	8.9	11.7	20.8	18.2	17.5	16.0	9.0	23.8	18.6	21.5	11.0	27.1	18.2	21.1	14.2	5.9	15.3	13.7	11.2	20.3	13.7	12.5	8.4	17.9	15.4	28.3	19.7	20.9	16.6	12.0	12.8	16.4	64.3	19.5	18.5	17.4	18.1	12.2	14.7	15.8	13.2	18.6	15.2	12.4	10.3	19.0	15.4	12.3	11.1	20.8	14.4	5.3	21.4	33.3	19.5	18.9	17.1	23.4	23.0	13.1	16.0	16.0	19.5	9.2	12.2	9.5	37.6	15.3	10.2	13.9	10.9
SMPD1	ASM	ENSG00000166311	"Sphingomyelin phosphodiesterase 1"	P17405	11	6390440-6394998	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Glycosidase, Hydrolase"	"Disease variant, Neurodegeneration, Niemann-Pick disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 131.3;Late spermatids: 200.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 139.1;fHDF/TERT166: 144.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA		2700000	"Cluster 15: NK-cells - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"				"unprognostic (8.76e-2)"	"unprognostic (2.66e-1)"	"unprognostic (6.99e-2)"	"unprognostic (2.28e-3)"	"prognostic unfavorable (7.72e-5)"	"unprognostic (9.46e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.90e-2)"	"unprognostic (8.06e-2)"	"unprognostic (1.72e-1)"	"prognostic favorable (7.47e-4)"	"unprognostic (4.35e-2)"	"prognostic favorable (4.57e-6)"	"unprognostic (4.27e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.71e-1)"	21.8	36.5	38.8	13.9	44.7	7.3	20.1	45.1	43.0	21.2	33.9	25.3	16.8	20.9	14.4	20.6	14.6	21.5	55.8	39.1	43.0	73.7	95.3	31.3	14.6	42.7	42.6	17.9	32.8	34.2	41.9	21.6	43.3	29.4	14.9	8.5	29.0	20.0	37.9	37.9	23.8	17.6	40.9	21.1	25.4	14.0	47.5	17.8	34.0	29.4	11.0	23.6	21.0	46.8	16.4	13.1	10.1	26.5	139.1	72.2	17.1	60.4	95.0	27.7	33.0	22.0	11.9	4.7	27.4	144.0	59.3	7.4	8.4	12.7	13.0	21.0	9.6	5.1	19.5	6.0	62.3	3.7	37.4	96.0	23.4	25.9	17.7	100.9	61.6	1.7	9.1	30.5	58.9	17.0	0.1	6.5	3.9	23.2	22.3	1.2	5.5	7.0	23.9	6.2	17.0	9.7	27.6	19.5	38.5	12.9	7.3	7.0	53.9	103.0	10.9	59.1	15.4	37.6	44.0	3.5	93.7	10.8	47.1	1.9	2.5	3.4	6.4	2.1	5.0	1.5	5.5	5.0	1.3	3.1	10.0	10.1	2.5	6.6	0.6	1.7	4.7	3.2	38.8	44.7	45.1	43.0	39.1	43.0	42.7	42.6	43.3	40.9	47.5	46.8	14.1	25.6	14.4	10.7	12.2	7.9	22.8	15.3	6.8	12.6	13.7	9.0	37.7	24.3	12.8	25.8	25.0	38.8	11.5	131.3	11.7	53.4	50.0	6.2	13.0	18.6	23.8	9.9	5.8	38.2	14.4	31.4	15.8	21.0	10.8	9.4	26.7	88.5	34.1	20.2	5.5	20.3	24.4	15.5	6.2	200.7	11.5	15.8	55.2	4.7	7.8	16.4	36.0	6.6	15.5	24.7	83.1	13.5	23.1	26.0	51.7	75.1	2.4	5.2	0.0	8.9	17.1	1.4	3.1	7.5	8.0	34.3	23.3	10.2	18.0	15.4
SMPD2	"ISC1, nSMase"	ENSG00000135587	"Sphingomyelin phosphodiesterase 2"	O60906	6	109440724-109443919	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 53.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 179.4;Late spermatids: 359.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018110, HPA018125"	Uncertain		Approved	"Vesicles,Plasma membrane,Cell Junctions"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 71: Testis - DNA repair"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Vesicles, Plasma membrane"	"Cell Junctions"	"HPA018110: AB_1857292, HPA018125: AB_1857293"	"unprognostic (1.61e-1)"	"unprognostic (8.01e-2)"	"unprognostic (1.97e-1)"	"unprognostic (8.79e-3)"	"unprognostic (3.88e-2)"	"unprognostic (2.38e-1)"	"prognostic unfavorable (1.17e-4)"	"unprognostic (7.08e-2)"	"unprognostic (7.59e-2)"	"unprognostic (1.41e-1)"	"prognostic favorable (1.00e-3)"	"unprognostic (3.60e-2)"	"unprognostic (2.14e-3)"	"unprognostic (7.94e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.45e-2)"	"prognostic favorable (1.70e-4)"	6.9	8.8	7.6	8.6	7.4	12.7	10.5	9.6	7.8	12.6	15.1	12.7	13.5	7.1	15.5	24.5	21.4	8.7	6.7	7.7	6.9	12.2	7.6	9.7	13.3	7.6	7.9	8.2	17.7	22.1	11.1	6.0	7.2	13.2	12.6	6.5	15.6	5.8	4.1	21.7	12.3	4.9	7.6	13.3	14.2	53.0	7.0	10.3	13.3	1.7	17.1	10.4	14.3	8.8	13.1	14.8	7.7	12.2	13.2	7.1	25.5	4.3	15.7	10.5	9.8	14.0	10.3	7.1	9.0	9.3	22.1	16.4	7.8	18.7	6.3	9.1	20.5	8.2	15.9	8.7	11.0	9.1	9.4	7.7	21.3	9.3	18.4	11.8	9.8	12.4	16.3	12.2	5.3	18.7	14.8	19.7	2.1	17.3	7.5	10.4	3.6	7.7	19.3	21.8	10.1	8.4	8.2	24.9	19.3	6.2	7.9	17.2	6.3	4.7	6.8	3.8	16.3	8.3	2.3	4.6	9.1	8.6	8.5	6.2	9.0	10.8	6.9	8.6	7.8	14.4	7.8	8.2	11.2	20.4	5.6	5.9	2.5	7.3	7.8	14.3	8.2	6.0	7.6	7.4	9.6	7.8	7.7	6.9	7.6	7.9	7.2	7.6	7.0	8.8	3.9	12.8	7.2	1.6	15.9	9.8	12.9	13.8	8.6	1.3	8.9	6.7	2.1	7.2	11.8	12.9	4.2	10.3	9.1	26.1	1.9	19.2	179.4	28.4	4.0	4.4	8.4	4.2	1.4	19.8	18.5	6.1	25.0	4.3	0.0	3.5	3.6	3.6	9.5	0.0	0.5	27.1	14.2	4.1	11.2	359.7	9.3	7.2	8.8	2.8	9.9	3.7	6.2	0.0	1.7	15.4	27.7	9.1	9.8	15.0	37.5	9.3	67.1	4.9	13.1	3.1	5.8	69.9	10.9	13.8	18.6	17.0	7.6	8.7	17.8	16.9
SMPD3	NSMASE2	ENSG00000103056	"Sphingomyelin phosphodiesterase 3"	Q9NY59	16	68358327-68448508	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Lipid metabolism, Sphingolipid metabolism"	"Developmental protein, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 61.5;lymphoid tissue: 52.0"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 77.1;Gastric mucus-secreting cells: 70.8;Horizontal cells: 301.2;Proximal enterocytes: 115.1"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"amygdala: 8.0;basal ganglia: 29.7;cerebral cortex: 24.9;hippocampal formation: 25.4"	"Immune cell enriched"	"Detected in many"	7	"plasmacytoid DC: 138.9"	"Lineage enriched"	"Detected in many"	7	"dendritic cells: 138.9"	"Cell line enhanced"	"Detected in some"		"HMC-1: 9.7;MOLT-4: 14.7;RPMI-8226: 12.4;SCLC-21H: 13.4"	"Region enhanced"	"Detected in all"		"basal ganglia: 115.2"	"Region enhanced"	"Detected in all"		"basal ganglia: 67.7"	"CAB033885, HPA065535, HPA069383"	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 62: Horizontal cells - Visual perception"	"Endoplasmic reticulum"		"CAB033885: AB_1126788, HPA065535: , HPA069383: "	"unprognostic (1.21e-1)"	"prognostic favorable (7.72e-4)"	"unprognostic (5.61e-3)"	"prognostic favorable (3.86e-4)"	"unprognostic (2.46e-1)"	"unprognostic (5.85e-4)"	"unprognostic (7.87e-2)"	"unprognostic (8.12e-3)"	"unprognostic (2.77e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.04e-3)"	"unprognostic (5.02e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.93e-3)"	6.8	2.1	8.0	3.6	29.7	1.8	2.8	1.8	24.9	2.7	0.1	13.8	61.5	1.4	0.1	2.1	3.8	9.0	1.5	25.4	0.5	4.0	7.4	2.5	4.2	0.0	0.2	4.8	2.6	0.1	16.5	0.2	0.6	4.6	6.9	6.5	3.0	0.3	2.4	13.6	57.7	0.7	0.5	3.4	23.2	8.6	5.1	52.0	2.7	0.0	1.9	1.7	2.5	2.3	0.3	0.8	0.4	0.1	0.0	0.0	5.5	0.4	0.0	0.4	0.1	3.1	1.0	0.4	0.6	0.3	0.2	1.2	0.0	0.0	0.1	0.3	0.7	0.1	2.7	0.3	0.0	0.0	9.7	0.0	0.0	0.0	0.2	0.5	0.0	0.9	0.9	0.3	0.3	0.2	14.7	2.8	0.6	4.9	0.1	0.7	0.2	12.4	0.0	0.1	13.4	2.7	0.4	1.6	0.7	0.2	1.1	0.9	0.0	0.4	0.8	1.4	0.1	2.3	1.2	0.3	0.2	0.9	0.2	4.4	0.0	20.7	2.3	0.1	0.3	1.7	0.2	0.6	0.1	0.9	0.6	0.3	0.1	0.1	0.0	138.9	1.9	1.2	8.0	29.7	1.8	24.9	25.4	0.5	0.0	0.2	0.6	0.5	5.1	2.3	0.3	3.2	1.1	1.0	2.6	0.1	1.5	0.6	0.0	50.8	1.8	0.6	2.9	15.7	1.5	0.0	0.0	0.0	77.1	44.7	0.0	1.3	8.5	3.0	0.3	0.6	25.8	0.4	33.8	0.9	0.1	5.2	70.8	0.5	0.0	0.2	0.7	9.4	0.3	301.2	20.4	34.7	2.0	1.0	0.5	18.6	15.2	2.9	0.0	1.9	0.6	0.9	1.0	10.6	1.7	1.6	39.9	45.9	2.5	3.6	115.1	0.0	14.6	3.9	0.0	0.2	0.3	10.0	2.1	0.1	1.0	0.0	6.2	0.2	21.6	5.4
SMPD4	"FLJ20297, FLJ20756, KIAA1418, NET13, nSMase-3, NSMASE3"	ENSG00000136699	"Sphingomyelin phosphodiesterase 4"	Q9NXE4	2	130151392-130182750	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046279, HPA049426"	Approved		Approved	"Nuclear membrane,Cytosol"		NA	Yes			"Cluster 39: Non-specific - mRNA processing"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Nuclear membrane"	Cytosol	"HPA046279: AB_2679611, HPA049426: AB_2680762"	"unprognostic (5.02e-2)"	"unprognostic (9.61e-3)"	"unprognostic (6.31e-2)"	"prognostic unfavorable (7.47e-5)"	"unprognostic (1.69e-1)"	"unprognostic (8.80e-2)"	"prognostic unfavorable (8.37e-6)"	"unprognostic (3.27e-2)"	"unprognostic (1.72e-1)"	"unprognostic (7.47e-2)"	"unprognostic (1.49e-2)"	"prognostic unfavorable (1.73e-4)"	"prognostic unfavorable (8.16e-8)"	"unprognostic (1.74e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.47e-3)"	"unprognostic (2.09e-1)"	9.9	10.8	4.2	11.1	4.9	25.4	10.9	5.3	6.2	15.5	3.1	12.1	9.5	15.5	5.0	13.8	15.9	9.2	11.7	4.0	7.0	8.6	9.2	10.6	15.7	7.5	5.0	14.6	13.3	15.2	22.7	14.9	6.3	11.8	11.1	4.7	12.9	11.7	13.3	13.5	11.5	12.9	2.4	11.2	10.3	17.7	6.0	19.8	16.0	12.0	15.7	11.8	12.3	10.0	89.1	41.5	46.2	39.2	29.1	21.8	58.7	41.5	42.0	76.3	62.8	119.2	47.0	56.2	41.2	49.9	36.3	43.8	64.0	64.4	40.4	72.7	61.2	60.5	36.2	90.1	31.2	68.5	34.7	25.6	39.4	77.0	27.2	21.1	44.9	51.4	82.2	40.8	40.7	44.3	72.2	32.0	77.0	40.1	56.4	74.3	44.2	59.0	27.0	38.6	66.8	36.3	42.8	54.5	22.7	24.9	37.8	34.8	32.8	57.0	49.3	33.0	49.4	34.3	44.0	79.2	51.4	38.7	44.0	1.8	9.2	14.8	12.9	11.2	14.3	8.9	9.6	11.6	9.6	9.1	9.0	10.5	4.3	12.1	8.1	6.0	9.2	10.4	4.2	4.9	5.3	6.2	4.0	7.0	7.5	5.0	6.3	2.4	6.0	10.0	17.4	3.2	11.3	4.9	20.8	15.0	9.1	8.8	12.0	19.8	21.5	23.0	3.9	5.7	8.0	7.3	12.5	23.8	16.4	7.9	9.8	9.2	22.7	16.0	19.7	12.0	13.1	21.2	6.9	12.2	26.5	12.2	18.8	26.3	6.3	29.0	10.4	17.3	14.1	15.2	6.7	12.8	4.1	13.2	7.7	41.7	14.6	10.2	16.0	1.0	8.8	9.9	11.3	7.5	10.4	11.8	10.5	18.4	27.0	9.4	7.7	5.9	9.9	16.0	0.0	14.1	12.8	25.0	25.6	18.7	20.6	15.6	15.6	16.0	15.2	9.6
SPHK1	SPHK	ENSG00000176170	"Sphingosine kinase 1"	Q9NYA1	17	76376584-76387860	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Calmodulin-binding, Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Ductal cells: 105.4;Muller glia cells: 165.1;Pancreatic endocrine cells: 101.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 4.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 127.6;TIME: 108.9;U-251 MG: 142.1"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"olfactory bulb: 5.7"	"HPA022829, HPA028761"	Uncertain		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 1: Pancreatic cells - Digestion"	"Plasma membrane, Cytosol"		"HPA022829: AB_1857438, HPA028761: AB_10600814"	"unprognostic (1.04e-1)"	"unprognostic (6.30e-2)"	"unprognostic (1.09e-2)"	"unprognostic (8.66e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.68e-2)"	"unprognostic (9.32e-3)"	"unprognostic (3.13e-1)"	"unprognostic (7.43e-2)"	"unprognostic (8.99e-3)"	"unprognostic (2.18e-1)"	"prognostic unfavorable (5.14e-6)"	"unprognostic (1.39e-1)"	"unprognostic (4.82e-2)"	"unprognostic (8.29e-2)"	"unprognostic (1.10e-3)"	18.9	4.1	4.0	10.5	3.0	17.3	18.0	2.1	3.9	11.0	2.3	7.0	1.9	6.7	3.9	23.8	9.4	11.9	17.5	2.9	3.9	21.4	3.8	24.3	8.1	4.0	4.1	4.3	14.4	4.8	4.9	2.5	4.5	7.3	1.1	8.4	19.9	1.5	3.2	15.6	7.0	3.2	2.3	5.0	6.7	5.8	8.5	3.5	10.6	0.8	4.1	11.3	13.1	3.9	36.9	3.7	15.2	0.8	7.6	7.0	15.8	82.6	54.0	67.8	40.8	19.4	3.9	1.8	7.4	61.0	28.9	7.7	11.7	105.4	16.4	1.6	6.2	0.5	28.3	127.6	16.6	1.3	2.9	13.6	2.1	105.9	41.3	28.8	66.0	3.7	17.3	0.2	13.5	46.6	3.5	0.6	0.9	8.2	29.7	2.5	4.1	2.8	3.7	0.5	2.0	3.6	8.3	0.9	74.4	9.1	3.0	5.1	108.9	105.8	20.8	82.3	142.1	1.7	0.4	1.6	80.5	6.5	16.1	1.5	1.9	0.0	0.7	0.9	0.2	0.0	0.1	0.2	0.5	0.1	0.0	0.1	0.2	0.0	0.2	4.8	0.0	0.8	4.0	3.0	2.1	3.9	2.9	3.9	4.0	4.1	4.5	2.3	8.5	3.9	22.0	0.0	0.0	1.0	2.8	12.6	57.0	18.6	2.8	1.5	31.1	29.1	5.3	47.1	6.6	1.8	0.0	1.2	9.1	1.0	0.0	105.4	0.2	15.3	13.5	51.2	0.0	22.3	0.5	12.7	16.9	27.5	3.1	60.7	7.0	0.4	4.2	0.2	30.1	33.7	1.6	2.4	6.1	8.9	45.4	1.4	3.7	39.9	12.4	1.0	61.5	165.1	3.1	0.0	0.1	101.8	1.2	19.9	3.5	68.9	0.8	2.5	2.0	3.9	0.0	17.3	54.3	0.0	9.5	6.7	10.7	1.4	4.2	0.8	0.4	27.0
SPHK2		ENSG00000063176	"Sphingosine kinase 2"	Q9NRA0	19	48619291-48630717	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Bipolar cells: 68.5;Cone photoreceptor cells: 77.2;Rod photoreceptor cells: 79.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 64.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049062			Supported	Nucleoplasm		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 24: NB-4 - Immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm		"HPA049062: "	"unprognostic (5.33e-2)"	"unprognostic (4.11e-2)"	"unprognostic (9.61e-2)"	"prognostic unfavorable (5.19e-4)"	"unprognostic (2.10e-1)"	"unprognostic (7.19e-3)"	"unprognostic (3.04e-1)"	"unprognostic (4.45e-3)"	"unprognostic (7.28e-2)"	"unprognostic (2.80e-1)"	"prognostic favorable (9.30e-4)"	"unprognostic (1.25e-1)"	"prognostic favorable (2.59e-5)"	"unprognostic (1.18e-2)"	"unprognostic (9.97e-2)"	"unprognostic (4.21e-2)"	"unprognostic (7.06e-2)"	9.4	10.5	18.9	6.8	20.6	3.4	9.6	23.5	29.3	9.4	9.1	16.5	22.1	12.0	2.1	9.2	11.6	3.1	7.3	25.9	19.4	23.1	31.8	8.5	5.9	36.0	30.5	15.5	8.9	7.4	16.5	2.2	37.2	13.3	3.6	3.2	7.6	4.4	7.8	4.8	18.9	2.6	21.2	11.4	14.8	24.1	30.6	5.3	16.0	3.1	3.1	10.7	7.3	26.1	8.4	22.3	8.2	15.3	8.5	3.6	16.3	8.5	6.8	9.3	11.1	39.8	10.4	15.0	5.9	5.3	5.6	6.4	7.5	6.9	1.3	17.5	19.4	16.9	11.5	13.7	13.5	11.1	17.3	6.5	3.6	6.5	4.4	4.4	5.2	20.9	11.7	12.5	4.7	8.3	27.2	64.7	11.2	6.0	10.7	23.3	6.5	10.0	4.3	5.3	29.3	23.1	8.3	12.7	8.3	4.5	7.1	6.9	8.5	13.6	7.7	10.9	17.1	24.5	31.0	16.4	7.9	12.2	12.6	11.7	6.2	2.9	4.3	7.1	4.0	5.0	3.4	4.2	5.5	8.6	4.8	4.8	2.4	5.6	6.2	5.4	3.7	3.5	18.9	20.6	23.5	29.3	25.9	19.4	36.0	30.5	37.2	21.2	30.6	26.1	3.7	6.4	7.7	8.5	13.3	3.3	5.7	5.6	4.6	68.5	6.8	6.5	1.5	12.8	6.2	11.0	77.2	6.8	13.6	20.6	1.9	6.2	11.0	6.2	6.1	6.5	16.2	2.1	9.1	5.0	6.3	5.3	15.3	6.9	4.5	14.5	6.4	19.8	8.3	45.4	11.2	11.3	4.1	12.3	7.3	18.4	16.4	6.5	3.6	6.5	11.4	20.8	33.0	6.0	11.9	6.8	16.7	12.8	7.1	6.2	44.2	18.6	4.9	79.9	6.6	6.3	5.4	18.1	6.3	7.3	2.8	4.5	12.3	8.9	17.3	4.3
SPTLC1	"hLCB1, HSAN1, HSN1, LCB1, SPTI"	ENSG00000090054	"Serine palmitoyltransferase long chain base subunit 1"	O15269	9	92000087-92115413	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	"Acyltransferase, Transferase"	"Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 94.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010860, CAB018747, HPA063907"	Supported		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 7: Non-specific - Mitochondria"	"Endoplasmic reticulum"		"CAB018747: AB_2195864, HPA010860: AB_1080086, HPA063907: AB_2685148"	"unprognostic (1.22e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.23e-2)"	"unprognostic (3.03e-2)"	"unprognostic (4.22e-3)"	"unprognostic (1.27e-1)"	"unprognostic (4.06e-1)"	"unprognostic (3.55e-3)"	"unprognostic (8.37e-2)"	"prognostic favorable (1.36e-6)"	"unprognostic (1.13e-1)"	"unprognostic (2.41e-2)"	"unprognostic (4.28e-1)"	"unprognostic (1.49e-1)"	35.6	32.6	24.0	27.3	27.0	23.3	44.1	26.0	34.2	43.1	28.6	42.3	34.7	40.4	41.3	54.3	36.7	34.1	21.5	24.3	26.6	42.8	23.4	33.6	25.7	27.8	27.5	43.8	26.5	48.0	17.3	42.4	28.0	32.9	44.1	19.8	31.3	28.1	14.2	41.3	37.9	31.4	27.9	26.3	37.1	26.5	25.6	25.9	53.0	18.6	34.4	37.2	34.7	31.6	73.0	48.8	46.8	41.6	120.0	92.0	78.4	74.7	94.2	65.3	66.3	31.5	150.7	38.6	45.1	93.9	78.3	198.4	49.7	68.1	73.0	39.8	36.1	36.7	32.7	51.7	80.5	65.5	49.9	82.6	92.6	68.0	74.8	72.3	62.5	43.5	83.8	46.6	91.1	69.6	34.7	47.6	67.5	97.4	57.9	39.4	58.7	33.3	84.1	37.9	35.0	37.2	104.4	81.1	61.3	62.4	39.2	54.2	72.3	58.8	48.0	73.9	56.8	33.2	44.4	23.9	74.2	39.3	79.4	32.4	33.1	20.2	16.7	36.1	17.0	15.4	18.0	17.4	30.6	15.5	21.4	16.6	33.3	18.5	34.2	18.4	25.7	25.5	24.0	27.0	26.0	34.2	24.3	26.6	27.8	27.5	28.0	27.9	25.6	31.6	40.7	38.5	38.3	27.7	22.1	10.6	13.6	14.5	26.2	6.9	33.2	20.6	4.1	4.3	25.9	36.8	14.6	12.7	24.4	8.0	9.8	53.4	94.8	34.7	42.5	23.1	2.4	7.2	35.3	56.4	15.6	32.3	13.7	47.4	24.6	26.9	6.1	4.3	11.0	6.7	32.5	7.2	12.2	5.7	10.3	26.1	6.2	24.6	12.4	20.6	22.0	13.7	7.2	36.7	52.1	60.8	7.1	6.0	26.2	9.8	11.7	28.5	28.0	8.7	13.1	12.1	23.5	35.3	25.9	27.6	9.1	21.8	21.9	33.2	6.9	14.5
SPTLC2	"hLCB2a, KIAA0526, LCB2, LCB2A"	ENSG00000100596	"Serine palmitoyltransferase long chain base subunit 2"	O15270	14	77505997-77616637	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	"Acyltransferase, Transferase"	"Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 164.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 36: HEL - Hemostasis"	"Cluster 10: Non-specific - Unknown function"				"unprognostic (3.16e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.41e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (3.62e-4)"	"unprognostic (1.46e-2)"	"unprognostic (3.09e-1)"	"unprognostic (4.05e-1)"	"unprognostic (1.98e-2)"	"unprognostic (2.51e-1)"	"prognostic favorable (6.69e-8)"	"unprognostic (1.29e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.94e-2)"	"unprognostic (1.32e-1)"	17.6	12.2	14.6	12.6	26.7	33.7	18.3	24.0	19.4	15.2	9.9	18.5	14.5	10.5	7.6	22.8	14.2	11.8	6.7	15.3	18.1	17.6	7.7	13.1	12.0	30.7	21.5	10.4	5.7	10.7	6.2	20.4	31.5	8.4	19.8	14.2	13.7	8.8	3.9	12.2	17.4	11.6	25.3	19.6	20.4	5.0	21.7	10.3	10.9	6.1	13.3	15.0	10.8	52.7	28.9	18.5	14.1	15.5	14.3	17.8	23.7	41.7	30.8	28.2	29.3	23.7	62.3	28.8	10.4	42.7	14.5	34.7	38.1	23.7	42.5	12.6	11.0	82.5	13.4	14.3	12.1	8.4	25.8	11.7	11.4	18.4	20.4	16.3	40.6	19.4	16.2	13.5	16.2	24.9	22.2	28.7	9.2	45.4	16.8	23.5	14.3	10.0	32.9	63.4	13.6	17.1	15.0	50.3	15.8	24.7	61.8	15.3	25.9	25.7	18.2	9.6	9.7	7.6	13.4	19.1	17.3	29.4	14.8	18.3	31.3	27.1	6.1	24.2	5.7	6.7	5.1	6.8	31.2	7.9	3.5	5.8	19.1	17.7	31.8	11.1	6.0	13.4	14.6	26.7	24.0	19.4	15.3	18.1	30.7	21.5	31.5	25.3	21.7	52.7	125.1	28.9	27.3	24.8	27.3	32.4	28.3	27.0	15.4	15.7	24.3	18.4	8.9	15.7	30.7	47.8	35.5	11.9	28.3	37.6	1.9	24.0	1.6	44.1	36.0	53.1	13.2	51.3	31.2	16.1	12.3	18.9	43.3	36.0	51.3	37.2	68.2	7.2	25.1	5.0	29.5	39.3	20.3	75.9	19.8	1.7	14.6	66.2	19.6	83.4	51.3	8.8	32.0	59.3	164.0	35.0	30.4	15.8	11.0	27.0	28.4	8.8	33.5	20.0	32.9	10.5	25.5	7.3	19.0	37.7	29.1	6.6	23.3	14.6	33.0	60.0
SPTLC3	"C20orf38, FLJ11112, hLCB2b, LCB2B, SPTLC2L"	ENSG00000172296	"Serine palmitoyltransferase long chain base subunit 3"	Q9NUV7	20	13008972-13169103	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 28.4;Early spermatids: 27.9;Glandular and luminal cells: 47.4;Microglial cells: 35.6;Syncytiotrophoblasts: 46.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"NK-cell: 1.5"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 33.3;RPTEC TERT1: 43.7;U-2197: 30.4;U-87 MG: 57.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA044247, HPA048079"	Enhanced		Approved	Microtubules		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 44: Endometrium - Transcription"	Microtubules		"HPA044247: AB_2678872, HPA048079: AB_2680252"	"unprognostic (6.81e-2)"	"unprognostic (7.76e-2)"	"unprognostic (4.46e-2)"	"unprognostic (1.25e-3)"	"unprognostic (5.43e-2)"	"unprognostic (2.12e-1)"	"unprognostic (5.70e-2)"	"unprognostic (7.99e-2)"	"unprognostic (9.51e-2)"	"unprognostic (2.21e-1)"	"prognostic unfavorable (6.02e-4)"	"unprognostic (5.08e-2)"	"prognostic favorable (4.51e-7)"	"unprognostic (2.80e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.18e-1)"	4.6	4.3	1.4	1.4	1.4	0.6	8.3	1.2	1.3	7.4	8.5	6.1	15.7	4.7	16.8	5.9	6.7	10.9	6.4	1.5	2.7	18.2	20.0	7.8	1.3	2.4	2.1	7.1	5.6	11.0	2.7	20.9	2.4	5.9	7.4	2.8	6.7	3.6	0.4	25.6	16.2	3.9	1.8	2.9	4.5	6.4	3.8	5.0	24.4	2.0	1.7	5.7	5.1	2.5	1.5	2.4	1.8	0.0	14.1	20.2	11.4	0.0	3.2	2.1	8.2	18.6	9.3	0.0	1.2	0.6	18.2	25.0	0.0	7.0	3.0	0.0	0.1	0.0	5.6	26.4	1.3	0.0	0.2	11.5	21.4	8.4	2.8	7.7	1.4	4.4	0.0	33.3	23.7	0.5	0.1	0.0	0.1	2.2	2.9	2.3	4.2	15.1	43.7	18.2	0.0	0.3	0.2	2.3	0.1	3.1	18.6	0.5	3.3	9.2	3.1	30.4	2.2	0.2	0.0	0.0	57.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	1.5	0.0	0.0	0.0	0.0	1.4	1.4	1.2	1.3	1.5	2.7	2.4	2.1	2.4	1.8	3.8	2.5	3.6	6.4	22.3	5.2	0.1	2.4	5.3	2.3	4.6	0.1	5.4	5.0	17.9	4.3	4.9	9.2	0.0	28.4	1.0	3.4	7.9	3.0	27.9	18.7	5.2	4.6	0.0	2.1	0.5	4.4	13.0	5.4	4.6	47.4	1.3	5.6	1.8	20.7	2.8	0.0	0.9	5.7	6.1	2.6	0.4	11.6	3.7	2.4	0.0	35.6	0.0	12.3	3.1	0.0	0.1	3.2	6.7	2.6	0.1	2.3	10.9	18.6	3.5	0.4	0.0	6.1	0.8	1.2	0.1	4.9	2.3	46.1	1.2	2.9	7.3	2.6
ST3GAL1	"SIAT4A, SIATFL, ST3GalA.1, ST3O"	ENSG00000008513	"ST3 beta-galactoside alpha-2,3-sialyltransferase 1"	Q11201	8	133454848-133571940	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid metabolism"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatocytes: 159.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 75.9;PC-3: 131.8;RT4: 102.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040466	Approved				"Intracellular and membrane"	NA	NA		860000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 24: Non-specific - Transcription regulation"			"HPA040466: AB_10805712"	"unprognostic (1.36e-2)"	"unprognostic (1.11e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.83e-3)"	"unprognostic (5.53e-3)"	"unprognostic (4.43e-2)"	"unprognostic (4.79e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.55e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.83e-3)"	"unprognostic (1.67e-2)"	"unprognostic (3.29e-2)"	"unprognostic (8.64e-3)"	"unprognostic (2.95e-2)"	25.7	22.5	8.8	22.8	8.6	22.6	12.2	5.3	9.4	11.4	12.3	6.5	3.6	11.6	12.7	14.0	15.5	19.0	53.1	9.6	6.3	44.5	67.7	19.2	23.1	7.9	11.2	13.3	15.4	10.9	9.9	13.8	6.9	8.0	5.5	10.0	24.9	10.2	43.8	5.9	9.9	10.6	7.2	21.2	16.1	4.3	7.4	17.4	66.1	49.3	21.6	34.4	10.9	7.2	14.0	6.6	3.0	8.3	28.6	15.0	14.4	15.4	35.5	5.7	4.4	13.3	15.1	3.3	10.3	28.2	2.7	4.2	9.4	11.3	4.9	37.6	1.7	28.4	22.5	25.4	22.0	5.9	22.1	17.8	5.7	19.5	11.7	27.2	26.4	7.5	0.5	42.5	4.4	14.9	8.4	8.0	2.1	75.9	131.8	9.9	3.7	24.3	2.7	102.2	0.7	2.0	6.8	23.3	6.9	15.4	4.3	8.1	26.3	18.3	28.5	15.7	6.9	53.0	39.3	3.6	41.7	19.8	18.5	47.8	8.8	41.7	24.1	8.1	22.9	22.7	25.2	28.3	5.3	38.6	34.4	32.4	16.1	43.2	20.4	12.6	17.2	18.9	8.8	8.6	5.3	9.4	9.6	6.3	7.9	11.2	6.9	7.2	7.4	7.2	29.4	6.4	56.8	38.2	68.4	5.7	14.4	14.8	21.1	13.4	13.7	8.4	63.2	12.8	22.2	1.8	2.1	9.7	65.5	4.6	5.9	41.3	3.4	8.9	29.2	44.3	0.0	38.5	36.7	25.4	53.5	47.8	10.7	28.1	8.8	12.1	37.9	159.8	37.8	60.6	34.6	0.6	16.2	52.5	29.0	2.1	36.7	48.8	14.2	49.6	59.8	11.5	47.4	5.0	2.4	39.4	0.0	71.8	29.1	10.9	0.0	48.5	6.5	23.3	13.1	28.1	23.6	0.2	2.8	30.0	3.4	26.4	79.9	6.5	0.3	43.6
ST3GAL2	"SIAT4B, ST3GalA.2, ST3GALII"	ENSG00000157350	"ST3 beta-galactoside alpha-2,3-sialyltransferase 2"	Q16842	16	70375977-70439237	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid metabolism"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 56.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 29.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017270	Approved		Uncertain	Vesicles	"Intracellular and membrane"	NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 72: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Vesicles		"HPA017270: AB_1857523"	"unprognostic (2.76e-2)"	"unprognostic (6.33e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.35e-1)"	"unprognostic (4.99e-1)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (2.79e-4)"	"unprognostic (1.14e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.91e-2)"	"prognostic favorable (2.33e-4)"	"unprognostic (9.54e-2)"	"prognostic unfavorable (3.34e-6)"	"unprognostic (7.42e-2)"	"unprognostic (8.83e-3)"	"unprognostic (4.64e-2)"	"unprognostic (5.20e-2)"	8.6	8.3	4.7	6.4	5.8	7.4	7.2	8.4	6.5	9.3	1.6	9.2	3.5	12.5	1.1	2.6	8.2	2.5	10.5	7.1	2.9	8.2	10.3	9.0	6.3	3.1	2.6	7.2	3.6	2.6	6.4	3.2	2.6	7.1	1.6	1.7	3.2	2.8	15.8	4.2	7.1	4.1	1.9	13.2	4.7	6.7	3.3	3.6	6.0	3.1	3.4	8.4	5.6	2.9	1.7	8.6	7.7	11.2	3.9	5.4	2.3	6.1	6.0	6.2	3.0	5.5	4.0	4.6	9.8	6.3	5.8	1.9	3.2	2.5	3.3	9.9	5.0	18.0	4.5	8.7	4.7	6.7	29.4	4.1	1.5	6.7	1.3	8.2	8.6	7.6	25.1	4.2	3.7	1.5	7.5	19.8	10.1	2.9	4.5	13.9	2.9	5.9	5.1	1.5	3.7	9.4	15.8	0.6	7.1	8.1	2.4	7.3	9.9	9.0	10.0	4.0	4.7	8.6	3.9	9.7	10.0	5.9	12.5	4.2	1.9	5.2	2.0	1.8	1.7	2.0	2.3	2.0	1.0	2.9	3.8	3.0	10.1	2.8	1.3	14.3	2.6	1.1	4.7	5.8	8.4	6.5	7.1	2.9	3.1	2.6	2.6	1.9	3.3	2.9	15.4	9.6	5.2	13.4	12.6	3.3	4.2	2.1	2.2	15.7	2.8	3.0	6.8	10.0	1.9	9.2	14.6	4.7	56.1	4.5	0.0	5.7	16.9	1.7	6.5	15.0	13.2	24.8	21.3	4.4	2.5	11.0	2.6	2.2	17.7	19.7	18.2	13.1	13.7	18.5	15.2	4.5	2.0	15.4	35.1	33.2	11.8	11.9	1.8	17.8	24.9	5.6	23.7	16.6	7.4	1.8	1.5	8.2	13.5	3.0	6.8	5.7	1.3	11.1	6.6	8.5	8.8	9.3	8.9	1.1	2.4	1.8	11.5	4.7	5.6	2.3
ST3GAL4	"CGS23, FLJ11867, NANTA3, SAT3, SIAT4, SIAT4C, STZ"	ENSG00000110080	"ST3 beta-galactoside alpha-2,3-sialyltransferase 4"	Q11206	11	126355640-126440344	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 270.0;Paneth cells: 214.3;Syncytiotrophoblasts: 962.5"	"Cancer enhanced"	"Detected in all"		"melanoma: 57.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 111.9;neutrophil: 71.8;plasmacytoid DC: 93.7"	"Group enriched"	"Detected in many"	12	"dendritic cells: 93.7;granulocytes: 111.9"	"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 234.7;WM-115: 515.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049827	Approved				"Intracellular and membrane"	NA	NA		15000	"Cluster 38: Basophils - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"			"HPA049827: AB_2680900"	"unprognostic (8.89e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.92e-2)"	"unprognostic (6.93e-2)"	"unprognostic (8.33e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.71e-3)"	"unprognostic (1.90e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.45e-1)"	"unprognostic (3.16e-3)"	"unprognostic (2.79e-2)"	"unprognostic (1.28e-1)"	"unprognostic (8.36e-3)"	"unprognostic (8.78e-3)"	23.4	117.1	25.2	14.4	41.2	19.0	19.5	43.5	28.9	29.2	36.5	58.1	4.2	16.3	87.6	70.7	19.2	23.9	60.0	24.3	28.7	41.0	28.4	38.2	10.0	42.3	41.3	111.3	13.7	1.7	15.7	35.3	39.5	22.6	66.4	10.8	44.2	16.0	6.1	16.7	12.3	19.0	31.9	41.5	13.3	42.2	37.6	6.3	14.7	7.7	22.7	49.3	33.8	57.2	26.4	21.4	17.0	13.6	46.8	39.4	38.5	30.2	56.6	26.5	18.2	11.4	44.5	7.0	21.9	47.0	88.0	37.1	34.0	19.2	20.0	27.7	9.7	62.8	52.7	13.4	29.9	78.8	126.1	31.5	30.7	39.9	60.9	47.7	34.6	27.5	41.4	18.8	32.2	107.3	25.7	76.5	10.2	166.2	136.6	25.8	50.3	3.3	6.0	74.1	29.5	18.4	32.8	193.5	234.7	10.6	66.3	52.2	13.2	61.7	14.2	44.1	56.2	2.0	4.3	4.0	28.5	118.7	515.8	111.9	5.3	0.7	5.2	8.7	4.8	0.4	1.7	3.3	20.6	0.1	0.6	2.6	71.8	4.7	3.8	93.7	0.3	6.4	25.2	41.2	43.5	28.9	24.3	28.7	42.3	41.3	39.5	31.9	37.6	57.2	10.3	9.6	0.6	17.0	1.9	10.6	6.6	23.0	0.6	4.0	12.8	6.7	25.9	5.7	23.1	31.3	10.4	115.9	37.5	149.2	49.0	6.1	1.5	3.2	9.8	15.0	5.3	3.4	16.3	6.6	72.3	43.2	2.0	10.2	41.9	270.0	31.8	11.9	17.8	5.0	17.5	115.7	16.2	5.9	14.9	7.2	76.1	11.2	78.2	3.7	9.5	5.4	18.6	5.0	83.3	5.3	214.3	93.6	6.7	16.5	0.0	3.9	5.5	10.0	13.1	4.3	43.1	1.5	17.4	0.7	6.7	962.5	8.4	36.8	23.2	41.1
ST3GAL5	"SIAT9, SIATGM3S, ST3GalV"	ENSG00000115525	"ST3 beta-galactoside alpha-2,3-sialyltransferase 5"	Q9UNP4	2	85837120-85905199	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 47.4"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 112.8;Oligodendrocyte precursor cells: 94.0;Oligodendrocytes: 108.4"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 41.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 54.4;RT4: 47.0;SK-MEL-30: 40.8;U-266/84: 42.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034708, HPA040425, HPA068928"	Uncertain		Approved	Vesicles		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Vesicles		"HPA034708: AB_10601594, HPA040425: AB_2676978, HPA068928: AB_2686060"	"unprognostic (7.90e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.84e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.12e-2)"	"unprognostic (5.81e-3)"	"unprognostic (1.38e-1)"	"unprognostic (6.45e-2)"	"unprognostic (5.03e-3)"	"unprognostic (3.43e-2)"	"prognostic unfavorable (2.25e-7)"	"unprognostic (2.22e-1)"	"unprognostic (5.74e-2)"	"prognostic favorable (4.99e-4)"	"prognostic favorable (4.48e-4)"	17.5	47.4	17.1	4.6	26.9	2.3	8.5	16.4	20.1	5.4	7.9	5.0	1.0	9.9	0.9	2.7	10.4	8.1	4.2	16.0	24.7	2.8	9.8	14.6	9.1	24.7	22.6	10.1	3.9	0.4	12.8	17.7	23.1	6.7	2.6	31.0	7.1	0.5	12.4	6.1	6.9	3.5	20.6	20.0	5.6	10.8	23.6	5.0	27.9	3.5	4.4	20.8	5.9	41.6	0.3	27.0	2.5	54.4	22.0	11.8	8.0	5.9	18.0	5.6	5.0	0.5	19.6	0.7	0.2	10.2	2.5	1.0	3.6	6.4	7.0	0.2	3.2	0.6	1.1	1.0	17.6	0.4	7.8	6.9	0.8	2.1	0.8	10.1	13.7	7.4	0.8	30.2	18.3	1.8	1.9	3.1	0.2	9.6	0.0	3.5	17.0	11.0	2.9	47.0	3.8	3.8	0.2	0.1	40.8	5.4	0.2	1.1	4.5	0.1	2.7	0.1	0.4	30.0	42.5	0.5	4.2	5.6	27.7	0.6	0.8	0.1	0.6	3.0	0.8	1.1	0.3	0.4	0.5	0.7	0.3	0.3	0.6	0.6	2.4	0.2	0.1	0.3	17.1	26.9	16.4	20.1	16.0	24.7	24.7	22.6	23.1	20.6	23.6	41.6	8.5	86.6	112.8	37.5	29.1	5.6	27.6	20.5	1.2	56.6	3.1	2.3	1.9	40.0	33.9	3.7	58.4	0.4	48.3	0.2	3.9	12.0	12.3	9.0	27.8	8.1	6.7	0.4	46.9	16.6	1.1	21.7	6.1	8.5	34.8	35.2	29.6	21.1	35.6	72.3	60.2	0.1	12.2	45.4	18.1	12.0	8.1	24.9	32.0	45.9	20.1	56.0	12.3	94.0	108.4	6.2	0.1	1.9	19.5	6.8	0.0	3.7	10.7	45.2	0.0	21.3	5.0	8.4	16.1	0.2	3.8	0.3	28.9	6.3	0.1	8.3
ST6GALNAC2	"SIAT7, SIAT7B, SIATL1, ST6GalNAII, STHM"	ENSG00000070731	"ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 2"	Q9UJ37	17	76565377-76586956	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"Early spermatids: 501.1;Late spermatids: 1763.3"	"Cancer enhanced"	"Detected in all"		"melanoma: 22.0"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	9	"neutrophil: 47.0"	"Lineage enriched"	"Detected in many"	16	"granulocytes: 47.0"	"Cell line enhanced"	"Detected in some"		"BEWO: 25.4;HaCaT: 33.8;HBEC3-KT: 28.5;hTCEpi: 73.1;MCF7: 36.4;SK-MEL-30: 112.5;T-47d: 23.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"	NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 31: Spermatids - Spermatogenesis"				"unprognostic (8.93e-3)"	"unprognostic (5.86e-3)"	"unprognostic (1.67e-2)"	"unprognostic (5.18e-3)"	"unprognostic (3.37e-2)"	"unprognostic (3.79e-2)"	"unprognostic (8.79e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.37e-2)"	"unprognostic (5.69e-2)"	"prognostic unfavorable (6.48e-4)"	"unprognostic (1.57e-1)"	"unprognostic (5.17e-3)"	"unprognostic (3.85e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.33e-1)"	5.6	2.9	1.0	1.9	1.1	1.0	12.2	1.2	1.4	14.9	33.0	13.8	1.0	4.8	10.3	16.4	50.5	1.9	4.5	2.0	1.6	9.6	1.2	17.5	0.6	5.4	6.7	1.2	6.3	7.5	2.1	6.0	4.1	11.1	6.0	52.8	11.3	10.2	18.3	51.6	4.8	2.3	4.2	3.7	7.1	33.9	2.6	1.5	25.2	18.5	4.8	9.5	14.5	2.7	2.6	0.0	0.0	0.0	0.5	0.0	25.4	0.0	0.6	0.0	0.0	0.0	2.1	0.0	0.5	1.7	0.1	33.8	0.3	28.5	0.0	0.0	0.0	0.0	1.2	0.0	1.2	0.0	0.0	0.0	73.1	0.1	9.0	3.8	0.1	0.0	0.0	0.0	0.4	36.4	0.0	0.0	0.0	0.9	1.0	0.0	0.0	0.0	0.0	9.8	0.5	0.0	4.1	0.1	112.5	1.3	23.4	0.7	0.3	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	11.9	0.0	2.9	5.2	0.0	1.8	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	47.0	0.2	0.4	0.0	0.0	0.4	1.0	1.1	1.2	1.4	2.0	1.6	5.4	6.7	4.1	4.2	2.6	2.7	0.2	0.0	1.5	2.6	0.8	32.9	44.0	104.2	23.9	7.9	0.4	1.5	5.1	7.2	21.0	0.0	27.1	12.5	0.0	2.4	0.0	0.3	501.1	4.5	1.1	3.9	0.0	0.0	0.5	0.0	21.1	2.0	4.6	0.6	1.3	0.0	7.9	1.5	3.0	0.0	1.3	4.8	8.2	5.0	6.9	1763.3	7.5	3.8	65.8	1.0	2.7	84.9	0.0	0.0	0.2	0.1	0.5	7.2	0.2	15.2	0.7	0.5	39.3	79.7	19.7	7.3	3.4	7.6	4.6	28.8	30.3	10.5	2.2	0.0	1.6	37.6
ST6GALNAC3	SIAT7C	ENSG00000184005	"ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 3"	Q8NDV1	1	76074746-76634603	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 21.0"	"Group enriched"	"Detected in many"	4	"Microglial cells: 912.5;Oligodendrocytes: 698.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 35.8;HUVEC TERT2: 45.9;SK-MEL-30: 62.3;TIME: 20.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054566, HPA055399"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA054566: AB_2682526, HPA055399: AB_2682806"	"unprognostic (7.85e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.99e-2)"	"unprognostic (2.70e-4)"	"unprognostic (2.76e-2)"	"unprognostic (2.21e-2)"	"unprognostic (6.55e-3)"	"unprognostic (7.31e-2)"	"unprognostic (2.14e-1)"	"unprognostic (4.57e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.95e-2)"	"unprognostic (9.97e-4)"	"unprognostic (3.33e-4)"	"unprognostic (5.44e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.44e-4)"	8.8	1.4	5.8	1.8	13.3	3.1	6.4	14.3	8.4	1.9	10.4	2.0	0.7	5.9	0.5	1.9	2.7	2.5	4.4	6.9	9.0	8.7	2.0	5.2	2.0	15.2	10.6	2.3	0.9	4.4	2.1	3.1	17.2	1.1	2.4	3.9	1.1	1.6	1.6	0.8	1.4	4.5	13.3	1.4	1.5	0.3	11.3	0.9	13.3	6.5	0.7	2.6	1.6	21.0	0.2	0.0	35.8	0.0	0.6	0.0	0.0	0.0	4.2	0.6	0.4	11.9	0.1	0.6	2.4	0.3	2.3	0.1	0.0	0.4	0.3	0.0	2.5	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.6	0.0	0.0	1.1	45.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	2.9	0.0	1.8	1.7	0.0	0.0	0.0	2.7	8.8	0.0	0.0	62.3	8.3	0.0	0.2	20.6	0.3	2.8	0.1	3.3	0.0	0.0	0.0	0.0	8.4	5.5	0.0	6.3	2.8	0.0	2.2	0.0	2.6	0.3	0.5	2.3	3.8	1.3	1.4	3.9	0.3	4.3	0.0	0.0	1.9	5.8	13.3	14.3	8.4	6.9	9.0	15.2	10.6	17.2	13.3	11.3	21.0	59.8	3.2	1.5	174.3	5.6	0.3	0.2	0.0	0.6	3.2	0.6	1.0	1.2	0.0	0.0	3.7	0.0	0.1	0.2	0.5	0.0	0.0	0.0	0.1	4.5	23.2	0.0	0.4	107.0	0.0	0.1	2.5	3.6	0.1	0.0	0.8	66.0	0.8	1.1	0.0	101.4	0.5	0.0	9.8	0.7	0.8	0.0	3.7	5.4	912.5	3.0	12.3	1.0	23.1	698.3	0.2	3.4	0.0	0.2	0.1	0.0	0.0	0.0	0.5	0.0	1.1	1.3	0.2	0.7	0.1	0.4	0.1	2.0	6.9	0.3	0.1
ST6GALNAC4	"SIAT3C, SIAT7D, ST6GALNACIV"	ENSG00000136840	"ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4"	Q9H4F1	9	127907886-127917041	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 72.0"	"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 67.8;Erythroid cells: 112.2;Plasma cells: 93.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	9	"plasmacytoid DC: 233.9"	"Lineage enriched"	"Detected in all"	9	"dendritic cells: 233.9"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 105.3;RPMI-8226: 149.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009042			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 6: Erythroid cells - Oxygen transport"	"Golgi apparatus"	Nucleoplasm	"HPA009042: AB_1079963"	"unprognostic (2.05e-3)"	"unprognostic (2.32e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.53e-2)"	"unprognostic (3.18e-1)"	"unprognostic (2.32e-1)"	"prognostic unfavorable (8.63e-7)"	"unprognostic (1.62e-2)"	"unprognostic (4.26e-1)"	"prognostic unfavorable (5.12e-4)"	"unprognostic (1.04e-1)"	"unprognostic (3.04e-1)"	"prognostic unfavorable (8.39e-4)"	"unprognostic (1.30e-3)"	"unprognostic (2.72e-1)"	"unprognostic (2.64e-2)"	"unprognostic (2.03e-2)"	20.9	16.9	11.2	10.6	10.4	40.0	16.6	11.9	15.2	18.1	12.7	18.6	14.9	18.5	6.3	15.2	19.3	8.6	34.2	11.5	9.9	20.5	9.0	27.7	14.0	10.6	9.8	25.1	72.0	7.4	20.8	5.3	9.6	13.6	6.6	1.0	11.8	15.3	24.4	9.7	19.4	7.5	10.4	37.2	15.1	5.4	10.2	5.9	11.3	10.2	9.4	17.9	14.7	9.7	9.5	15.9	4.1	20.1	27.4	20.8	3.0	16.3	17.6	16.2	9.4	9.1	17.0	60.2	24.0	20.2	22.8	23.0	8.2	17.2	2.7	105.3	7.2	19.3	48.8	34.2	33.3	1.6	19.1	25.6	18.0	14.4	12.9	13.1	43.2	11.4	14.0	38.9	7.8	4.4	3.8	2.2	4.6	30.7	38.9	18.3	10.5	149.6	16.5	0.5	33.8	7.8	23.6	49.8	3.0	1.3	10.3	12.2	31.3	13.1	15.2	41.3	25.8	63.5	35.0	18.8	26.2	8.4	1.9	3.7	9.0	0.3	11.1	8.0	12.3	25.1	6.9	13.3	11.3	18.6	8.6	11.9	1.1	18.9	14.5	233.9	13.3	10.2	11.2	10.4	11.9	15.2	11.5	9.9	10.6	9.8	9.6	10.4	10.2	9.7	15.0	9.6	26.5	2.3	35.5	2.2	12.2	21.1	8.6	3.1	5.2	4.8	12.2	10.0	9.9	1.8	0.0	1.1	48.1	27.0	1.9	16.1	0.2	2.5	13.8	14.8	67.8	112.2	3.7	14.1	15.6	10.7	6.6	2.6	8.2	7.1	12.1	1.9	23.0	0.0	4.9	16.6	8.2	13.3	10.0	0.6	17.4	9.2	7.2	1.9	11.2	15.0	11.3	2.0	1.0	9.3	9.1	42.9	93.9	12.8	17.1	20.6	5.1	1.9	13.1	9.2	10.9	0.3	1.5	9.3	3.1	4.5	10.2	34.0	13.0	10.6
ST6GALNAC5	"MGC3184, SIAT7E, ST6GalNAcV"	ENSG00000117069	"ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 5"	Q9BVH7	1	76867480-77067546	"Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 5.9"	"Group enriched"	"Detected in some"	8	"Excitatory neurons: 480.3;Inhibitory neurons: 417.3"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 10.9"	"Region enhanced"	"Detected in many"		"cerebral cortex: 5.9;hippocampal formation: 5.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 4.7;fHDF/TERT166: 5.4;HaCaT: 2.7;SH-SY5Y: 4.1;U-2 OS: 4.4;U-251 MG: 2.6"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"hippocampal formation: 51.3"	"HPA065593, HPA070354"	Uncertain		Approved	Vesicles	"Intracellular and membrane"	NA	Yes		180000		"Cluster 10: Brain - Neuronal signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles		"HPA065593: AB_2685515, HPA070354: AB_2686260"	"unprognostic (1.32e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.82e-2)"	"unprognostic (2.04e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.72e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.10e-2)"	"unprognostic (5.90e-3)"	"unprognostic (9.66e-2)"	"unprognostic (6.88e-2)"	"unprognostic (1.69e-2)"	0.1	3.0	1.5	1.5	1.1	0.0	1.2	0.0	5.9	0.7	0.0	1.8	0.2	0.1	0.0	1.0	1.9	2.2	0.5	5.5	0.0	0.1	0.0	3.6	0.4	0.0	0.0	1.6	0.1	0.0	1.9	0.1	0.0	1.0	0.6	3.2	0.5	0.3	0.0	0.2	0.9	3.0	0.0	0.2	1.5	0.3	0.0	0.0	0.0	0.0	0.3	1.6	0.6	0.0	1.2	0.0	4.7	0.0	0.0	0.0	0.0	0.4	1.5	1.1	0.4	0.0	0.1	0.0	0.0	5.4	0.0	2.7	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.3	0.4	0.0	0.0	1.1	4.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	4.4	0.0	2.6	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.1	0.0	5.9	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.5	0.5	35.6	0.1	0.0	0.0	0.1	0.0	20.7	2.8	1.7	1.1	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.7	0.2	1.9	0.4	0.0	0.0	480.3	0.0	0.1	0.8	0.0	0.2	1.3	0.9	0.0	0.0	0.1	0.0	417.3	0.2	0.0	0.0	0.0	2.3	0.6	0.1	0.0	8.4	0.0	0.7	0.0	10.6	6.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	1.3	0.0	0.2	0.4	0.1	0.5	0.0	0.0	0.1	0.2	0.0	0.0	0.1
ST6GALNAC6	"SIAT7F, ST6GALNACVI"	ENSG00000160408	"ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6"	Q969X2	9	127885321-127905408	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 258.8;Intestinal goblet cells: 100.6;Paneth cells: 178.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"NK-cells: 23.7;T-cells: 25.6"	"Cell line enhanced"	"Detected in all"		"ASC diff: 157.1"					"Low region specificity"	"Detected in all"			HPA018890	Approved				"Intracellular and membrane"	NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA018890: AB_1857531"	"unprognostic (2.27e-1)"	"unprognostic (5.23e-2)"	"unprognostic (2.81e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.81e-2)"	"unprognostic (5.71e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.84e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.40e-3)"	"unprognostic (3.24e-3)"	"unprognostic (3.31e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.10e-2)"	"unprognostic (9.85e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.67e-2)"	95.8	37.4	155.5	21.4	156.0	17.7	68.7	129.5	177.8	48.7	120.2	75.5	9.5	48.6	50.0	35.0	67.2	28.4	61.3	165.6	130.9	50.1	63.5	66.7	27.5	133.4	137.2	83.0	52.8	32.4	26.0	22.0	128.3	40.2	126.4	16.0	28.3	41.5	46.0	37.4	35.2	38.0	128.3	64.1	43.9	17.6	140.6	14.9	32.5	40.2	23.1	56.6	42.6	134.6	12.0	9.2	18.9	36.9	157.1	91.9	7.4	29.7	69.6	43.7	35.9	16.3	10.0	13.8	13.4	68.1	28.4	21.9	25.6	23.7	19.0	50.9	14.0	13.4	19.0	16.7	48.1	3.3	18.9	94.9	27.5	34.0	15.1	61.6	40.9	11.9	12.2	14.6	54.9	9.9	8.4	19.3	9.1	12.3	17.5	24.6	27.0	14.3	32.2	2.4	13.1	21.3	21.4	8.8	7.6	12.3	9.3	29.0	26.7	27.6	16.3	30.5	15.8	18.4	9.8	21.5	24.5	4.1	8.7	3.3	1.2	0.1	25.3	1.9	18.5	5.3	16.5	18.8	1.8	3.9	10.0	13.7	0.6	23.7	5.0	2.1	25.6	12.4	155.5	156.0	129.5	177.8	165.6	130.9	133.4	137.2	128.3	128.3	140.6	134.6	1.3	3.2	4.3	13.1	10.5	23.2	17.2	15.7	9.1	22.0	0.9	0.6	8.7	8.6	9.5	0.0	6.2	4.3	11.7	258.8	0.0	0.3	2.5	0.8	1.7	20.6	38.5	26.1	11.5	0.4	7.7	26.6	3.6	1.4	7.0	0.2	46.8	28.5	11.6	25.2	10.7	100.6	18.3	10.0	35.6	9.4	66.5	4.1	24.9	8.4	3.2	58.7	46.4	5.5	3.8	0.3	178.3	60.9	8.9	20.5	0.3	0.0	16.1	8.5	85.5	41.2	31.9	1.4	4.8	10.3	26.9	3.6	17.7	0.5	84.7	18.6
ST8SIA1	"SIAT8, SIAT8A"	ENSG00000111728	"ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1"	Q92185	12	22063773-22437041	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 15.0"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 133.2;Inhibitory neurons: 152.0;Oligodendrocyte precursor cells: 198.0"	"Cancer enhanced"	"Detected in some"		"glioma: 2.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 6.5;ASC TERT1: 4.2;hTERT-RPE1: 3.0;RPTEC TERT1: 3.3;SK-MEL-30: 6.2;WM-115: 6.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026775	Approved					NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 70: Brain - Nervous system development"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA026775: AB_1857534"	"unprognostic (1.98e-1)"	"unprognostic (5.76e-3)"	"unprognostic (1.79e-1)"	"unprognostic (9.58e-2)"	"unprognostic (2.89e-1)"	"unprognostic (6.44e-3)"	"unprognostic (1.76e-2)"	"unprognostic (1.07e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.99e-1)"	"unprognostic (6.37e-3)"	"unprognostic (2.80e-2)"	"unprognostic (1.07e-8)"	"unprognostic (1.10e-1)"	"unprognostic (1.95e-1)"	"unprognostic (5.28e-2)"	"unprognostic (3.16e-2)"	1.0	3.5	7.3	2.5	7.0	1.2	2.9	15.0	6.6	2.6	0.0	3.7	0.1	2.3	0.6	1.3	1.3	1.0	2.3	6.3	9.8	0.7	0.2	2.0	4.6	11.6	9.2	1.2	0.5	6.4	0.2	0.1	9.3	3.1	1.6	6.0	1.4	2.0	0.4	2.1	1.3	2.2	8.6	1.3	1.1	0.4	6.8	0.9	0.7	0.4	4.8	4.1	1.8	6.4	0.0	0.3	6.5	0.0	1.0	4.2	0.6	0.0	0.0	0.1	0.3	0.2	0.1	0.8	0.0	0.0	0.1	0.3	0.0	0.1	0.4	0.0	0.0	0.8	0.1	0.0	0.0	0.2	0.0	0.4	0.7	0.1	0.6	3.0	0.1	0.0	0.0	0.4	0.2	0.0	0.9	0.2	1.6	2.6	0.0	0.0	0.1	0.1	3.3	0.0	0.0	0.1	0.0	0.1	6.2	0.2	0.5	0.0	0.0	0.5	0.6	0.0	1.0	0.5	0.4	0.5	1.0	0.0	6.5	0.3	0.0	0.0	0.1	0.0	0.2	0.0	0.7	0.6	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.8	0.1	7.3	7.0	15.0	6.6	6.3	9.8	11.6	9.2	9.3	8.6	6.8	6.4	0.6	0.0	1.8	43.1	0.4	4.5	0.4	1.4	0.0	9.6	7.2	5.8	4.1	0.0	1.6	0.0	45.9	3.6	1.7	0.1	1.9	0.0	12.8	8.7	2.9	1.3	0.0	3.2	133.2	0.0	13.8	8.3	0.0	0.3	34.1	2.6	1.8	0.0	0.9	5.0	152.0	0.0	0.0	0.0	2.7	5.0	0.3	0.5	12.4	17.8	0.2	46.2	0.0	198.0	4.7	0.0	0.0	0.0	0.7	3.5	0.0	0.5	9.4	4.2	0.0	43.9	2.3	6.3	6.3	0.0	2.4	3.7	5.9	31.3	0.0	0.2
ST8SIA4	"PST, PST1, SIAT8D"	ENSG00000113532	"ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4"	Q92187	5	100806933-100903282	"Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 14.0"	"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 73.3;Kupffer cells: 92.4;Langerhans cells: 149.3;Microglial cells: 101.2;monocytes: 97.5;Plasma cells: 73.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 91.7"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 41.1;HDLM-2: 69.3;Karpas-707: 57.2;NB-4: 27.9;RPMI-8226: 44.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA051126, HPA053995"	Approved		Approved	"Golgi apparatus"	"Intracellular and membrane"	NA	NA		980000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"	"Golgi apparatus"		"HPA051126: AB_2681352, HPA053995: AB_2682336"	"unprognostic (2.25e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.45e-3)"	"unprognostic (1.91e-1)"	"unprognostic (5.46e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (7.80e-7)"	"unprognostic (6.07e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.23e-2)"	5.8	1.9	2.2	14.0	2.4	7.6	2.2	1.6	2.4	1.9	2.5	3.3	3.2	1.6	0.5	1.1	1.8	5.0	2.3	1.8	4.5	0.7	2.6	5.7	12.3	4.8	3.6	0.5	0.8	1.0	0.6	11.1	5.2	1.3	4.2	0.6	1.2	0.8	0.8	0.8	4.5	2.8	2.7	11.8	3.0	0.4	4.3	9.5	2.0	1.7	10.3	5.5	1.1	4.5	0.0	6.1	41.1	0.0	2.6	3.9	1.0	0.0	0.0	0.0	0.3	0.0	0.0	3.3	0.1	0.0	1.0	0.1	1.0	0.1	0.1	69.3	0.0	2.5	0.4	0.0	0.0	13.0	5.0	3.2	0.0	0.1	0.1	5.3	7.7	10.1	0.0	57.2	2.4	0.6	18.6	27.9	0.3	0.0	0.3	10.3	0.7	44.8	0.2	0.0	0.9	0.0	0.0	0.0	0.1	0.2	0.0	11.6	2.7	0.4	0.2	0.0	0.6	18.6	20.3	3.9	1.0	15.8	5.1	58.0	18.5	22.9	13.1	21.7	9.9	11.1	8.7	11.1	12.2	9.9	5.4	10.1	91.7	10.6	24.0	3.7	17.4	12.2	2.2	2.4	1.6	2.4	1.8	4.5	4.8	3.6	5.2	2.7	4.3	4.5	35.8	6.4	14.1	1.6	49.7	8.3	0.4	2.1	2.2	0.6	0.9	0.9	2.3	1.5	10.1	0.0	0.0	9.4	44.0	0.0	1.9	0.2	0.2	0.9	1.6	28.4	0.0	8.2	6.8	0.0	42.4	5.0	1.1	0.3	24.1	0.1	7.1	0.1	22.6	0.0	73.3	0.2	4.1	92.4	149.3	0.7	0.0	57.5	14.2	101.2	97.5	3.2	34.0	4.5	1.6	0.0	0.0	0.4	73.8	0.2	0.0	0.3	16.6	0.9	13.1	1.2	3.7	0.5	0.8	0.4	5.5	19.2	37.7	0.7	0.0	0.5
ST8SIA5	SIAT8E	ENSG00000101638	"ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5"	O15466	18	46667821-46759257	"Metabolic proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 12.2;brain: 17.0;parathyroid gland: 6.2"	"Group enriched"	"Detected in some"	5	"Excitatory neurons: 106.1;Inhibitory neurons: 75.5;Oligodendrocyte precursor cells: 32.2"	"Cancer enriched"	"Detected in single"	8	"glioma: 2.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"WM-115: 87.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043813, HPA046771"	Approved		Approved	"Plasma membrane,Midbody"		Yes	NA		24000		"Cluster 6: Brain - Smell perception"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Midbody"		"HPA043813: AB_2678683, HPA046771: AB_2679798"	"unprognostic (3.19e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.33e-4)"	"unprognostic (2.99e-2)"	"unprognostic (4.83e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.84e-2)"	"unprognostic (6.55e-2)"	"unprognostic (8.85e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.79e-2)"	0.1	12.2	4.0	0.0	12.9	0.2	0.0	17.0	11.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	3.1	6.2	0.0	1.0	0.0	0.0	0.0	0.4	0.1	0.1	0.0	6.2	0.5	0.0	1.4	0.1	0.0	0.7	0.0	0.0	2.7	0.1	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	7.7	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	5.1	4.2	0.2	0.0	0.1	9.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	8.3	0.0	87.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.0	12.9	17.0	11.4	6.2	0.0	0.4	0.1	1.4	0.0	0.0	7.7	0.1	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	3.4	0.1	0.0	7.8	0.0	0.0	1.8	0.0	0.0	0.0	0.1	1.9	0.0	3.1	0.0	0.1	0.2	0.0	0.0	106.1	0.0	0.0	0.2	0.0	0.0	0.0	12.9	0.0	0.0	0.1	0.0	75.5	0.2	0.0	0.0	0.0	7.3	0.0	0.0	0.0	3.7	0.0	1.1	0.0	32.2	9.1	0.1	0.0	0.4	0.0	0.2	0.0	0.1	0.2	0.6	0.0	0.6	0.2	0.8	0.1	0.0	0.0	0.0	0.0	7.7	0.0	0.1
STT3A	"ITM1, MGC9042, STT3-A, TMC"	ENSG00000134910	"STT3 oligosaccharyltransferase complex catalytic subunit A"	P46977	11	125591712-125625215	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"		"Glycosyltransferase, Transferase"	"Cancer-related genes, Congenital disorder of glycosylation, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 391.8"	"Cell type enhanced"	"Detected in all"		"Plasma cells: 91.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030735	Approved					NA	NA		23000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA030735: AB_10603342"	"unprognostic (8.25e-3)"	"unprognostic (5.45e-2)"	"unprognostic (3.02e-2)"	"prognostic favorable (1.32e-4)"	"unprognostic (5.10e-2)"	"unprognostic (1.72e-2)"	"prognostic unfavorable (3.57e-4)"	"unprognostic (8.40e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.16e-2)"	"unprognostic (8.96e-3)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (4.96e-4)"	"unprognostic (2.60e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.82e-2)"	38.5	39.2	14.6	44.6	17.7	31.8	55.8	17.9	16.9	84.9	29.8	54.0	42.2	60.8	140.4	30.2	56.3	39.5	38.5	15.0	20.1	45.8	69.0	39.0	32.9	19.4	18.4	68.0	69.0	391.8	29.0	63.8	19.6	56.2	59.5	40.0	80.1	77.2	18.4	31.6	42.1	58.9	17.5	34.4	51.4	44.5	17.5	34.8	83.9	24.4	48.8	50.4	33.3	23.1	113.1	99.5	123.7	173.6	230.1	176.4	133.8	198.5	238.5	158.6	196.6	304.2	294.3	143.6	236.2	297.3	222.4	202.7	173.5	176.2	208.5	114.8	90.0	341.0	63.7	215.1	254.4	208.4	153.6	138.4	125.8	219.5	424.5	186.1	182.2	63.9	147.1	210.6	205.4	82.7	84.4	65.6	78.6	221.8	106.0	98.9	107.1	221.5	173.7	170.1	77.5	66.2	142.9	229.3	72.5	144.9	267.8	148.1	164.5	227.7	82.0	97.6	159.7	66.3	82.4	109.6	87.4	206.3	184.7	96.2	46.7	36.6	56.1	45.4	77.9	42.8	53.7	52.0	65.2	32.1	37.1	44.4	15.7	52.8	41.8	158.3	44.0	47.5	14.6	17.7	17.9	16.9	15.0	20.1	19.4	18.4	19.6	17.5	17.5	23.1	17.4	28.9	25.0	6.8	20.8	16.2	14.3	40.3	12.5	11.6	15.2	9.8	23.3	27.1	29.1	16.5	20.9	45.4	21.7	16.1	1.9	30.1	10.6	22.9	51.0	17.3	15.6	19.6	7.6	27.2	73.4	33.0	26.0	57.0	17.1	29.0	32.2	38.5	30.7	1.7	8.9	37.3	20.3	23.6	31.9	5.4	21.5	17.3	24.9	9.4	12.6	13.2	11.3	11.6	10.9	28.6	12.2	18.8	91.9	19.3	15.6	13.6	23.6	15.1	19.7	23.1	32.8	33.5	13.1	21.9	14.8	45.6	14.6	22.3	26.9	13.9
STT3B	"FLJ90106, SIMP, STT3-B"	ENSG00000163527	"STT3 oligosaccharyltransferase complex catalytic subunit B"	Q8TCJ2	3	31532638-31637616	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 264.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036448, HPA036646"	Approved		Supported	"Endoplasmic reticulum"		NA	NA		17000	"Cluster 15: NK-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 25: Spermatids - Spermatogenesis"	"Endoplasmic reticulum"		"HPA036448: AB_2675129, HPA036646: AB_10673472"	"unprognostic (2.17e-2)"	"unprognostic (2.23e-1)"	"prognostic favorable (7.91e-5)"	"unprognostic (1.60e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.74e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.60e-1)"	"unprognostic (3.26e-3)"	"unprognostic (3.68e-2)"	"unprognostic (3.86e-2)"	"unprognostic (9.18e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.71e-3)"	"unprognostic (1.02e-1)"	42.8	59.9	21.1	52.2	29.5	63.7	57.1	23.3	27.0	62.1	30.9	59.7	47.9	51.8	90.3	44.8	45.3	60.2	49.4	22.6	30.7	49.6	74.8	49.3	59.9	24.3	23.1	105.5	45.7	76.6	24.8	60.3	23.9	56.3	61.4	38.6	49.9	51.3	62.1	44.7	49.1	57.7	25.4	44.2	55.1	94.3	26.1	71.8	80.7	57.8	58.8	56.6	32.1	27.6	77.9	128.0	115.4	121.7	142.0	142.3	249.7	142.3	124.9	104.2	119.9	117.7	164.5	134.0	67.8	130.0	85.8	63.9	108.1	123.5	135.9	377.1	70.2	115.0	120.7	126.4	109.4	252.0	131.1	109.8	129.7	148.8	186.7	160.7	107.1	168.3	62.8	209.6	144.0	44.4	246.8	154.8	92.9	129.6	70.7	252.3	62.6	196.0	122.0	110.7	48.7	59.4	141.3	207.2	84.5	98.3	93.4	132.8	209.3	139.8	88.6	139.7	127.3	129.0	166.4	111.4	126.9	170.0	117.6	2.1	3.3	6.2	3.1	3.9	5.0	2.4	5.6	4.4	2.9	2.7	5.3	4.3	1.2	6.1	2.9	5.5	3.0	2.0	21.1	29.5	23.3	27.0	22.6	30.7	24.3	23.1	23.9	25.4	26.1	27.6	32.1	86.6	57.7	34.6	69.6	68.1	58.4	34.1	74.6	51.0	57.2	29.5	71.1	54.3	76.0	44.1	68.8	67.3	65.3	41.8	13.7	34.1	162.8	25.0	65.9	42.0	45.1	50.9	61.5	45.3	100.5	49.6	45.3	43.5	31.1	43.6	37.9	68.2	54.8	45.4	59.4	57.5	36.7	58.0	76.0	264.9	36.4	71.5	51.6	53.4	49.1	34.2	56.7	60.3	73.3	36.5	50.0	32.7	144.2	74.1	50.5	31.5	42.2	37.4	26.3	39.0	53.3	90.9	55.2	65.0	61.8	95.4	78.3	68.4	66.1	69.4
TMPPE	FLJ45032	ENSG00000188167	"Transmembrane protein with metallophosphoesterase domain"	Q6ZT21	3	33090421-33097146	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 5.5"	"Cell type enhanced"	"Detected in some"		"Rod photoreceptor cells: 2.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 2.4"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in many"	6	"BEWO: 27.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027019	Approved		Approved	Nucleoplasm,Mitochondria		Yes	No			"Cluster 7: Monocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Mitochondria"		"HPA027019: AB_1848942"	"unprognostic (1.14e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.37e-1)"	"unprognostic (5.03e-2)"	"unprognostic (2.96e-2)"	"unprognostic (6.34e-3)"	"unprognostic (8.14e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.25e-3)"	"unprognostic (9.58e-2)"	"unprognostic (1.60e-7)"	"unprognostic (1.61e-1)"	"unprognostic (5.40e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.33e-2)"	0.6	0.5	0.8	1.4	0.7	5.5	0.6	0.7	1.2	0.6	4.3	1.0	1.2	0.5	0.6	0.6	0.9	0.6	0.4	1.5	0.5	1.0	0.6	1.1	1.1	1.4	1.4	0.6	0.7	1.9	0.3	1.2	1.6	0.5	1.2	2.8	0.7	0.6	0.2	1.1	1.1	0.8	0.2	1.5	1.3	0.3	1.7	0.5	1.0	0.3	1.3	0.8	0.4	0.2	1.4	1.9	1.0	1.7	1.2	1.0	27.2	0.6	1.0	1.6	0.9	2.7	3.8	0.8	1.2	1.7	0.9	1.4	1.7	1.5	2.6	4.2	0.6	3.4	1.9	2.1	0.9	3.0	4.7	1.1	1.2	2.0	1.4	0.8	1.9	1.7	2.6	2.9	1.2	1.3	1.2	1.3	1.0	0.4	1.1	1.5	0.6	1.9	1.5	1.9	0.2	0.6	0.9	2.6	0.6	1.3	1.4	4.2	2.7	2.4	3.0	1.3	2.6	2.3	1.6	0.4	3.0	2.2	1.7	0.0	1.1	0.3	0.1	2.4	0.6	0.3	0.2	0.0	1.0	0.1	0.0	0.0	1.9	0.0	1.1	0.2	0.2	0.4	0.8	0.7	0.7	1.2	1.5	0.5	1.4	1.4	1.6	0.2	1.7	0.2	0.3	0.0	1.3	0.0	0.8	0.8	0.1	0.0	0.0	1.2	0.4	0.4	0.4	0.0	0.2	0.0	0.0	1.1	1.9	1.4	0.0	0.4	0.0	0.8	0.6	0.4	0.0	0.4	0.0	0.8	1.7	0.3	0.0	1.1	0.0	0.4	0.4	0.6	0.9	1.7	0.0	0.2	2.0	1.3	1.2	0.0	0.0	1.1	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.5	1.4	0.4	1.0	0.2	1.4	0.3	0.4	2.2	0.0	0.2	0.7	0.0	0.0	1.5	0.9	0.4	0.6	0.5	0.6	0.2
UGCG	GCS	ENSG00000148154	"UDP-glucose ceramide glucosyltransferase"	Q16739	9	111896814-111935369	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters"	"Lipid biosynthesis, Lipid metabolism, Sphingolipid metabolism"	"Glycosyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 112.9"	"Cell type enhanced"	"Detected in all"		"Glandular and luminal cells: 294.5;Urothelial cells: 534.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	21	"plasmacytoid DC: 109.7"	"Lineage enriched"	"Detected in all"	21	"dendritic cells: 109.7"	"Cell line enhanced"	"Detected in all"		"LHCN-M2: 195.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024124	Approved					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 22: Epithelial cell types - Mixed function"			"HPA024124: AB_1858595"	"unprognostic (1.22e-2)"	"prognostic favorable (6.62e-4)"	"unprognostic (5.39e-2)"	"prognostic favorable (4.44e-5)"	"unprognostic (1.53e-2)"	"unprognostic (9.70e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.95e-2)"	"unprognostic (3.22e-1)"	"unprognostic (9.84e-3)"	"unprognostic (2.24e-2)"	"unprognostic (4.92e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.77e-2)"	39.1	65.6	9.5	34.6	9.6	112.9	25.2	11.1	10.9	23.1	10.4	20.5	23.8	16.3	7.3	40.8	15.7	42.6	14.4	9.7	13.1	29.7	32.5	33.7	41.8	11.0	12.4	12.0	16.6	5.5	12.5	27.6	10.3	13.8	17.8	12.2	14.1	7.7	9.0	32.8	31.7	21.4	10.2	35.5	47.9	7.9	11.6	20.5	9.9	7.7	46.8	72.3	28.5	13.7	93.4	9.8	15.7	10.5	33.2	39.7	8.3	57.0	59.7	65.3	87.9	19.8	70.0	21.9	44.1	38.0	142.9	46.6	18.4	24.7	69.6	8.9	10.7	8.9	14.3	9.8	23.7	9.8	13.8	39.6	18.9	62.4	89.1	151.0	20.3	10.8	49.4	41.5	195.7	15.9	10.7	10.9	17.9	31.4	10.1	12.4	111.5	7.1	151.0	35.2	7.6	12.0	25.3	21.1	66.1	92.2	113.6	10.1	96.6	30.0	15.2	84.8	41.1	7.7	30.3	10.2	37.0	6.1	41.6	0.1	0.3	0.2	1.2	0.7	2.0	4.2	2.2	1.6	1.9	5.3	2.0	2.0	1.2	1.4	1.0	109.7	3.6	1.4	9.5	9.6	11.1	10.9	9.7	13.1	11.0	12.4	10.3	10.2	11.6	13.7	128.0	41.7	51.1	17.6	66.6	75.7	151.6	90.6	76.8	29.8	71.8	37.8	11.8	47.1	130.7	29.5	62.6	7.3	262.4	69.8	17.6	108.2	20.6	125.0	83.4	116.1	18.5	26.5	40.4	50.6	12.8	64.6	121.8	294.5	10.8	18.3	90.7	20.6	21.4	18.5	41.9	55.1	36.7	34.0	109.2	5.9	49.0	49.1	58.7	24.4	44.4	8.4	9.2	25.1	12.8	72.2	65.1	38.4	33.3	216.6	42.6	77.2	143.9	16.5	13.1	153.2	74.9	1.8	8.7	99.7	122.2	3.4	41.4	30.5	22.1	534.7
UGGT1	"HUGT1, UGCGL1"	ENSG00000136731	"UDP-glucose glycoprotein glucosyltransferase 1"	Q9NYU2	2	128091200-128195677	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012761, HPA015127"	Enhanced		Uncertain	Cytosol		NA	NA		4000000	"Cluster 24: B-cells - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 52: Non-specific - Transcription"	Cytosol		"HPA012761: AB_1858597, HPA015127: AB_1858596"	"unprognostic (1.57e-1)"	"unprognostic (1.80e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.87e-1)"	"unprognostic (4.63e-2)"	"unprognostic (6.45e-2)"	"unprognostic (7.03e-3)"	"unprognostic (3.13e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.09e-3)"	"unprognostic (7.05e-2)"	"prognostic unfavorable (6.37e-4)"	"unprognostic (3.86e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.23e-2)"	"unprognostic (8.38e-3)"	8.1	8.5	4.2	13.7	4.6	21.8	7.6	4.8	6.5	9.1	5.0	12.4	9.0	7.3	19.9	8.0	6.5	6.5	8.0	4.3	4.6	8.2	14.9	8.4	12.3	4.7	4.4	5.1	14.8	8.7	6.5	8.7	5.0	8.7	10.0	9.7	8.6	6.2	13.2	8.8	10.2	6.2	4.0	9.4	10.7	6.4	4.8	11.7	10.4	13.0	12.6	7.5	6.6	5.6	34.8	11.8	22.0	47.6	28.0	22.3	34.3	39.4	16.7	12.7	11.3	26.0	24.9	49.4	15.4	28.3	11.3	25.3	16.8	16.8	25.5	31.5	8.2	43.4	14.9	82.3	28.0	58.6	25.9	16.3	13.0	25.4	23.0	25.0	29.8	19.8	28.4	25.6	26.9	24.4	23.5	33.5	39.5	24.0	12.4	19.2	21.3	20.9	23.8	25.2	11.7	17.4	27.3	36.0	24.4	22.5	14.4	40.2	43.1	34.6	24.4	20.1	28.4	27.3	40.4	22.3	29.3	31.4	32.6	3.8	2.5	2.5	2.3	2.5	2.3	1.6	1.9	2.1	1.9	3.3	1.6	2.3	3.7	1.9	2.5	3.1	1.6	1.4	4.2	4.6	4.8	6.5	4.3	4.6	4.7	4.4	5.0	4.0	4.8	5.6	14.6	35.3	24.7	24.8	14.3	8.2	6.4	11.1	5.7	19.8	11.2	7.1	16.7	12.8	20.7	3.7	22.9	10.5	22.1	21.5	1.9	14.0	9.2	18.4	27.7	16.5	22.8	31.5	40.6	19.5	20.1	16.6	21.9	22.2	11.4	20.8	17.9	39.7	16.6	20.2	37.6	21.9	8.2	25.4	16.4	2.3	14.9	20.0	14.2	32.8	26.0	7.5	15.5	31.2	46.5	19.4	10.4	13.5	31.5	13.3	25.3	8.4	12.7	20.2	6.6	18.5	13.3	10.0	8.5	9.4	10.7	10.8	18.9	16.0	22.8	10.1
UGGT2	"FLJ10873, FLJ11485, HUGT2, MGC117360, MGC150689, MGC87276, UGCGL2"	ENSG00000102595	"UDP-glucose glycoprotein glucosyltransferase 2"	Q9NYU1	13	95801580-96053482	"Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 112.0;Excitatory neurons: 215.1;Inhibitory neurons: 169.6;Oligodendrocyte precursor cells: 209.1;Oligodendrocytes: 207.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 5.9;eosinophil: 2.6;intermediate monocyte: 6.2;myeloid DC: 3.6;non-classical monocyte: 6.0"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA047955	Uncertain				"Intracellular and membrane"	NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA047955: AB_2680222"	"unprognostic (5.32e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.83e-1)"	"unprognostic (9.33e-2)"	"unprognostic (8.70e-2)"	"prognostic unfavorable (9.99e-4)"	"prognostic unfavorable (5.47e-4)"	"unprognostic (1.55e-1)"	"unprognostic (9.21e-2)"	"unprognostic (7.75e-3)"	"unprognostic (6.27e-2)"	"unprognostic (5.65e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.61e-2)"	11.8	6.9	5.1	5.1	6.3	3.8	9.3	1.1	9.1	8.2	6.3	6.9	5.4	10.3	16.0	4.0	7.8	6.0	8.7	5.7	4.3	7.5	8.3	6.7	3.0	3.6	2.9	7.8	10.7	7.6	8.8	11.2	3.5	7.4	6.2	7.8	8.0	7.3	4.0	4.8	4.6	10.0	2.8	3.8	7.8	12.0	3.5	1.2	11.4	4.3	2.6	8.2	6.0	8.1	20.3	9.6	19.8	10.2	32.5	34.4	16.0	32.5	25.2	15.6	26.6	14.6	17.2	7.0	11.8	22.0	11.4	12.4	7.0	7.0	22.9	0.2	8.6	9.0	19.1	9.6	19.0	25.4	20.9	20.6	7.4	5.9	18.7	28.8	14.2	0.1	5.8	11.5	22.1	6.0	0.2	10.9	8.4	15.1	5.8	0.1	14.4	10.5	13.6	19.4	4.1	15.3	18.6	18.4	13.2	26.9	16.4	12.1	23.1	15.7	10.2	17.6	17.1	16.1	8.3	8.8	40.9	13.3	21.2	0.4	5.9	2.6	0.1	6.2	0.0	1.2	0.1	0.1	3.6	0.4	0.1	0.1	0.4	1.1	6.0	0.3	0.0	1.9	5.1	6.3	1.1	9.1	5.7	4.3	3.6	2.9	3.5	2.8	3.5	8.1	22.2	16.0	19.9	112.0	3.9	4.0	10.3	10.6	10.2	19.5	11.0	13.1	13.1	7.2	16.3	14.7	31.3	18.3	0.5	5.8	0.0	13.9	44.7	13.2	34.3	17.7	4.8	7.8	215.1	18.9	17.3	32.4	12.2	20.9	18.3	22.4	12.8	8.6	7.5	18.5	169.6	7.1	8.2	7.1	11.9	15.4	22.1	8.5	3.6	76.8	6.8	11.8	0.0	209.1	207.3	18.6	5.2	16.6	9.8	9.9	4.0	5.6	15.1	17.1	32.9	28.2	32.3	38.1	26.3	8.0	3.1	13.8	1.6	19.5	7.8	7.5